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ABSTRACT 
Title: Prevalence of diabetes and depression, and their association: a population-based study 
in Northeastern Brazil. 
Background: Diabetes and depression are common and rapidly increasing non-
communicable diseases throughout the world. Currently, about 382 million people have 
diabetes worldwide, while depression affects approximately 350 million people. Some studies 
have found a frequent co-existence of depression, hyperglycemia, diabetes and diabetes-
related complications. Moreover, comorbid depression in diabetes has been associated with 
poorer adherence to diabetes treatment regimens, increased risk of work loss and functional 
disability, increased mortality rates, higher health care costs, and decreased quality of life. 
Although the association between these two conditions has been found by several, the 
transcultural validity of these findings still needs to be demonstrated. 
Objectives: The main objectives of the study were to investigate the prevalence of type 2 
diabetes and depression, and the association between depressive symptoms and newly 
diagnosed diabetes in Northeastern Brazil. In addition, we wanted to investigate the 
agreement between two different types of depression scales: the Montgomery-Åsberg 
Depression Rating Scale (MADRS) and the Hamilton Depression Rating Scale (HDRS).  
Methods: The prevalence of diabetes was assessed in the Northeast region of Brazil in a 
randomized population-based survey following the WHO criteria of 1999. Seven hundred and 
fourteen subjects participated in the study. Depression was assessed by MADRS and HDRS, 
before the diagnosis of diabetes was made known to the participants and investigators. Socio-
demographic and economic information, as well as anthropometric measures were collected. 
Results: A high prevalence of diabetes was found (Total 16%; Male 13.2% and Female 
17.4%). Following MADRS, the rate of depression was 15% (Male 7% and Female 19.1%). 
According to HDRS, the rate of depression was 15.5% (Male 8.3% and female 19.3%). The 
agreement between MADRS and HDRS was found to be excellent (Kappa of 0.913, p < 
0.001). Depression was the second strongest risk indicator for the occurrence of diabetes after 
controlling for potential confounding fators. 
Conclusions: We found a high prevalence of both diabetes and depression in this population. 
Depression was a strong independent risk indicator for the occurrence of diabetes. An inverse 
significant association between diabetes and the risk for developing depressive symptoms 
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was also observed. The results may indicate that the treatment of depression should be 
included both for prevention and treatment of diabetes.  
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1.1   COUNTRY PROFILE 
 The Federative Republic of Brazil is by far the largest and most populous country in 
South America. Initially inhabited by indigenous people, Brazil was officially discovered by 
the Portuguese in 1500. After more than three centuries of Portuguese dominance, Brazil 
became an independent country in 1822, maintaining a monarchical system of government 
until 1889, when the monarchy was ousted and a republic established by the military. 
Throughout the next century, the country alternated between short periods of elected 
government and long periods of authoritarian rule. Finally in 1985, the ruling military 
dictatorship peacefully relinquished power, and today Brazil is a stable democracy (1).  
 A brief overview of the country will be provided in the following paragraphs. 
1.1.1   Geography 
          Figure 1.1: Map of Brazil 
 
 Located in eastern South America along the Atlantic Ocean, Brazil is the fifth largest 
country in the world, and the third largest in the Americas. It shares borders with every 
country in South America, except for Ecuador and Chile. Brazil is officially divided into five 
regions (North, Northeast, Center-West, Southeast and South), and is composed of 26 states 
and 1 federal district, the capital, Brasília. Geographically diverse, Brazil has a wide range of 
weather conditions, topographies and natural resources (2, 3). 
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1.1.2   People and Demography 
 According to the Brazilian Institute of Geography and Statistics (IBGE), the 
population of Brazil was approximately 191 million in 2010 (unofficial sources have 
estimated that the population in 2014 surpassed 200 million), with a sex ratio of 0.95 
male/female and about 84.3% of the total population living in urban areas. The Brazilians are 
mainly concentrated in the Southeastern (around 80 million inhabitants) and Northeastern (53 
million inhabitants) regions, whereas the two largest regions, the Center-West and the North, 
that together constitute 64.1% of the total territory, have only 29.1 million people (4).  
As a consequence of five centuries of miscegenation between European colonizers 
(mainly Portuguese), slaves from Africa, and autochthonous Amerindians, the Brazilians 
compose one of the most heterogeneous societies in the world. Despite criticism, IBGE 
classifies the different ethnic groups in Brazil according to the self-perception of the skin 
color. Thus, as reported by the 2010 Demographic Census, about 47.7% of the population 
described themselves as White, 43.1% as Brown (mixed white and black - pardo in 
Portuguese), 7.6% as Black, 1.1% as Yellow (Asian), and 0.4% as Amerindian (officially 
called indígena, that is indigenous). Although some minority languages are used throughout 
the country (Amerindian languages and other languages spoken by immigrants and their 
descendants), Brazil's official language is Portuguese, which is spoken by almost all 
Brazilians and is virtually the only one used in mass communication channels (3, 4). 
The Brazilian demographic transition began in the mid-1950s. However, it was only 
during the past decades that it became an issue of greater interest. Recently, Brazil has 
experienced steady declines in fertility (total fertility rate in 1960 was 6.3 children 
born/woman, compared to 1.81 in 2013), substantial reductions in population 
growth rate (2.99% in the period 1950/1960, compared to 1.17% in 2000/2010), 
and an age pyramid weighted more towards adults and elderly (between 2002 and 2012, 
the population aged under 25 decreased from 47.4% to 39.6%, while the population 
group aged over 45 increased from 23% to 29%) (5, 6). Like in other capitalist countries, 
the Brazilian ongoing demographic transition has been directly related to the 
processes of industrialization and urbanization. The adoption of an agricultural 
production model, characterized by wealth concentration and low demand of labor force, had 
an important effect on the demographic dynamics, by continuously compelling agricultural 
workers to leave the countryside towards the cities. Additionally, the increases of per 
12 
 
capita income and education levels of the population have also been indicated as 
crucial elements to explain the Brazilian demographic transition. Many studies 
have pointed out that birth rates are inversely associated with both income and 
education, two indicators that have shown significant progress in the country, 
especially more recently (6).  
1.1.3   Education 
 Education is regarded as a universal right and government funded. In 2010, 
approximately 5.8% of the Gross Domestic Product (GDP) was spent on education (3). Data 
from the National Households Sample Survey have shown that between 1992 and 2009 the 
average schooling levels among the Brazilian population raised from 5.8 years to 8.2 years of 
study (6). In 2008, approximately 95% of children and adolescents aged 7–17 years were 
enrolled in school (7). Although there has been an increase in school access, primary and 
secondary public education is still very deficient, and those who can afford it prefer private 
schools. According to the 2010 Brazilian Demographic Census, the literacy rate for the total 
population, defined as the percentage of those aged 15 and older who are able to read and 
write, was 90.4% (90.1% among males and 90.7% among females). However, among those 
aged 65 and over, about 29.4% are illiterate. The highest rates of illiteracy are found in the 
Northeast region (19.1% in 2010), and the lowest rates in the South (5.1%) (4). 
1.1.4   Economy 
 Recently, Brazil has appeared in the international arena as one of the emerging 
economies that constitute a new group of countries (the BRICS, formed by Brazil, Russia, 
India, China and South Africa). According to the International Monetary Fund and the World 
Bank, Brazil is the largest economy in South America, and the seventh largest in the world in 
purchasing power parity (PPP) and in terms of market exchange rates. In 2014, Brazil’s GDP 
per capita (PPP) was estimated as $12,528, ranking the country in the 77th position (8). In 
addition to presenting large and well-developed agricultural, mining, manufacturing, and 
service sectors, Brazil has been expanding its participation in the international markets and 
firmly improving its macroeconomic stability. In 2010, GDP growth rate reached 7.5% (the 
highest growth rate in the past 25 years), nevertheless rising inflation and the deteriorating 
international economic picture have slowed growth in 2011-2014. Currently, unemployment 
is at historic lows (unemployment rate is around 5.7%), although 21.4% of the population is 
still below the poverty line (which represents around 40 million people). Despite some 
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improvements, Brazil’s fiscal and current account balances have eroded during the past three 
years, since the government has attempted to boost economic growth through targeted tax 
cuts for industry and incentives to spur household consumption. The level of poverty and 
income inequality remain high (Brazil is one of the world's leaders in terms of income 
inequality) and disproportionately affect the Northeast, North, and Center-West, women, and 
some ethnic groups (black, brown, and indigenous populations). Moreover, disparities in 
opportunities promote social exclusion and contribute to high rates of crime in the country (3).  
1.1.5   Government and Politics 
The government of Brazil is a federal republic, with a presidential system. Five 
fundamental principles constitute the basis of the Brazilian Federation: “sovereignty, 
citizenship, dignity of human beings, the social values of labor and freedom of enterprise, 
and political pluralism”. During most of its democratic history, Brazil has had a multi-party 
system, with proportional representation in the Congress. The president is both chief of state 
and head of government and is elected for a four-year period (re-election for a second term is 
also possible) (9). Dilma Rousseff is the current president (since 2011), and was the first 
woman to be elected president in Brazil.  
1.1.6   Health Profile 
 During the past decades, mainly due to the progress in social determinants of health 
and establishment of a comprehensive national health system in 1989, Brazil has experienced 
important improvements in health status and life expectancy. Nevertheless, as a consequence 
of urbanization and social and environmental change, new health problems have emerged, 
while some old health issues still remain unabated (7). 
 Over the past forty years, life expectancy at birth has increased by more than 6 months 
per calendar year (in 1960, it was about 54.5 years; while in 2009 was 72.9 years). 
Underweight prevalence in children younger than 5 years has been reduced (from 5.6% in 
1989, to 2.2% in 2006–07), and the under-5 mortality has been falling by 4.8% a year since 
1990. Although maternal mortality trends have been difficult to measure with precision due 
to better reporting, modeled estimates have indicated an annual rate of decline of 
approximately 4%. Despite of those improvements, illegal abortions remain highly prevalent, 
along with increasing rates of preterm deliveries and over-medicalisation of child-birth 
(caesarean section rates are the highest in the world) (7).  
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 It is noteworthy to mention that Brazil has shown striking or partial progress against 
the majority of infectious diseases (almost complete eradication of some vaccine-preventable 
diseases (polio, measles, and diphtheria), diarrhoea, and Chagas’ disease; partial success in 
control of malaria, hepatitis A and B, tuberculosis and schistosomiasis; and low prevalence of 
HIV (<0.5%), which has been stable since 2000). However, the efforts to control dengue 
fever and visceral leishmaniasis have repeatedly failed. Increased deforestation and 
population mobility have expanded areas of transmission for some endemic diseases (e.g., 
yellow fever), and caused previously rural diseases to appear in urban areas (e.g., visceral 
leishmaniasis and leprosy). Additionally, environmental changes have been associated with 
emergence of new infectious diseases (e.g., Brazilian haemorrhagic fever and hantaviruses) 
(7). 
 Concomitant with falling smoking rates, mortality rates due to chronic diseases have 
decreased by 20% from 1996 and 2007, largely due to reductions in cardiovascular and 
chronic respiratory diseases. Nevertheless, hypertension, obesity, diabetes, and cancers have 
increased, and neuropsychiatric disorders are now the most important contributor to disease 
burden. Although homicides and traffic-related injuries / deaths have shown a slight decline, 
they still remain at epidemic levels (7). 
 Since 1989, all Brazilians have been entitled to free health care at primary, secondary, 
and tertiary level through a national health system, called the Unified Health System (SUS - 
Sistema Único de Saúde), funded by taxes and social contributions. With the establishment of 
the SUS, the access to primary health care through the Family Health Strategy has been 
increasing throughout the country. This change has caused recorded effects on infant, and 
possibly adult mortality, as well as reductions in unnecessary hospital admissions. A 2008 
survey showed that 93% of those who sought health care were able to obtain it. Several 
intervention strategies for maternal and child health are now being delivered through the 
primary health care structure rather than as independent vertical programs, with almost 
universal coverage (7).  
 With respect to human resources for health, in 2007, only 1.7 doctors, 0.9 nurses, and 
1.2 dentists were available per 1000 population. In order to increase the number of doctors, 
nurses, dentists, as well as public-health professionals and auxiliary health personnel, the 
Brazilian ministries of health and education have been investing heavily in new training 
programs. Even though currently health workers already represent about 10% of the Brazilian 
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workforce, many challenges remain, such as: uneven regional distribution of qualified 
personnel, high turnover, lack of structured careers, and major salary differences between 
regions, states, and municipalities (7). 
1.2   BACKGROUND 
1.2.1   Non-Communicable Diseases (NCDs) 
 Non-communicable or chronic diseases can be described as diseases that present a 
long duration and usually a slow progression (10). This group of diseases, which include 
cardiovascular diseases (CVDs), cancers, chronic respiratory diseases, neuropsychiatric 
disorders and diabetes, has become a major global health problem and a relevant threat to 
human health and development (11). 
NCDs are the leading cause of death worldwide, with a remarkably greater impact on 
the world’s low- and middle-income populations. According to the World Health 
Organization (WHO), NCDs caused 63% of all deaths globally in 2008 (about 36 million 
deaths), and nearly 80% of those, particularly premature deaths, occurred in low- and middle-
income countries (LMICs). Moreover, the total number of deaths from NCDs is projected to 
rise globally by 15% between 2010 and 2020, and the greatest increase is expected to be 
observed in LMICs (11). Concerning the global burden of disease, relevant increases in 
disability-adjusted life years (DALYs) have been expected to occur among many of the 
leading NCDs. For instance, DALYs attributable to cardiovascular diseases have been 
projected to rise from 11.1% in 1990 to 14.7% in 2020, whereas those due to neurological, 
mental, and substance use disorders, to rise from 10.5% to 14.7% in the same period (12). 
 In Brazil, a large middle-income country, NCDs have also become the main sources 
of morbidity and mortality. In 2007, 72% of all deaths were due to NCDs (CVDs, chronic 
respiratory diseases, diabetes, cancer, and others, including renal diseases), and only 10% to 
infectious or parasitic diseases. This figure contrasts with that found in 1930, when about 46% 
of all deaths were attributed to infectious diseases (13). According to a study published in 
2004 concerning the disease burden in Brazil, NCDs have been responsible for 66% DALYs; 
while infectious, maternal, perinatal disorders and nutritional deficiencies have accounted for 
24%; and external causes for 10% (14). Among the NCDs, neuropsychiatric disorders 
(including depression, psychoses and disorders attributed to alcohol misuse) are the single 
largest contributor to the disease burden in the country. In addition, the occurrence of 
hypertension and diabetes has been facing important increases as well as that of obesity (13). 
  To a large extent, NCDs are caused by 
harmful use of alcohol, unhealthy diets and insufficient physical activity),
pervasive features of rapid unplanned urbanization,
lifestyles. Reflecting the underlying socioeconomic determinants
risk factors falls increasingly on the most disadvantaged and vulnerable populations in the 
developing world. Poverty exposes people to
resulting NCDs and their signif
and income push vulnerable individuals deeper into the poverty cycle. In many LM
detection of NCDs has been done late, when most of the patients already require expensive 
hospital care for complications or acute events. Due to the high household spending 
diseases and their risk factors, less money becomes available for
shelter (Figure 1.2) (11). 
Figure 1.2: Poverty and NCDs C
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growing epidemic of NCDs and its devastating socioeconomic consequences have caused a 
profound negative effect on the progress towards sustainable development goals. Therefore, 
in the absence of urgent and sustained action, the impact of NCDs will continue to rise and 
the goal of reducing poverty in the world will be significantly undermined (11). 
On the positive side, strong evidence has shown that cost-effective, population-wide 
and individual interventions exist and can be successfully implemented in a wide range of 
resource settings. Through the reduction of the above mentioned risk factors, as well as 
through the control of other underlying metabolic / physiological factors (such as 
hypertension, obesity, dyslipidemia, and impaired glucose metabolism), NCDs can be largely 
prevented. Further strengthening of health systems to provide appropriate and cost-effective 
services, making possible an early detection and timely treatment of NCDs, is another 
important approach for reducing their impact. Nevertheless, adequate political commitment 
and full engagement of non-health sectors and key stakeholders are also essential in the 
promotion of stronger and more focused international and national responses to fight the 
NCDs epidemic (11).  
 
1.2.2   Diabetes Mellitus (DM) 
 
1.2.2.1   Definition, Classification and Diagnosis of DM 
 According to the WHO, DM can be defined as a heterogeneous metabolic disorder 
characterized by chronic hyperglycemia with abnormalities of carbohydrate, protein and fat 
metabolism. It results from defects in insulin secretion, insulin action, or both (15). 
 As reported by the American Diabetes Association (ADA), the classification of DM 
can be stated as follows (16): 
• Type 1 Diabetes: accounts for 5-10% of the cases, and results from the destruction 
of the β-cells of the pancreas, which usually leads to absolute insulin deficiency. 
• Type 2 Diabetes: responsible for ~90-95% of those with diabetes, and 
encompasses individuals with insulin resistance and usually relative, rather than 
absolute, insulin deficiency; 
• Other specific types: genetic defects of β-cell function, genetic defects in insulin 
action, endocrinopathies, diseases of the exocrine pancreas, etc; 
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• Gestational Diabetes Mellitus (GDM): any degree of glucose intolerance that was 
initiated or first recognized during pregnancy. 
Based on new knowledge generated from research and clinical practice, the 
recommendations for the diagnosis of DM have been changing over the years, concerning 
both the cutoff points and tests to be used. For decades, the diagnostic criteria of diabetes 
mellitus have mostly relied on glucose measurements, either by the Fasting Plasma Glucose 
(FPG) levels or the 2-h values in the 75-g Oral Glucose Tolerance Test (OGTT). 
Nevertheless, after extensive review of established and emerging evidence, the use of 
Glycated Haemoglobin (HbA1c) in the diagnosis of diabetes has been recommended by the 
WHO, ADA, and other international organizations (16).  
According to the ADA, there are now four possible ways to diagnose diabetes (16): 
1. A1C ≥ 6.5%. The test should be performed in a laboratory using a method that is 
National Glycohemoglobin Standardization Program (NGSP) certified and 
standardized to the Diabetes Control and Complications Trial (DCCT) assay.* 
OR 
2. FPG ≥ 126 mg/dl (7.0 mmol/l). Fasting is defined as no caloric intake for at least 
8h.* 
OR 
3. 2-h plasma glucose ≥ 200 mg/dl (11.1 mmol/l) during an OGTT. The test should 
be performed as described by the WHO, using a glucose load containing the 
equivalent of 75 g anhydrous glucose dissolved in water.*  
OR 
4. In a patient with classic symptoms of hyperglycemia (such as polyuria, polydipsia, 
weight loss, sometimes with polyphagia, and blurred vision) or hyperglycemic 
crisis, a random plasma glucose ≥ 200 mg/dl (11.1 mmol/l). 
*In the absence of unequivocal hyperglycemia, criteria 1-3 should be confirmed by repeat testing, on a subsequent day. 
Additionally, as reported by the ADA (concerning individuals whose glucose levels 
do not meet criteria for DM, but present higher levels than those considered normal), the 
classification of the intermediate states of abnormal glucose regulation can be done as 
follows (17): 
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Table 1.1: Classification of Glucose Tolerance States according to the ADA 
State FPG level, 
mg/dl (mmol/l) 
2-h Plasma Glucose in 
OGTT, mg/dl (mmol/l)* 
Impaired Fasting Glucose (IFG) 100–125 (5.6–6.9) < 200 (< 11.1) 
Isolated IFG 100–125 (5.6–6.9) < 140 (< 7.8) 
Impaired Glucose Tolerance (IGT) < 126 (< 7.0) 140–199 (7.8–11.0) 
Isolated IGT < 100 (< 5.6) 140–199 (7.8–11.0) 
Combined IFG/IGT 100–125 (5.6–6.9) 140–199 (7.8–11.0) 
Normal Gucose Tolerance (NGT) < 100 (< 5.6) < 140 (< 7.8) 
*Standard 75-g OGTT. 
 
Of note, some studies have shown that, compared to the fasting glucose cutoff point 
of 100mg/dl (5.6mmo/l), an HbA1c cutoff point of 5.7% has a lower sensitivity but higher 
specificity as well as a higher positive predictive value to identify individuals at risk for 
future development of diabetes. Thus, an HbA1c range of 5.7 to 6.4% has been suggested to 
identify those with an increased risk for diabetes, and for CVDs (16). 
On the other hand, according to the WHO, the values for the diagnosis of DM and 
other categories of hyperglycaemia are (18):  
Table 1.2: Diagnosis of DM and other Categories of Hyperglycaemia (WHO Criteria) 
 Glucose Concentration, mmol/l (mg/dl)* 
Whole Blood Plasma 
DM 
Fasting 
or 
2-h post glucose load** 
or both 
Venous 
≥ 6.1 (≥ 110) 
 
≥ 10.0 (≥ 180) 
 
Capillary 
≥ 6.1 (≥ 110) 
 
≥ 11.1 (≥ 200) 
Venous 
≥ 7.0 (≥ 126) 
 
≥ 11.1 (≥ 200) 
Capillary 
≥ 7.0 (≥ 126) 
 
≥ 12.2 (≥ 220) 
IGT 
Fasting (if measured) 
and 
2-h post glucose load** 
 
< 6.1 (< 110) 
 
 
≥ 6.7 (≥ 120) and  
< 10.0 (< 180) 
 
< 6.1 (< 110) 
 
 
≥ 7.8 (≥ 140) and 
< 11.1 (< 200) 
 
< 7.0 (< 126) 
 
 
≥ 7.8 (≥ 140) and 
< 11.1 (< 200) 
 
< 7.0 (< 126) 
 
 
≥ 8.9 (≥ 160) and  
< 12.2 (< 220) 
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IFG 
Fasting 
 
and (if measured) 
2-h post glucose load** 
 
≥ 5.6 (≥ 100) and 
< 6.1 (< 110) 
 
< 6.7 (< 120) 
 
≥ 5.6 (≥ 100) and 
< 6.1 (< 110) 
 
< 7.8 (< 140) 
 
≥ 6.1 (≥ 110) and 
< 7.0 (< 126) 
 
< 7.8 (< 140) 
 
≥ 6.1 (≥ 110) and 
< 7.0 (< 126) 
 
< 8.9 (< 160) 
* "For epidemiological or population screening purposes, the fasting or 2-h value after 75 g oral glucose may be used alone. For clinical 
purposes, the diagnosis of diabetes should always be confirmed by repeating the test on another day unless there is unequivocal 
hyperglycaemia with acute metabolic decompensation or obvious symptoms". 
** "If 2–h plasma glucose is not measured, status is uncertain as diabetes or IGT cannot be excluded" (19). 
  
  
 In a report published in 2011, the WHO also states that HbA1c can be used as a 
diagnostic test for diabetes. A value of 6.5% was recommended as the cut point for 
diagnosing DM. However, an HbA1c less than 6.5% does not exclude DM diagnosed using 
glucose tests (20). 
 
1.2.2.2   Prevalence and Trends of DM Worldwide and in Brazil 
 
Costly and burdensome, diabetes is now a huge-scale pandemic and one of the most 
challenging public health problems in the 21st century. Poorly managed diabetes is associated 
with dysfunction and failure of several organs (specially the eyes, nerves, kidneys, heart, and 
blood vessels), which can cause disability, decreased quality of life, and reduced longevity. 
Dramatic increases in the incidence and prevalence rates of diabetes, particularly type 2 
diabetes mellitus (T2DM), have taken place in the past decades worldwide, along with 
growing numbers of premature deaths. Previously considered "a disease of the wealthy", 
developing countries are now facing a firestorm of diabetes and its disabling and life-
threatening complications, following demographic ageing, and profound environmental, 
lifestyle and occupational changes. Currently, approximately 80% of the 382 million people 
with diabetes in the world live in LMICs. It has been estimated that this number of people 
with diabetes will increase by 55% by the year 2035, and the greatest growth will be 
observed in the developing nations. Additionally, impaired glucose tolerance (IGT) - early 
metabolic abnormality preceding diabetes, that greatly increases the risk of developing 
T2DM and is also linked with the occurrence of CVDs - has also become a major public 
health problem, with projections for further rises (Figure 1.3) (21). 
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Figure 1.3: Global Prevalence and Projections of Diabetes and IGT  
 
According to the International Diabetes Federation (IDF), in South and Central 
America, about 8% of the adult population (24.1 million people) have diabetes, while 7.4% 
(22.4 million) have IGT. By the year 2035, it has been expected that the number of people 
with diabetes in the region will rise by nearly 60%, to almost 38.5 million (21).  
 In Brazil, a large population-based survey (known as the Brazilian Multicenter Study) 
conducted on a representative sample (n = 21,847)  of the urban population aged 30 to 69 
years in nine large cities between 1986 and 1988, showed that the prevalence of DM was 7.6 
and that of impaired glucose tolerance 7.8%, without significant differences between genders. 
However, the DM prevalence in the 60-69-yr age-group was 17.4% (22). More recently, 
between 1996 and 1997, another cross-sectional study conducted in Southeastern Brazil 
found that the overall rates of diabetes and impaired glucose tolerance were 12.1 and 7.7%, 
respectively, while the rates for the 60-69 year age group were 21.7% and 11.3%, 
respectively (23).  
 Currently, according to the IDF, Brazil has an overall estimated diabetes prevalence of 
9%, and it is the country in the South and Central America region with the highest number of 
people with the disease (11.9 million), followed by Colombia (2.1 million) and Argentina 
(1.6 million). It has also been projected that by the year 2035 there will be 19.2 million 
Brazilians with diabetes, which will rank Brazil in 4th place among the countries with the 
highest numbers of people with diabetes in the world (21). 
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1.2.2.3   Associated Factors for DM 
 Although the specific etiologies of type 2 diabetes still remain uncertain, the condition 
is thought to be developed from an interaction between lifestyle and genetic factors. It has 
been shown that the activation of genes that predispose an individual to diabetes requires the 
presence of behavioral and environmental factors. It is interesting to note that the most 
significant increases in T2DM have taken place precisely among populations in which rapid 
and major lifestyle changes have occurred. According to the IDF, the risk factors for T2DM 
can be classified as non-modifiable and modifiable as stated below (24): 
• Non-modifiable Risk Factors: 
- Genetic Factors: The genetics of type 2 diabetes is complex and not clearly defined 
(16). Studies have found that some ethnic groups present a significant higher 
prevalence of T2DM compared to others, when exposed to similar environments (for 
instance, indigenous populations in North America, Pacific Islanders, Australian 
Aborigines, people of Asian and African origin, etc) (24). Additionally, it has been 
shown that individuals with a family history of T2DM are at a higher risk of 
developing the disease, even though identifying genetic variants that can explain such 
excess risk has been a challenge (25). 
- Age: Although the prevalence of T2DM increases remarkably with older age, its 
occurrence has risen in children and adolescents in recent years (21). 
- History of GDM: Despite glucose tolerance usually returning to normal after the 
delivery, women who have had GDM are at a greater risk of developing T2DM later 
in life as well as developing GDM in subsequent pregnancies. Their babies also 
present a higher lifetime risk of obesity and developing T2DM (21). 
- Polycystic Ovary Syndrome (PCOS): Women with PCOS have been found to be 
insulin resistant, have defects in insulin secretion, and be at a higher risk of IGT and 
T2DM (26). 
• Modifiable Risk Factors: 
- Overweight and Obesity: Several studies have shown that obesity is the most 
important risk factor for T2DM. Interventions targeted to decrease obesity have also 
reduced T2DM incidence. The prevalence of overweight and obesity are increasing 
dramatically worldwide, not only among adults but also among children and 
adolescents. According to the 2008 WHO estimates, more than half a billion adults 
were obese worldwide, with the highest prevalence rates found in the Americas. In 
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Brazil, about 51.7% and 18.8% of the population were overweight and obese 
respectively (11, 24, 27). 
- Physical Inactivity: Both cross-sectional and longitudinal studies have shown that 
physical inactivity is an independent predictor of T2DM. Considering the same levels 
of obesity, more physically active individuals have a lower incidence of T2DM (24). 
Although the rates of insufficient physical activity are highest in high-income nations, 
considerable levels have also been seen in some middle-income countries (11). In a 
nationwide survey conducted in 1996 in Brazil, only 3.3% of the adults reported 
doing 30 minutes of leisure-time physical activity, at least 5 days a week (13). 
- Nutritional Factors: It has been suggested that a high total calorie and low dietary 
fiber intake, a high glycemic load and a low polyunsaturated to saturated fat ratio may 
contribute to the development of T2DM (24). Although repeated national surveys of 
dietary patterns have not been conducted in Brazil, data from 4 representative surveys 
of family food expenditure conducted from the mid-1970s to the mid-2000s have 
indicated a decrease in the purchase of traditional food items (rice, beans and 
vegetables), and a great rise (around 400%) in the purchase of processed foods 
(processed meat, cookies, soft drinks, etc) (13). 
- Previously identified glucose intolerance (IGT and/or IFG): As previously mentioned, 
people with IGT and/or IFG are at high risk of developing T2DM. Nevertheless, 
healthy diet and physical exercise have been documented to be effective in preventing 
the progression to diabetes (21). 
- Metabolic Syndrome (MS): Over the past decades, a dramatic increase in the number 
of people with MS has occurred globally. Although several definitions have been 
issued to identify individuals with MS, those most widely used share some core 
characteristics: glucose intolerance, central obesity, insulin resistance, dyslipidemia 
(decreased high-density lipoprotein cholesterol - HDL-c -, increased triglycerides - 
TG -), and hypertension (all well documented risk factors for CVDs). It has been 
indicated that the risk for T2DM in the MS is high, ranging between three- and 20-
fold (28). 
- Intrauterine environment: It has been indicated that intrauterine exposure to diabetes 
per se conveys a high risk for diabetes and obesity in the offspring that is above any 
genetically transmitted susceptibility (29). It has also been hypothesized that poor 
fetal and early post-natal nutrition may be detrimental to the development and 
function of the endocrine pancreas, predisposing the individual to the occurrence of 
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T2DM later in life (30). Although some authors have suggested that an inverse linear 
relation exists between birth weight (BW) and risk for T2DM, a recent meta-analysis 
has indicated that such relation is U-shaped and not linearly inverse, meaning that not 
only low BW (as previously thought), but also high BW are associated with later-life 
increased risk of diabetes (31). 
- Inflammation: In the past years, it has been found that chronic low-grade 
inflammation (increased levels of cytokines such as C-reactive protein - CRP - , tumor 
necrosis factor α -TNF-α, etc) plays an important role in the development of T2DM 
(32).  
1.2.3   Depression 
 
1.2.3.1   Definition, Etiology / Pathophysiology, Classification of Mood Disorders and 
Diagnosis of Depression 
 
 The general term "depression" can be used in a number of different ways. It may refer 
to a state of mood, a symptom manifesting itself in many different mental disorders, a 
syndrome or a clinical diagnosis (33). Commonly, depression or more specifically major 
depression or unipolar depression can be described as a heterogeneous mood disorder 
characterized by depressed mood, loss of interest or pleasure, thoughts of death and suicide, 
fatigue and loss of energy, poor concentration, feelings of guilt or low self-worth, and 
disturbed sleep or appetite. Moreover, depression is often accompanied by symptoms of 
anxiety, and may present a highly variable course, as well as an inconsistent response to 
treatment (34, 35). It has been postulated that approximately one third of the risk for the 
development of depression is inherited and two thirds is environmental (36). Furthermore, 
studies have shown that depression occurs as a result of complex interactions between social, 
psychological and biological factors. Life situations, thoughts, emotions, physical state and 
actions have been identified as major factors that contribute to the development and 
maintenance of depressive symptoms (Figure 1.4), while depression can, in turn, lead to more 
stress and dysfunction and worsen the life situation of the affected individual (37, 38).   
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Figure 1.4: Depression and the Complex Interactions with Social, Psychological and 
Biological Factors  
 
  
 For many years, psychiatrists and neuroscientists have attempted to better elucidate 
the biology of depression. Despite its complexity and heterogeneity, substantial progress has 
been made in our understanding of its underlying pathophysiology (39). There are many 
theories that seek to identify a biochemical origin of depression. Among them, the 
Monoamine Hypothesis (Monoamines are neurotransmitters and neuromodulators, including 
serotonin, dopamine, norepinephrine, and epinephrine), despite its multiple limitations, has 
been considered one of the most prominent and widely researched. According to this 
hypothesis, a deficiency of certain neurotransmitters in the brain (i.e., dopamine, 
norepinephrine, and seretonin) is responsible for the corresponding features of depression 
(40). Additionally, hormone levels and the stress response have also been investigated in 
depressed individuals. One of the most enduring and reproducible findings in biological 
psychiatry is the hyperactivity of the Hypothalamic-Pituitary-Adrenal (HPA) axis in some 
patients with depression. The HPA axis consists of a complex set of direct influences and 
feedback interactions involving the hypothalamus, pituitary and adrenal glands. In addition, 
the axis also receives regulation from other structures in the brain (e.g., the hippocampus, 
amygdala, paraventricular nuclei, etc). As a major part of the neuroendocrine system, the 
HPA axis plays an essential role in maintaining the body homeostasis, by adapting the 
organism to changes in the internal and external environments. It controls reactions to stress 
and regulates many body processes, including digestion, the immune system, mood and 
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emotions, sexuality and energy storage and expenditure. During a physical or emotional 
stressor, the axis is activated. The hypothalamus secretes two hormones (corticotropin-
releasing hormone - CRH, and arginine vasopressin - AVP), which will cause an increase in 
the release of the adrenocorticotropin hormone (ACTH) from the pituitary. Then, ACTH is 
carried in the blood to the adrenal cortex and stimulates the production and secretion of 
cortisol. Finally, the loop is completed by the negative feedback of cortisol to the 
hypothalamus and pituitary (41). Cortisol is a stress hormone, that stimulates the production 
of glucose, increases lipolysis and circulating free fatty acids, as well as decreases insulin 
secretion from beta cells and insulin sensitivity (42). In depression, it has been shown that a 
continual activation of the HPA axis and an impaired negative feedback control take place, as 
well as adrenal hypertrophy. CRH is hyper secreted from the hypothalamus, which increases 
the release of ACTH, and consequently the cortisol levels are raised. The cortisol receptors 
become desensitized, which results in increased activity of the pro-inflammatory immune 
mediators, and disturbances in noradrenalin and serotonin transmission (43). Of note, it has 
been known for many years that approximately 50% of all depressed individuals have a 
sustained elevation of plasma cortisol levels. Thus, it has been postulated that chronically 
high levels of cortisol result in obesity, insulin resistance and type 2 diabetes (42).  
 Even though depression is related to the normal emotions of sadness and bereavement, 
when the external cause of these emotions dissipates, depression does not remit and it is 
usually out of proportion to their cause. It is important to note that it takes more than just 
tearfulness or short-lived emotional responses to challenges in everyday life to indicate the 
presence of depression (35). In order to establish a diagnosis of clinical depression or major 
depressive disorder (MDD), a detailed and careful history of symptoms, thoughts, feelings 
and behavior patterns must be collected from the individual and from others (other family 
members, for example), in addition to a systematic evaluation for mental status, as well as 
specialized tests and investigations as needed. Relevant progress has been made during the 
past decades concerning the standardization of clinical assessment and the reliability of the 
diagnosis. Uniform definitions of signs and symptoms, structured and semistructured 
standardized interview schedules, and standard diagnostic criteria have provided the grounds 
for achieving a high degree of reliability in the diagnosis of mental disorders (44, 45). 
According to the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders 
(DSM-5), published by the American Psychiatric Association in 2013, the mood disorders 
mainly include (46):  
• Major Depressive Disorder; 
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• Persistent Depressive Disorder (previously called dysthymic disorder): state of 
chronic low mood most of the time for at least two years, often with fewer or less 
serious symptoms than major depression; 
• Bipolar Disorder (also known as manic-depression or manic-depressive disorder): 
characterized by mood that alternates between two emotional extremes, or poles: the 
sadness of depression and the euphoria of mania; 
• Cyclothymic Disorder: milder yet more enduring type of bipolar disorder, in which a 
person's mood alternates between a less severe mania (hypomania) and a less severe 
depression; 
• Mood Disorder due to a General Medical Condition: significant disturbance in mood 
(including either / or both: 1) Depressed mood or significantly reduced level of 
interest or pleasure in most or all activities. 2) Mood that is euphoric, heightened, or 
irritable), that is directly related to the presence of a medical condition; 
• Substance / Medication-Induced Depressive Disorder: significant disturbance in 
mood, with symptoms of either depressed or euphoric mood (or both) that develop 
during (or within four weeks of) intoxication or withdrawal, or are caused by 
medication use; 
• Disruptive Mood Dysregulation Disorder: condition in which a child up to age 18 
years exhibits persistent irritability and frequent episodes of extreme behavioral 
dyscontrol; 
• Premenstrual Dysphoric Disorder: condition in which a woman has severe depression 
symptoms, irritability, and tension before menstruation. 
 Furthermore, according to the DSM-5, for the diagnosis of MDD, single episode (46): 
• At least five of the nine symptoms below must have been present for the same two 
weeks or more, and this represents a change from previous functioning. One of the 
symptoms must be either (a) depressed mood, or (b) loss of interest. 
1. Depressed mood most of the day, nearly every day, as indicated by either 
subjective report or observation made by others. For children and adolescents, 
this may be characterized as an irritable mood. 
2. Markedly diminished interest or pleasure in all, or almost all, activities most of 
the day, nearly every day. 
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3. Significant weight loss when not dieting or weight gain (e.g., a change of more 
than 5% of body weight in a month), or decrease or increase in appetite nearly 
every day. 
4. Difficulty falling or staying asleep (insomnia), or sleeping more than usual 
(hypersomnia) nearly every day. 
5. Psychomotor agitation or retardation nearly every day (observable by others). 
6. Fatigue or loss of energy nearly every day. 
7. Thoughts of worthlessness or excessive or inappropriate guilt nearly every 
day. 
8. Diminished ability to think, or concentrate, or indecisiveness, nearly every 
day. 
9. Recurrent thoughts of death or suicide (with or without a specific plan), or 
suicide attempt. 
• The symptoms do not indicate a mixed episode. 
• The symptoms cause clinically significant distress or impairment in social, 
occupational or other important areas of functioning. 
• The symptoms are not due to the direct physiological effects of a substance (e.g., 
alcohol, drugs, medication), or a general medical condition (e.g., hypothyroidism). 
1.2.3.2   Prevalence and Trends of Depression Worldwide and in Brazil 
 Currently, it is estimated that depression affects about 350 million people all over the 
world (34). Due to its relatively high lifetime prevalence worldwide, and its association with 
substantial disability and premature mortality, depression has become an important global 
public health priority. Additionally, depression has been associated with large decrements in 
quality of life and daily functioning (47), as well as increased absenteeism and reduced 
productivity at work (48). The co-occurrence of depression with other chronic diseases such 
as angina, arthritis, asthma, and diabetes, incrementally worsens health compared with 
depression alone, with any of the chronic disorders alone, and with any combination of 
chronic diseases without depression. Ranked as the fourth leading cause of burden among all 
diseases in 2000, depression accounted for 4.4% of total DALYs (49). It has been projected 
that by the year 2020, depression will be the second biggest contributor to the burden of 
disease worldwide, while it will be the first leading cause of DALYs in developing regions 
(12).  
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 In the past decades, several large-scale epidemiological studies have been conducted 
in order to estimate the rates of depression. Although there have been many efforts to 
compare the prevalence and incidence rates of depression across different countries, these 
comparisons have been usually problematic since different study designs, sampling methods, 
diagnostic tools, and statistical analyses have been used worldwide. Nevertheless, the 
availability of large-scale community surveys using similar methods has made the 
comparison possible. A cross-national collaborative group including investigators from 10 
countries (the United States, Canada, Puerto Rico, France, West Germany, Italy, Lebanon, 
Taiwan, Korea, and New Zealand) has reported that the lifetime rates for major depression 
varied widely across the countries, ranging from 1.5 cases per 100 adults in Taiwan to 19.0 
cases per 100 adults in Beirut. The annual rates ranged from 0.8 cases per 100 adults in 
Taiwan to 5.8 cases per 100 adults in New Zealand (50). Concerning the global trends of 
depression, although many longitudinal studies have shown an increasing prevalence, this 
finding is not universal. Surveys conducted in the United States, Sweden, Germany, Canada, 
and New Zealand, using comparable methods and modern diagnostic criteria, have found a 
clear increase in the risk of depression over time. Nevertheless, in studies from Puerto Rico 
and South Korea, for instance, no increase in lifetime prevalence was found (51). 
 In Latin America, rare population-based studies of depression have been conducted, 
and most of them have used diagnostic methods of low reliability, thus producing descriptive 
data with limited application for mental health planning. In Brazil, the currently available 
estimates are mainly based on very few population-based surveys of psychiatric morbidity 
(52). A cross-sectional study (n=6,476) carried out in 1997 in order to estimate the prevalence 
of DSM-III psychiatric diagnoses in three large cities of Brazil (Brasília, São Paulo and Porto 
Alegre), has found prevalence rates of depression as 1.9%, 2.8% and 10.2%, respectively (53). 
Another survey from 2002 conducted in two boroughs of São Paulo, according to the 10th 
revision of the International Statistical Classification of Diseases and Related Health 
Problems (ICD-10) criteria, showed that 45.9% of the total sample (n=1,464) had at least one 
lifetime diagnosis of mental disorder, 26.8% in the year, and 22.2% in the month prior to 
interview. Mood disorders had the second highest prevalence, and among them, depressive 
episode had the greatest occurrence (prevalence of lifetime diagnosis: 16.8%, 12-month: 
7.1%, and 1-month: 4.5%) (54). Additionally, a survey from 2001 carried out in a small 
Brazilian community, also according to ICD-10 criteria, found that lifetime, 1-year and 1-
month prevalence rates of depression were 15.6%, 10.0% and 8.2% respectively. Of note, the 
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1-month prevalence found in this community was unexpectedly higher than that observed in 
similar studies from other developed and developing countries. Since psychiatrists and other 
mental health professionals in Brazil are usually concentrated in big cities, and the health 
services in small communities are often not adequately prepared to approach mental health 
disorders, it is likely that depression is a major unidentified condition in such communities 
(52). 
1.2.3.3   Associated Factors for Depression 
 The occurrence of depression has been associated with a number of medical, 
psychosocial and demographic factors (33). 
 It has been consistently found that women suffer from higher rates of depression than 
men (33, 55). Although the reasons still remain unclear, many attempts have been made in 
order to explain such phenomenon. The explanations include the possibility that this sex 
difference in rates does not reflect the reality because of artifacts produced by methods of 
reporting symptoms (women perceive, acknowledge, report, and seek help for stress and 
symptoms differently than men and these factors account for the sex ratio findings), or that 
they are legitimate because of biological susceptibility (genetic transmission and female 
endocrine physiological processes), and psychosocial factors (the long-standing 
disadvantaged social status of women, or female-learned helplessness) (56). Furthermore, it 
has been observed that this sex difference is age specific. Whereas a notable sex difference 
has been found in middle life, the difference has not been relevant in either childhood or 
advanced old age (33). 
 The relationship between depression and age has been given considerable research 
attention, however the studies have reached conflicting results, with greatly varying patterns 
of age group differences (57). In Brazil, according to the previously mentioned study 
conducted in São Paulo in 2002, the highest rates for mood disorders were found among 
people between 25–54 years old (54). However, a large population-based study conducted in 
Norway (n=62,344) showed that both the mean level as well as the number of cases of 
depression increased close to linearly with age (56). Yet some American studies have shown 
that depressive symptoms were most prevalent in younger women and tended to decrease 
with age, whereas the prevalence in men increased with age. Other studies from Europe have 
observed an increase in depressive symptoms in women up to late middle age, and a decrease 
thereafter, while no age trend was found among men (33).  
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 Some other factors that have been reported as important predictors of depression 
include low income, illiteracy, lack of social support, as well as alcohol and smoking habit 
(58, 59). Additionally, marital status has also been connected with the onset and prevalence 
of depression. It has been observed that depression occurs more often among widowed and 
divorced persons compared to those who are married, never got married or are cohabiting 
(59).  
 Higher rates of depression have been found frequently in patients with several medical 
conditions, such as myocardial infarction, DM, human immunodeficiency virus (HIV)-related 
illness, cancer, cerebrovascular accident, Parkinson’s disease, etc. The progressive functional 
impairment associated with many chronic medical illnesses may result in depression, and 
depression is associated with additive decrements in function. Increasing evidence indicates 
that both depressive symptoms and MDD may be associated with increased morbidity and 
mortality from conditions such as DM and heart disease. The adverse effect of depression on 
health habits (smoking, unhealthy diet, and sedentary lifestyle), its negative impact on 
adherence to medical regimens, as well as direct adverse physiologic effects (i.e., decreased 
heart rate variability, increased adhesiveness of platelets) may explain this association with 
higher morbidity and mortality rates (60). 
 Numerous studies have also shown that a positive family history of depression is 
associated with an increased risk of the condition in offspring. Although it is likely that part 
of that effect is genetic, it has also been reported that even after controlling for the familial 
effect, little parental socio-economic status (low level of education and occupational status) 
increases the risk of offspring depression (61). Additionally, trauma in early life, including 
childhood physical or sexual abuse, has been strongly connected with the occurrence of 
depression in adult life (62).  
1.2.4   Relationship between Diabetes and Depression 
 
 As previously mentioned, diabetes and depression are common and rapidly increasing 
NCDs throughout the world. Both are related to significant reductions in life expectancy, 
decreased quality of life, as well as increased functional disability (63).  
 The association between the two conditions was first noted in the literature in 1684 
when Thomas Willis suggested that diabetes was the result of sadness or prolonged sorrow 
(64). After that time, research on this relationship was sparse until the past 20 years. Lately, 
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many studies have found a frequent co-existence of depression, hyperglycemia, diabetes and 
diabetes-related complications. Moreover, comorbid depression in diabetes has been 
associated with poorer adherence to diabetes treatment regimens (65), decreased work 
productivity and increased disability (66), lower quality of life (67), higher rates of 
retinopathy and macrovascular complications (68), as well as increased mortality rates, 
beyond that due to having either diabetes or depression alone (69). A recent meta-analysis of 
longitudinal studies indicated that depressed adults have a 37% increased risk of developing 
type 2 diabetes. The findings of such meta-analysis have also suggested that depression could 
be considered as an additional risk factor for T2DM, even comparable in size to physical 
inactivity and smoking (42). Conversely, another meta-analysis showed that diabetes doubles 
the odds of co-morbid depression (70). Furthermore, some studies have indicated that 
depression may cause a negative impact on glycemic control (which may result in increased 
occurrence of complications and disability), and improvements in depressive symptoms may 
lead to a significantly better diabetic control (71, 72). On the other hand, better glycemic 
control in patients with type 2 diabetes may result in better mood and general well-being, and 
fewer physical symptoms (73, 74). It has been estimated that depression is neither recognized 
nor treated in approximately two thirds of subjects with both the conditions, and also presents 
a chronic and severe course in these patients (74). Additionally, this co-morbidity has been 
associated with higher health care costs, and the implementation of more effective depression 
screening programs and depression treatment for patients with diabetes might lead to a 
decreased economic burden and better clinical outcomes (75). 
 In order to promote a better understanding of the impact of depression on diabetes 
care and treatment outcomes, an interesting conceptual framework has been developed by 
Piette at al. (Figure 1.5) (68).  
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Figure 1.5: Conceptual Framework Linking Depression to Diabetes Outcomes 
 
 According to this model, there are four main pathways through which depression may 
affect the outcomes among patients with both diabetes and depression:  
1. Depression produces a direct impact on health-related quality of life, as well as on 
physical, social, and role functioning of patients with both depression and diabetes. 
Thus, even if diabetes-related pathophysiology and outcomes do not change, by 
addressing the patients' depressive symptoms, an improvement on their quality of life 
will probably take place. 
2. Diabetes patients with co-morbid depression are more likely to present low levels of 
physical activity. Studies have suggested that patients who are more physically active 
present better diabetes-related outcomes, while those who are less physically active 
are more likely to develop depression. The promotion of physical activity may be a 
treatment approach that can improve both patients’ physiologic risk factors for 
complications associated with diabetes and their mental health. 
3. It has been suggested that depression affects patients' self-care behaviors. Depressed 
patients are less likely to optimally manage their diabetes self-care due to their lack of 
energy and motivation, negative pattern of cognition, as well as their passive coping 
strategies.  
4. Depressed patients are more likely to establish an impaired patient-provider 
communication, and consequently they are less likely to follow through on the 
recommended treatment plans, which may lead to poorer outcomes. Furthermore, 
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probably because of poor adherence, decreased self-care and difficult interactions 
with providers, depressed patients tend to use more health services and have higher 
healthcare costs. 
 The figure also indicates a theoretical effect of treating depression with medication 
and focused counseling. Successful depression treatment may result in a greater self-efficacy 
for diabetes care, which is associated with better glycemic control and global funtioning (68). 
 Although there is a growing body of evidence showing the association between 
diabetes and depression, the direction of this relationship and the exact pathophysiological 
mechanisms behind it are still not fully understood. While one line of investigation lends 
support to the hypothesis that depression is a consequence of diabetes, another line of 
research seeks to demonstrate that depressive symptoms are a risk factor for the development 
of diabetes. Furthermore, it has also been suggested that the answer for such a conundrum 
may not be as a simple as a unidirectional relationship, and rather that the co-morbidity of 
diabetes and depression is part of a bidirectional interaction between the two conditions (76).  
1.2.4.1   Depression as a Consequence of Diabetes 
 The increased risk of depression among individuals with diabetes has been frequently 
conceptualized as having two possible mechanisms. First, the psychosocial burden of having 
a chronic medical condition like diabetes may promote the development of depressive 
symptoms. It has been observed that when the burden of diabetes increases, the probability of 
mood symptoms also increases. Perceived disability and awareness of having a chronic 
disease such as diabetes may impose higher levels of psychological stress, especially among 
those with poor social support. Additionally, diabetes requires high levels of self-care (proper 
medication management, strict dietary regimens, frequent monitoring of blood glucose 
values), may generate medical complications and decreased mobility, which can contribute to 
a negative psychological impact. Second, biochemical factors associated with diabetes, may 
also result in an increased risk of depression. For instance, hyperglycemia and 
hyperinsulinemia increase the activity of the HPA axis, inducing arousal of the nervous 
system, which in turn may lead to depression (76, 77). 
 A large-scale research study conducted in the Netherlands, after adjustment for 
lifestyle and demographic variables, found that individuals with diagnosed T2DM had nearly 
2 times increased risk of depressive symptoms compared to those without a diagnosis. 
However, no significant increased risk of depressive symptoms was seen in subjects with 
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impaired FPG concentration and undiagnosed T2DM. Similarly to some other studies, these 
findings suggest that the psychosocial burden of a chronic disease, rather than the disturbed 
glucose homeostasis, is associated with depression (77). Nevertheless, there have also been 
studies providing evidence that depression is a consequence of the diabetes 
pathophysiological process itself, above and beyond the burden of a chronic disease. For 
instance, in the Vietnam Experience Study, data from over 4,000 male veterans were 
collected to investigate the link between fasting glucose values, diabetes diagnosis, and 
depression. It was observed that both known and undiagnosed diabetes were associated with 
an increased risk of depressive symptoms. Men with undiagnosed T2DM were almost twice 
as likely to have major depression compared to those with normal fasting glucose 
concentrations (78).  
1.2.4.2   Depression as a risk factor for the onset of diabetes 
 The idea that depression is a risk factor for the development of diabetes has been often 
explained by two possible ways. Some studies have indicated that depressive symptoms such 
as reduced interest or pleasure in activities, sleep and appetite dysregulation, fatigue, and 
decreased ability to think or concentrate can make individuals with depression less likely to 
engage in health-promoting behaviors. Thus, depression has been associated with higher BMI, 
consumption of hypercaloric diets, sedentary lifestyle and smoking, which can ultimately 
lead to T2DM (76). Additionally, it has also been suggested that a low intake or impaired 
metabolism of omega-3 polyunsaturated fatty acids (PUFAs) may contribute to both diabetes 
and depression; even though the evidence on fatty acid levels in diabetic depressive patients 
is still sparse (42). 
 On the other hand, it has also been suggested that the biochemical changes associated 
with depression or its treatment may promote a cascading effect that results in the onset of 
diabetes. As described previously, depression is associated with increased activity of the HPA 
axis (higher release of cortisol) and sympathetic nervous system (SNS), and increased 
production of proinflammatory cytokines (associated with endocrine changes and greater risk 
of diabetes). Chronically elevated cortisol levels increase the risk of developing metabolic 
syndrome (characterized by central adiposity, or excess accumulation of abdominal fat, and 
insulin resistance), which also increases the risk of developing diabetes. Concerning 
depression treatment, there has been research showing an association of some types of 
selective serotonin reuptake inhibitors (SSRI) and tricyclic antidepressants with 
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hyperglycemia and increased risk of diabetes (76). However, a recent intervention study 
conducted among 26 non-diabetic Pakistani women with newly diagnosed depression showed 
a significant improvement of insulin sensitivity following the treatment of depression with 
citalopram (a type of SSRI that has not shown significant effects on insulin sensitivity or 
changes in glycaemic control) (79).  
1.2.4.3   Evidence for a bidirectional relationship  
 It has been hypothesized that a reciprocal interaction underlies the relationship 
between depression and diabetes. Depression and related genetic, biological, and 
psychosocial factors may increase the risk for T2DM onset and subsequent diabetes 
complications. On the other hand, consequences of these complications may include 
increased illness intrusiveness and emotional distress, thereby increasing the risk for 
depression (76). 
 A meta-analysis published in 2008 showed that subjects with T2DM have a 15% 
increased risk of depression compared to those without diabetes, and depressed people have a 
60% increased risk of developing T2DM (80). Additionally, Golden et al. also identified a 
bidirectional longitudinal association between depressive symptoms and T2DM. In this study, 
individuals with normal glucose levels and elevated depressive symptoms were at an 
increased risk for developing T2DM over three years, whereas those with T2DM and little 
depressive symptomatology at baseline were at an increased risk of developing depressive 
symptoms over the same period (81). 
 
1.3   RATIONALE AND SIGNIFICANCE OF THE STUDY 
As mentioned previously, the association between depression and diabetes has been 
observed by several (82); however, the transcultural validity of these findings still needs to be 
demonstrated (83). Since social and cultural factors have been found to influence the 
prevalence of psychiatric disorders, it is likely that the occurrence of depression in people 
with diabetes will present variations among and within societies (84). Therefore, the 
relationship between diabetes and depression should preferably be studied in different 
cultural environments (83). In Brazil, few studies have been published about this topic and, to 
the best of our knowledge, no research based on representative community surveys, including 
different age groups, has come out so far. Thus, it remains unclear whether these findings on 
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the association between the two conditions reported in some countries are similar in a middle-
income country like Brazil.  
In addition, Brazil has experienced a rapid demographic and economic transition, with 
profound consequences to the society as a whole and more specifically to nutritional and 
lifestyle patterns. Industrialization, urbanization and an increasing globalization of unhealthy 
food habits among other factors have exposed the Brazilian population to greater risks of 
chronic diseases, including diabetes and depression (13). 
Many studies conducted elsewhere may have been biased, since they have been 
largely conducted in specialized diabetic centers or elderly homes with a large number of 
older patients (many of which already have other complications). Moreover, these data have 
been collected from prevalent cases of diabetes or depression and many have used self-
reported data on diabetes. Older age is known to be related with other different chronic 
diseases, and the presence of multiple chronic conditions in addition to diabetes may impact 
negatively on the quality of life and increase functional limitations, which may contribute to 
the onset of depression. Thus, the occurrence of depression in people with pre-existing 
diabetes may have been overestimated (83). This research project recruited participants from 
the general population, and depression and diabetes were evaluated simultaneously. The 
diagnosis of diabetes was not disclosed to them before the assessment of depression was 
completed. Therefore, it is likely that the debated confounding factor of the duration of a 
chronic disease, like diabetes, leading patients to depression could be avoided. 
All the data collected are likely to contribute for the development of strategies to 
prevent diabetes, depression and possibly cardiovascular diseases as well. New approaches 
for the treatment of diabetes may be developed by including the treatment of depression for 
possible improved glycaemic control. Timely treatment and strategies to prevent 
complications applied to the participants who were diagnosed with diabetes, depression and / 
or another medical condition may reduce morbidity, mortality and lifelong complications. 
Furthermore, the results of this study may add some important knowledge to the general 
understanding of the relationship between diabetes and depression, which in turn may lead to 
a better management of both the conditions; and they may also give grounds to the 
development of new hypotheses for exploration and new management and preventive 
guidelines. 
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1.4   HYPOTHESIS 
Higher prevalence of depression among people with newly diagnosed diabetes 
compared to those without diabetes in a city in the northeast of Brazil. 
 
1.5   RESEARCH QUESTIONS 
- What is the prevalence of diabetes? What is the prevalence of depression? 
- Is there an association between diabetes and depression in this population?  
 
1.6   OBJECTIVES  
• Main Objective:  
- To investigate the prevalence of type 2 diabetes and depression, and the 
association between depressive symptoms and newly diagnosed diabetes in Brazil. 
 
• Specific Objectives: 
- To assess the prevalence of diabetes and depression among people aged 20 years 
and above. 
- To investigate the prevalence of depression among people with newly diagnosed 
diabetes compared to those without diabetes in northeastern Brazil. 
- To identify the risk indicators of diabetes and depression including biophysical 
(blood pressure, anthropometry, body fat percentage) and biochemical (total 
cholesterol, triglycerides, high-density lipoprotein cholesterol, low-density 
lipoprotein cholesterol) parameters. 
- To examine the association of different measures of obesity (BMI, WHR and 
body fat percentage) and its association with diabetes and / or depression. 
- To assess the association of plasma cortisol levels with the occurrence of 
depression and diabetes.  
- To assess the agreement between two measures of depression (MADRS: 
Montgomery-Åsberg Depression Rating Scale; and HDRS: Hamilton Depression 
Rating Scale) in the studied population. 
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CHAPTER 2 
 
MATERIALS AND METHODS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2.1   STUDY AREA 
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Figure 2.1: Geographical Location
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availability of nurse assistants and health volunteers willing to be trained and participate in 
the execution of the study, etc. 
 
2.2   STUDY DESIGN AND POPULATION 
This population-based research study was based on a cross-sectional design, and was 
conducted over a period of approximately 6 months (from August, 2012 to January, 2013). 
The study collected data from 714 subjects who were residents in Pindoretama – CE. 
 
2.3   SAMPLE SELECTION 
 
2.3.1   Inclusion Criteria 
• Subjects of both genders;  
• Age ≥ 20 years; 
• Being able to communicate; 
• Willing to join the study. 
 
2.3.2   Exclusion Criteria 
• Subjects below 20 years of age; 
• Pregnant women; 
• Physically or mentally disabled individuals who were unable to follow simple 
questions and examinations. 
 
 Following the above mentioned exclusion criteria, eight hundred and six randomly 
selected subjects were invited to participate. Out of these, seven hundred and fourteen agreed 
to join the study.  
 Additionally, when analyzing the association between diabetes and depression, those 
presenting at least one of the following characteristics were excluded: 
 
• Individuals reporting a current diagnosis of type 2 diabetes and / or depression; 
• History of Gestational Diabetes Mellitus (GDM); 
• Previous diagnosis of type 1 diabetes; 
• Acute or chronic severe cardiac, renal or hepatic illnesses; 
• Current use of anti-depressants for any reason. 
42 
 
 In total, eighty two subjects were excluded from the analysis of the association 
between diabetes and depression. 
 
2.3.3   Sample Size Calculation 
 The required sample size to this study was determined using the following formula: 
, 
where N is the total sample size,  p1 and p2 are pre-study estimates of the two proportions to 
be compared (p1 = 0.318 → prevalence of depression among people with diabetes, and p2 = 
0.195 → prevalence of depression among those without diabetes. These prevalence rates 
were taken from a previous study (87)), D = |p1 − p2| (the minimum expected difference) i.e. 
0.123, p̅ = (p1 + p2)/2, i.e. 0.256, zcrit= 1.96 (Standard Normal Deviate for a Significance 
Criterion = 0.05 and a Confidence Interval = 0.95), and zpwr= 1.282 (Standard Normal 
Deviate for a Statiscal Power = 0.90). Two-tailed statistical analyses were used.  
  Thus, N = 2 .[ 1.96 . 0.617 + 1.282 . 0.609]2 / 0.015 = 527.46 
 After the addition of an estimated 10% drop-out rate, a number of approximately 580 
was reached. 
2.3.4   Sample Selection Process 
The estimated sample size was randomly (using simple randomization methods) 
drawn from a population above 20 years of age, of both genders, using the health registry list 
of the city.  
 
2.4   DATA COLLECTION 
 
2.4.1   Survey Procedures 
Prior to the survey, the selected subjects were contacted by the CHWs in order to be 
invited to join the study. By the time of invitation, the CHWs briefly informed the potential 
respondents about the purposes of the study and methods of investigation. The necessary 
information and arrangements to assemble the participants in the study locations were 
organized. The data collection took place in the six main community health centers that are 
strategically located throughout the city (the initial time was different in different centers, but 
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within 6 months). In general, one month was spent on the fieldwork in each center. Thus, 
within that month, the subjects could choose the most appropriate day of the week to attend 
the survey. 
The participants were instructed twice (personally by the CHWs and by a phone call 
at the previous day of the data collection) to start fasting from 8 pm of the night before the 
blood glucose level measurements. The survey procedures were carried out between 6 and 8 
am. First, after the participants' arrival to the study place, the details about the research 
purpose and the investigations to be performed were explained again. Those who wanted to 
participate were given the informed consent. Then, venous blood samples were collected for 
FPG measurements. So, the subjects took a 75g oral glucose load (according to the WHO 
guidelines) in order to be prepared to the OGTT. They were also interviewed, with the use of 
questionnaires regarding socio-demographic, economic and physical activity information. 
The MADRS and HDRS were used to assess depression, and by this time, neither the 
participants nor the investigators were aware of the subjects' plasma glucose level results. 
Anthropometric, blood pressure and body fat percentage measurements were also taken. 
Another blood sample was collected two hours after the 75g oral glucose load. Capillary 
HbA1c measures were taken after the assessment of depression. Finally, a morning meal was 
given to the participants. 
 
2.4.2   Research Team Training and Fieldwork Supervision  
 One experienced nurse assistant highly qualified in venipuncture was responsible to 
draw the blood samples from the participants. Another nurse assistant was trained by the 
principal investigator, under the supervision of the local supervisor (Professor Renan 
Magalhães Montenegro Júnior), to conduct the capillary HbA1c assessment. Socio-
demographic, economic and physical activity data were collected by one research assistant 
that was adequately trained before the start of the study. Anthropometric, blood pressure and 
body fat percentage measurements were taken by another research assistant who was also 
carefully trained by the principal investigator, under the supervision of the local supervisor 
(Professor Renan Magalhães Montenegro Júnior). A nurse with experience in mental health 
disorders conducted the MADRS, while the HDRS was performed by the principal 
investigator. Both of them had prior experience of assessing depressive scores. They received 
proper training during five days and conducted the interviews under the supervision of an 
experienced psychiatrist (Professor Fábio Gomes de Matos e Souza, local supervisor).  
 All procedures performed in the study and methods of efficient data collection were 
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discussed among the team members. During the fieldwork, the principal investigator 
encouraged the research team members to discuss all problems faced and their potential 
solutions. 
 
2.4.3   Pretesting of Questionnaires 
 Pretesting of the questionnaires to assess general information, socio-demographic, 
economic, medical and physical activity data was conducted among 10 subjects in the local 
community in order to assess their feasibility, and catch and solve unforeseen problems. As a 
result, the wording of the questionnaires was improved, unnecessary questions were 
eliminated and others were added. Adjustments were made in order to reduce the length of 
time required to complete the survey. 
 
2.4.4   Interviewer-Guided Questionnaires 
 
2.4.4.1   Questionnaire to Assess General Information, Socio-Demographic, Economic 
and Medical Data  
 The questionnaire to assess general information, socio-demographic, economic and 
medical data was developed based on the existing literature and related experience. Face-to-
face interviews were conducted in the study sites. 
 The most relevant variables are described below: 
• General information, socio-demographic and economic features:  
- Age; 
- Gender; 
- Ethnicity → following the IBGE classification, the participants were asked 
about their self-perception of the skin color, and the different ethnic groups 
were categorized into: "white", "brown", "black", "yellow" (i.e. east Asian) 
and "indigenous"; 
- Marital Status → categorized into "married", "single", "divorced or separated", 
"cohabitant", "widow/er"; 
- Level of Education → number of years of institutional education was 
recorded. Years of education were further categorized into "illiterate", 
"primary school", "high school", and "university or higher"; 
- Occupation → categorized into "student", "agriculture", "industry and 
services", "domestic labour" (housewives or those who worked in other houses 
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performing domestic tasks, such as cleaning, cooking, etc), "construction" 
(mainly masons), "sick benefit" (those who were away from work due to some 
temporarily disabling condition), "retired", "unemployed", "other" (other 
occupations that did not fit in the previous categories). The various types of 
occupations were further subdivided into two groups: "manual labor" (types of 
occupations that usually entail moderate to high level of physical activity, such 
as jobs in agriculture and construction), and "not manual labor" (those who 
were retired, unemployed, students, etc, or types of occupations that entail low 
levels of physical activity, such as jobs in industries, services, etc). 
- Monthly Income → individual income per month. It was categorized into 
"low" (income lower or equal to 1 minimum wage in 2012, that corresponds 
currently to US$ 218.00), "middle" (income between 1 and 5 minimum 
wages), and "high" (income higher or equal to 5 minimum wages). 
• Individual history of diseases: the participants were asked about past and current 
diagnosis of some relevant diseases (hypertension, diabetes type 1 and 2, depression, 
cardiovascular diseases, cancer, etc). Use of medication was also investigated. 
• Family history of diseases: it was defined as having a father, mother, brother or sister 
with a diagnosis of type 2 diabetes, depression, cardiovascular disease, etc. 
• Lifestyle: 
- Smoking Habits → categorized into "never", "previous mild", "previous 
heavy", "current mild" and "current heavy". Previous was defined as those 
who have stopped smoking for at least 6 months. Current:  those who currently 
smoke or have stopped smoking for less than 6 months. Mild: less than 20 
cigarettes/day. Heavy: more than 20 cigarettes/day.  
- Alcohol Consumption → categorized into "no", "once a month or less", "2 to 4 
times a month", "2 to 3 times a week", "4 or more times a week". 
- Diet → the frequency of consumption of various types of food and beverages 
was assessed. It was measured by using four categories, ranging from "never" 
to "daily". The different items were further categorized into "fat" (fat used for 
cooking and on the bread, full cream milk and yoghurt), "carbohydrates" 
(bread, noodles, biscuits, cookies, roots, rice, wheat, tubers, etc), "sugars" 
(fruits, chocolates, cola with sugar), "protein" (beef, chicken, pork, fish, eggs, 
etc) and "vegetables". 
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2.4.4.2   International Physical Activity Questionnaire (IPAQ)  
 The interview administered IPAQ short form was applied to assess physical activity 
data. IPAQ short form is an instrument designed primarily for population surveillance of 
physical activity among adults (age range of 15-69 years). It assesses the time spent on 
walking, in vigorous- and moderate intensity activity and in sedentary activity. IPAQ assesses 
physical activity undertaken across a comprehensive set of domains including: 1) Leisure 
time physical activity; 2) Domestic and gardening (yard) activities; 3) Work-related physical 
activity; and 4) Transport-related physical activity (88). The items in the IPAQ short form 
were structured to provide separate scores on walking, moderate-intensity and vigorous-
intensity activity. Computation of the total score for the short form requires summation of the 
duration (in minutes) and frequency (days) of walking, moderate-intensity and vigorous-
intensity activities. Domain specific estimates cannot be estimated. According to the 
guidelines for data processing and analysis, the levels of physical activity are categorized into 
"low", "moderate" and "high" (89). In a study conducted in 12 countries including Brazil, 
data concerning the reliability and validity of the IPAQ short and long forms were collected. 
The results showed that the IPAQ instruments exhibited acceptable measurement properties, 
that were at least as good as other established self-report physical activity measures (90). 
 
2.4.4.3   Assessment of Depression  
 The MADRS and the HDRS were used for the assessment of depression scores. The 
MADRS is a 10-item questionnaire (the score of each item ranges from 0 to 6, and the total 
sum for the 10 items can range from 0 to 60), that takes about 10-15 minutes to be performed. 
Its scores are usually categorized into four groups: 0-12 (healthy), 13-19 (mild depression), 
20-34 (moderate depression) and 35-60 (severe depression) (91). In this study, total scores 
between 0 and 19 were considered as absence of depression, whilst scores ≥ 20 were taken as 
presence of depression. The HDRS is a 17-item questionnaire (eight items are scored on a 5-
point scale, ranging from 0 = not present to 4 = severe, while nine are scored from 0-2), that 
generally takes 15-20 minutes to be administered. Usually, scores above or equal to 23 
identify very severe depression; between 19 and 22, severe depression; 14-18, moderate 
depression; 8-13, mild depression; and 0-7, normal (92). In this study, total scores of 0-13 
were considered as absence of depression, whilst scores ≥ 14 indicated depression. Of note, 
the term "depression" applied here refers to an epidemiological definition of depression based 
on a threshold level of symptom scales, rather than a clinical diagnosis. 
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2.4.5   Anthropometric Measurements 
 Four anthropometric measures were taken, without shoes and with light clothes: 
weight, height, hip and waist circumferences.  
 The weight was taken by using a portable digital scale, placed on a flat surface, with 
the subject placing the arms by side, face forward and waiting still, and recorded to the 
nearest 0.1 Kg. The height was measured by using a well-mounted stadiometer, recorded to 
the nearest 0.1 cm, with the participant looking straight (keeping the tragus and the lateral 
orbital margin in the same horizontal plane), and in erect position. The body mass index 
(BMI) was calculated as the weight in kilograms divided by the square of height in meters 
(Kg/m2). The WHO classification of BMI was applied (Underweight: BMI < 18.5; Normal: 
BMI between 18.5 and 24.99; Overweight: BMI between 25 and 29.99; Obesity: BMI ≥ 30) 
(93).  
 The waist circumference was taken by placing a non-stretchable measuring tape 
horizontally on the midpoint between the lower part of the 12th rib and the top of the iliac 
crest, under the mid-axillary line. It was measured at the end of normal expiration, with the 
arms relaxed by the sides. To the hip girth measurement, a similar tape was positioned to the 
maximum circumference around the buttocks, with the subject standing straight, keeping 
hands by the sides, and facing palms inward. Waist and hip circumference were recorded to 
the nearest 0.1 cm. The waist-to-hip ratio (WHR) was calculated as the waist measurement 
divided by the hip measurement. Following the WHO cut-off points, for males, a WHR ≥ 
0.90cm was considered "high", i.e., substantially increased risk of metabolic complications, 
whereas for females a WHR ≥ 0.85cm was classified as "high" (94). 
 
2.4.6   Measurement of Body Fat Percentage (BF%) - Bioelectrical Impedance Method 
 The BF% was measured by a portable bipolar body fat analyzer (Omron®, Model 
HBF-306). The device works by a formula that calculates the fat percentage by taking into 
account gender, age, weight, height, and the electric resistance encountered by the micro 
currents (500 μA, 50 kHz) that are emitted from one hand grip, pass through the limb, torso 
and the next limb to the other hand grip, where the fluctuation in the value is recorded. The 
BF% measurement is displayed almost instantly (within 7 seconds). The BF% was measured 
with the participant holding the hand grips on both sides, standing up straight, with arms 
slightly outstretched and making a 90 degree angle with the chest. The "normal mode" was 
used.  
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2.4.7   Measurement of Blood Pressure (BP)  
 BP was measured twice, by using an electronic sphygmomanometer (Omron® BP785 
IntelliSense® Automatic Blood Pressure Monitor with ComFitTM Cuff). The subjects were 
asked to relax and the first measurement was taken after a resting time of at least 15 minutes, 
while the second approximately 5 minutes after the first. The participants were sitting with 
legs uncrossed and the left arm was used to the measurements. The mean value of two 
measurements was used for analysis. 
 
2.4.8   Biochemical Assessments 
 Peripheral venous blood samples were collected after at least 8 hours fasting from all 
study participants. The collected samples were transferred to a sterile container and stored 
immediately over ice and then centrifuged within approximately 1 hour of collection. Plasma 
was frozen and transported (within 2 hours) on dry ice, in vaccine carriers to the laboratory 
where the samples were stored at – 20° Celsius until the analyses were performed. The first 
fasting sample (10 ml) was used to carry out the analyses for the estimations of plasma 
glucose, total cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL-C), 
cortisol and insulin levels. The second sample (3ml) was analyzed for the estimation of 
plasma glucose levels after a 75g oral glucose load (OGTT). Fasting and 2-h plasma glucose 
levels were analyzed by glucose oxidase method, whereas fasting insulin was determined by 
chemiluminescence. Capillary HbA1c levels were measured by A1CNow® Multi-Test A1C 
System (Bayer). Total cholesterol was estimated by CHOD-PAP (cholesterol oxidase - 
phenol + aminophenazone) method, while HDL-C was determined by a homogenous 
enzymatic colorimetric method.  Triglycerides were determined by GPO-PAP (glycerol-3-
phosphate oxidase - phenol + aminophenazone) method. Low-density lipoprotein cholesterol 
(LDL-C) was estimated by using the Friedewald Formula (95). Cortisol was analyzed by 
chemiluminescence (Beckman Coulter). Quality control of the laboratory was assessed 
internally and externally.  
 
2.5   CATEGORIZATION OF DM, IFG, ISOLATED IFG, IGT AND ISOLATED IGT 
 The diagnosis of diabetes was based on both fasting and 2h-plasma samples for 
comparative analysis, according to the WHO criteria (18), i.e. fasting (venous) plasma 
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glucose value ≥ 7.0mmol/l (≥ 126mg/dl), or the plasma glucose value 2 hours after a 75g oral 
glucose load  ≥ 11.1mmol/l (≥ 200mg/dl), or both.  
 IFG cases were defined as those with FPG values ≥ 6.1 and < 7.0mmol/l (≥ 110 and < 
126mg/dl), while isolated IFG cases were those with FPG values ≥ 6.1 and < 7.0mmol/l (≥ 
110 and < 126mg/dl) and 2-h plasma glucose in OGTT < 7.8mmol/l (< 140mg/dl).  
 IGT cases were those with 2-h plasma glucose in OGTT ≥ 7.8 and < 11.1mmol/l (≥ 
140 and < 200mg/dl), whereas isolated IGT cases were defined as those with FPG values < 
6.1mmol/l (< 110mg/dl) and 2-h plasma glucose in OGTT ≥ 7.8 and < 11.1mmol/l (≥ 140 and 
< 200mg/dl). 
 
2.6   STATISTICAL METHODS 
2.6.1   Data Management 
 All information collected by questionnaires, clinical examinations and biochemical 
analyses were registered in a computer database by using SPSS (IBM Corp. Released 2013. 
IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp.). Missing values 
and data entry errors were checked carefully. 
2.6.2   Data Handling 
 Numerical data were presented as means and 95% confidence intervals (CIs), while 
categorical data as percentages and 95% CIs. The prevalence rates of diabetes and depression 
were determined by simple percentages. Chi-square tests were used to evaluate differences 
among categorical variables; t-tests and one-way analysis of variance (ANOVA) evaluated 
differences in continuous variables. Initial univariate analysis was carried out to determine 
whether selected independent variables were significantly associated with the occurrence of 
diabetes or depression. Multiple logistic regression models were used to control for potential 
confounding factors. The crude and multivariate-adjusted ORs, as well as 95% CIs were 
presented. They were calculated assuming the least prevalence of clinically relevant criteria 
as the reference value. A p-value < 0.05 was considered statistically significant and all p-
values presented were two-tailed.  
 Agreement between MADRS and HDRS, as well as between FPG and 2-h values in 
the 75-g Oral Glucose Tolerance Test (OGTT) were evaluated by the kappa statistic (poor - 
kappa < 0; slight - kappa: 0.01–0.20; fair - kappa: 0.21– 0.40; moderate - kappa: 0.41–0.60; 
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substantial - kappa: 0.61–0.80; and almost perfect - kappa: 0.81–0.99) (96). Bivariate 
Pearson's correlation coefficient was also used to evaluate the correlation between the 
depression scores assessed by MADRS and HDRS.  
 All statistical analyses were performed by using the software SPSS 22 version. The 
graphs were constructed by using the software Stata 13 (StataCorp. 2013. Stata Statistical 
Software: Release 13. College Station, TX: StataCorp LP). 
2.7   ETHICAL CONSIDERATIONS 
The study was conducted following the Helsinki Declaration of medical research. It 
was approved by the local Ethical Committee in Brazil, as well as by the Regional Committee 
for Research Ethics in Norway.  
Prior to the survey, a local meeting with local health authorities, CHWs and research 
team members was organized by the principal investigator. The purposes of the study and 
survey procedures were discussed and everyone was requested to give comments about the 
study. Their suggestions were incorporated into the study design.  
Written or verbal consent from all subjects was obtained prior to any investigation. In 
case of illiteracy, verbal consent was assured by a local witness (who could sign the informed 
consent) in order to secure the subjects` free participation. Prior to enrollment in the study, 
CHWs read out a paragraph to each potential respondent that described the purpose of the 
study and methods of investigation. At the day of data collection, the details about the 
research purpose, the investigations and examinations to be conducted, as well as the risks 
and benefits involved were explained again by the principal investigator. All respondents 
were informed of their right to refuse to take part in the research, withdraw from the study at 
any stage or to withhold their data from analysis. They were also reassured that there would 
not be any consequences of refusing to participate. Those who were not interested in joining 
the study were not included.  
The confidentiality of all health data gathered was ensured by limiting the 
accessibility of the information to the main investigators. Furthermore, each participant was 
assigned a unique identification number and all data were referenced to this number rather 
than a name. The information was kept in a locked cabinet and data analysis did not include 
identifying information.  
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Only qualified and trained health personnel were responsible to collect the blood 
samples, and precautions were made to prevent injuries. The risk of contracting blood borne 
diseases to both health personnel and participants was minimized by using good hygienic and 
protective measures while investigating, and collecting blood samples. In the examination of 
participants` anthropometric measurements, their privacy was maintained. To alleviate the 
problems, the participants were given a choice to be examined in a separate room, or in a 
place with screens. The removal of hats, clothes, etc in order to carry out the anthropometric 
measurements was done only if the participant agreed so. 
Questioning on sensitive issues when carrying out the depression scales (pessimistic 
and suicidal thoughts for example) was handled carefully in order to minimize any 
psychological burden. The participants were treated with respect and every effort was made 
to ensure their physical and emotional comfort. A medical doctor was present at the survey 
settings to manage any clinical problems that might happen.  
The written results of medical examinations were distributed and explained to the 
participants. All subjects who were diagnosed with any clinical condition were referred to the 
respective health center for further follow up. 
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 Data were collected from 714 subjects including new and previous cases of T2DM 
and depression. However, when analyzing the association between diabetes and depression 
(prevalence and logistic regression models), the data are restricted to the subjects noted as 
newly diagnosed diabetes (NDD) (n = 632). The results will be presented into 5 parts:  
3.1   Descriptive analysis of the study population. 
3.2   Diabetes:  
3.2.1   Prevalence of DM, IFG, isolated IFG, IGT and isolated IGT; 
3.2.2   Characteristics of the study population with and without diabetes;  
3.2.3   Socio-demographic / behavioural and clinical factors associated with diabetes / 
univariate and multivariate analyses. 
3.3   Depression: 
3.3.1   Prevalence of depression according to MADRS and HDRS; 
3.3.2   Characteristics of the study population with and without depression;  
3.3.3   Socio-demographic / behavioural and clinical factors associated with 
depression / univariate and multivariate analyses. 
3.4   Relationship between diabetes and depression (MADRS and HDRS): 
3.4.1   Characteristics of the study sample with or without diabetes / depression; 
3.4.2   Prevalence of DM among depressed subjects and prevalence of depression 
among diabetics compared to disease-free individuals; 
3.4.3   Univariate and multivariate regression models. 
3.5   Correlation between HDRS and MADRS. 
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3.1   DESCRIPTIVE ANALYSIS OF THE STUDY POPULATION  
 The baseline characteristics of 714 subjects are shown in tables 3.1 and 3.2. The mean 
ages of men and women were 46.17 and 44.57 respectively. BMI, hip circumference, body 
fat percentage, 2-hour Plasma Glucose, LDL-C, fasting insulin, as well as MADRS and 
HDRS scores were significantly higher in females compared to males, whereas WHR and 
SBP were significantly lower in females compared to male subjects (Table 3.1).  
 
Table 3.1: Baseline Characteristics of 714 Subjects by Gender from Northeastern Brazil 
Variables 
 
Males 
(n=242) 
Females 
(n=472) 
Total 
(n=714) 
    
Continuous Variables Mean (95% CI) Mean (95% CI) Mean (95% CI) 
    
Age (years)      46.17 (44.15-48.20)      44.57 (43.12-46.02)      45.11 (43.93-46.29) 
BMI (Kg/m2)      25.89 (25.35-26.44)      27.36 (26.86-27.86)**      26.87 (26.48-27.25) 
Waist circumference (cm)      89.49 (87.91-91.08)      90.32 (89.13-91.51)      90.04 (89.09-90.99) 
Hip circumference (cm)      95.53 (94.41-96.65)      100.14 (99.18-101.11)**      98.58 (97.82-99.34) 
WHR      0.94 (0.92-0.95)      0.90 (0.89-0.91)**      0.916 (0.907-0.924) 
Body Fat Percentage      24.96 (24.01-25.92)      36.81 (36.19-37.43)**      32.78 (32.12-33.45) 
SBP (mmHg)      133.39 (130.54-136.26)      124.71 (122.60-126.80)**      127.65 (125.93-129.36) 
DBP (mmHg)      77.83 (76.17-79.49)      76.25 (74.53-77.97)      76.78 (75.52-78.05) 
FPG (mmol/l)      5.26 (4.98-5.54)      5.59 (5.35-5.83)      5.48 (5.29-5.67) 
2-hour Plasma Glucose (mmol/l)      7.39 (6.87-7.91)      8.09 (7.66-8.53)*      7.86 (7.52-8.20) 
Capillary HbA1c (%)      6.22 (6.07-6.36)      6.37 (6.25-6.48)      6.31 (6.22-6.41) 
Total Cholesterol (mmol/l)      4.62 (4.49-4.74)      4.76 (4.67-4.85)      4.71 (4.64-4.78) 
Triglycerides (mmol/l)      1.73 (1.44-2.03)      1.45 (1.33-1.58)      1.55 (1.42-1.68) 
HDL-C (mmol/l)      1.23 (1.22-1.24)      1.22 (1.21-1.23)      1.22 (1.21-1.23) 
LDL-C (mmol/l)      2.74 (2.62-2.86)      2.91 (2.83-3.00)*      2.86 (2.79-2.92) 
Fasting Cortisol (mcg/dl)      14.03 (13.55-14.50)      14.20 (13.69-14.72)      14.14 (13.77-14.52) 
Fasting Insulin (micro UI/ml)      5.57 (5.01-6.13)      7.38 (6.91-7.85)**      6.77 (6.40-7.14) 
MADRS score      5.79 (4.88-6.69)      9.60 (8.79-10.41)**      8.31 (7.68-8.94) 
HDRS Score      4.70 (4.02-5.38)      7.53 (6.95-8.11)**      6.57 (6.11-7.03) 
 
   
CI: Confidence Interval. BMI: Body Mass Index. WHR: Waist-to-Hip Ratio. SBP: Systolic Blood Pressure. DBP: Diastolic Blood  
Pressure. FPG: Fasting Plasma Glucose. HDL-C: High-Density Lipoprotein Cholesterol. LDL-C: Low-Density Lipoprotein Cholesterol.  
MADRS: Montgomery-Åsberg Depression Rating Scale. HDRS: Hamilton Depression Rating Scale.  
BMI, waist circumference, hip circumference, WHR, FPG, 2-hour Plasma Glucose, HDL-C and MADRS scores have 1 missing value; SBP  
and DBP have 2 missing values; capillary HbA1c has 3; fasting cortisol and triglycerides have 5; total cholesterol has 6; fasting insulin has 11; 
body fat percentage has 16; and LDL-C has 35 missing values.  
The value in men had a significant difference compared to that in women at *p<0.05 or **p<0.01 by Independent Samples T test. 
 
 There was also a significant difference between males and females with regard to the 
types of ethnicity, education and monthly income levels, marital status, smoking and alcohol 
habits, amounts of physical activity, and fat intake (Table 3.2). 
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Table 3.2: Baseline Characteristics (Cont.) of 714 Subjects by Gender from 
Northeastern Brazil 
Variables 
 
        Males 
      (n=242) 
      Females 
      (n=472) 
        Total 
       (n=714) 
 
   
Categorical Variables       % (95% CI)        % (95% CI)        % (95% CI) 
 
   
Ethnicity*    
   White      11.6% (8.1-16.3)      19.5% (16.2-23.3)      16.8% (14.2-19.7) 
   Brown      84.7% (79.6-88.7)      78.6% (74.7-82.1)      80.7% (77.6-83.4) 
   Black      3.7% (1.9-7.0)      1.9% (1.0-3.6)      2.5% (1.6-3.9) 
 
Education**    
   Illiterate      19.4% (14.9-24.9)      10.2% (7.7-13.2)      13.4% (11.0-16.0) 
   Primary School      57.9% (51.5-63.9)      57.8% (53.3-62.2)      57.8% (54.2-1.4) 
   High School      20.6% (16.0-26.2)      27.1% (23.3-31.3)      24.9% (21.9-28.2) 
   University or Higher      2.1% (0.9-4.9)      4.9% (3.3-7.2)      3.9% (2.7-5.6) 
 
Monthly Income**    
   Low (≤ 1MW)      35.8% (29.9-42.1)      76.1% (71.9-79.7)      62.5% (58.9-65.9) 
   Middle (1MW - 5MW)      62.9% (56.6-68.8)      23.5% (19.9-27.6)      36.8% (33.3-40.4) 
   High (≥ 5MW)      1.3% (0.4-3.8)      0.4% (0.1-1.7)      0.7% (0.3-1.7) 
 
Occupation    
   Student      1.2% (0.4-3.8)      1.3% (0.6-2.8)      1.3% (0.7-2.4) 
   Agriculture      15.7% (11.6-20.9)      0.4% (0.1-1.7)      5.6% (4.1-7.6) 
   Industry and Services      40.1% (34.1-46.4)      23.9% (20.3-28.0)      29.4% (26.2-32.9) 
   Domestic Labour      0.8% (0.2-3.3)      43.0% (38.6-47.5)      28.7% (25.5-32.1) 
   Construction      11.2% (7.8-15.8)      0%      3.8% (2.6-5.5) 
   Sick Benefit      0%      0.8% (0.3-2.2)      0.6% (0.2-1.5) 
   Retired      24.8% (19.7-30.6)      20.3% (16.9-24.2)      21.7% (18.9-25.0) 
   Unemployed      2.9% (1.4-5.9)      4.8% (3.1-6.9)      4.1% (2.8-5.8) 
   Other      3.3% (1.7-6.5)      5.5% (3.8-7.9)      4.8% (3.4-6.6) 
 
Marital Status**    
   Single      18.6% (14.2-24.0)      24.3% (20.5-28.3)      22.3% (19.4-25.5) 
   Married / Cohabitant      74.8% (68.9-79.9)      62.8% (58.4-67.1)      66.9% (63.4-70.3) 
   Divorced / Separated      4.5% (2.5-8.0)      3.6% (2.3-5.7)      3.9% (2.7-5.6) 
   Widow(er)      2.1% (0.9-4.9)      9.3% (7.0-12.3)      6.9% (5.2-8.9) 
 
   
Family History DM (yes)      43.0% (36.9-49.3)      38.3% (34.1-42.8)      39.9% (36.4-43.6) 
Family History Depression (yes)      12.8% (9.1-17.7)      12.9% (10.2-16.3)      12.9% (10.6-15.6) 
 
Smoking**    
   Never      50.0% (43.7-56.3)      65.0% (60.0-69.2)      59.9% (56.3-63.5) 
   Previous Mild      18.2% (13.8-23.6)      14.3% (11.3-17.7)      15.5% (13.1-18.4) 
   Previous Heavy      11.2% (7.8-15.8)      1.9% (1.0-3.6)      5.2% (3.7-6.9) 
   Current Mild       16.1% (12.0-21.3)      16.7% (13.6-20.4)      16.5% (14.0-19.4) 
   Current Heavy      4.5% (2.5-8.0)      2.1% (1.1-3.9)      2.9% (1.9-4.5) 
 
   
Alcohol Consumption in the last 12 months**    
   No      47.1% (40.9-53.4)      72.3% (68.0-76.1)      63.7% (60.1-67.2) 
   Once a month or less      22.3% (17.5-28.0)      18.6% (15.4-22.4)      19.9% (17.1-23.0) 
   2 to 4 times a month      26.0% (20.9-32.0)      8.1% (5.9-10.9)      14.1% (11.8-16.9) 
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   2 to 3 times a week      2.9% (1.4-6.0)      0.4% (0.1-1.7)      1.3% (0.7-2.4) 
   4 or more times a week      1.7% (0.6-4.3)      0.6% (0.2-2.0)      1.0% (0.5-2.0) 
 
Physical Activity**    
   Low       55.3% (49.0-61.5)      72.1% (67.8-75.9)      66.4% (62.8-69.8) 
   Moderate      33.5% (27.8-39.7)      21.8% (18.3-25.8)      25.8% (22.7-29.1) 
   High      11.2% (7.8-15.8)      6.1% (4.3-8.7)      7.8% (6.1-10.1) 
 
   
Food Intake    
 
   
Sugar     
   Low (never - 3 times a month)      0%       0.6% (0.2-2.0)      0.4% (0.1-1.3) 
   Medium (1 - 6 times a week)      12.0% (8.4-16.7)      11.1% (8.5-14.2)      11.4% (9.2-13.9) 
   High (Daily)      88.0% (83.3-91.6)      88.3% (85.1-91.0)      88.2% (85.7-90.4) 
 
   
Carbohydrate     
   Low (never - 3 times a month)      0.9% (0.2-3.3)      0.7% (0.2-2.0)      0.7% (0.3-1.7) 
   Medium (1 - 6 times a week)      1.2% (0.4-3.8)      0.6% (0.2-2.0)      0.8% (0.4-1.9) 
   High (Daily)      97.9% (95.1-99.1)      98.7% (97.2-99.4)      98.5% (97.2-99.1) 
 
   
Protein     
   Low (never - 3 times a month)      0%      0%      0% 
   Medium (1 - 6 times a week)      97.1% (94.0-98.6)      96.4% (94.3-97.8)      96.6% (95.0-97.7) 
   High (Daily)      2.9% (1.4-6.0)      3.6% (2.2-5.7)      3.4% (2.3-5.0) 
 
   
Fat**    
   Low (never - 3 times a month)      7.9% (5.1-12.0)      2.2% (1.1-3.9)      4.1% (2.8-5.8) 
   Medium (1 - 6 times a week)      26.4% (21.3-32.4)      20.3% (16.9-24.2)      22.4% (19.5-25.6) 
   High (Daily)      65.7% (59.5-71.4)      77.5% (73.5-81.1)      73.5% (70.2-76.6) 
 
   
Vegetables     
   Low (never - 3 times a month)      7.0% (4.4-11.0)      11.0% (8.5-14.2)      9.7% (7.7-12.1) 
   Medium (1 - 6 times a week)      9.1% (6.1-13.4)      5.5% (3.8-8.0)      6.7% (5.1-8.8) 
   High (Daily)      83.9% (78.7-88.0)      83.5% (79.8-86.6)      83.6% (80.7-86.2) 
 
   
CI: Confidence Interval. MW: Minimum Wage in 2012, that corresponds currently to US$ 218.00. DM: Diabetes Mellitus. 
Marital status has 1 missing value, and monthly income has 2 missing values. 
Physical Activity level was measured by using the International Physical Activity Questionnaire (IPAQ). 
Smoking → Previous: defined as those who have stopped smoking for at least 6 months; Mild: less than 20 cigarettes/day. Heavy: more 
than 20 cigarettes/day. 
The value in men had a significant difference compared to that in women at *p<0.05 or **p<0.01 by Chi-square test or Fisher's Exact test. 
 
  
 Clinical characteristics of the study subjects by ethnicity are described in table 3.3. A 
borderline non-significant difference regarding the mean values of capillary HbA1c was 
found between whites and browns (p = 0.054). However, there was no significant difference 
among the three types of ethnicity concerning all the other clinical characteristics. 
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Table 3.3: Clinical Characteristics of 714 Subjects from Northeastern Brazil by 
Ethnicity 
         White        Brown        Black 
n = 714            120            576            18 
 
   
 
      Mean (95% CI)       Mean (95% CI)       Mean (95% CI) 
 
 
  
FPG (mmol/l)      5.26 (4.83-5.70)      5.54 (5.33-5.75)      4.98 (4.18-5.78) 
2-hour Plasma Glucose (mmol/l)      7.43 (6.81-8.04)      7.96 (7.57-8.36)      7.43 (5.27-9.60) 
Capillary HbA1c (%)      6.08 (5.92-6.23)*      6.37 (6.26-6.47)*      6.26 (5.81-6.71) 
Fasting Cortisol (mcg/dl)      14.60 (13.61-15.58)      14.08 (13.67-14.50)      13.06 (10.94-15-19) 
Fasting Insulin (micro UI/ml)      6.75 (5.98-7.52)      6.81 (6.39-7.24)      5.51 (3.56-7.46) 
Total Cholesterol (mmol/l)      4.59 (4.41-4.78)      4.73 (4.65-4.81)      4.89 (4.38-5.40) 
Triglycerides (mmol/l)      1.30 (1.16-1.44)      1.60 (1.44-1.75)      1.63 (1.04-2.21) 
HDL-C (mmol/l)      1.23 (1.20-1.25)      1.22 (1.21.1.23)      1.23 (1.18-1.28) 
LDL-C (mmol/l)      2.79 (2.61-2.96)      2.87 (2.79-2.94)      2.98 (2.47-3.49) 
BMI (Kg/m2)      26.92 (25.97-27.86)      26.91 (26.49-27.33)      25.08 (22.23-27.93) 
Body Fat Percentage      33.73 (32.14-35.32)      32.70 (31.96-33.43)      29.43 (23.55-35.31) 
WHR      0.90 (0.88-0.91)      0.92 (0.91-0.93)      0.95 (0.85-1.05) 
SBP (mmHg)      128.04 (123.60-132.48)      127.57 (125.67-129.46)      127.56 (116.20-138.92) 
DBP (mmHg)      75.53 (73.23-77.83)      77.10 (75.61-78.59)      75.14 (69.63-80.65) 
MADRS score      7.77 (6.32-9.22)      8.40 (7.69-9.11)      8.83 (4.21-13.46) 
HDRS score      6.13 (5.07-7.18)      6.67 (6.15-7.19)      6.33 (3.29-9.38) 
 
 
  
CI: Confidence Interval. FPG: Fasting Plasma Glucose. HDL-C: High-Density Lipoprotein Cholesterol. LDL-C: Low-Density 
Lipoprotein Cholesterol. BMI: Body Mass Index. WHR: Waist-to-Hip Ratio. SBP: Systolic Blood Pressure. DBP: Diastolic 
Blood Pressure. MADRS: Montgomery-Åsberg Depression Rating Scale. HDRS: Hamilton Depression Rating Scale. 
*p = 0.054 tested by One-Way ANOVA. 
 
 
 Following the WHO recommended classification of adult underweight, overweight 
and obesity, the percentage distribution of BMI status of the study participants (total and by 
gender) is shown in the figure below: 
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Figure 3.1: Percentage Distribution of BMI Status in 713 Participants from 
Northeastern Brazil 
  
 
 
 
3.2   DIABETES 
 
3.2.1   Prevalence of DM, IFG, Isolated IFG, IGT and Isolated IGT 
 
 The overall prevalence of DM (new and pre-existing cases) was 16%. The total 
prevalence of diabetes increased significantly with higher age (p < 0.001), as well as the 
prevalence in males (p = 0.041) and females (p < 0.001). No significant difference was found 
between males and females (Table 3.4 and Figure 3.2). 
 
 
 
 
 
 
0
10
20
30
40
50
Pe
rc
e
n
ta
ge
 
Di
st
rib
u
tio
n
 
%
Underweight Normal Overweight Obese
BMI Categories
Male Female
Total
59 
 
Table 3.4: Prevalence of DM by Age and Gender in 714 Participants from Northeastern 
Brazil 
 
 
 
 
 
Age (years) 
 
 
Male 
________________________ 
 
      n                 Prevalence 
                of DM 
 
 
Female 
_________________________ 
 
      n                 Prevalence 
                             of DM 
 
Total 
_________________________ 
    
      n                Prevalence 
                            of DM               
 
 
  % (95% CI) 
 % (95% CI)        % (95% CI) 
 
  
  
  
   20-35    76      5.3 (2.0-13.3)* 159      6.9 (3.9-12.1)** 235      6.4 (3.9-10.3)** 
 
  
  
  
   36-50    78      15.4 (8.9-25.3) 163      17.2 (12.1-23.8) 241      16.6 (12.4-21.9) 
 
  
  
  
   ≥ 51    88      18.2 (11.4-27.8) 150      28.7 (22.0-36.5) 238      24.8 (19.7-30.7) 
 
  
  
  
Total    242      13.2 (9.5-18.1) 472      17.4 (14.2-21.1) 714      16.0 (13.5-18.8) 
 
  
  
  
CI: Confidence Interval. DM: Diabetes Mellitus.  
*p<0.05 or **p<0.01 by using Chi-square test for variation among the age categories. 
 
 
 A substantial agreement between FPG and 2-h values in the 75-g Oral Glucose 
Tolerance Test (OGTT) was found when diagnosing DM (Kappa = 0.74, p < 0.001) (Table 
3.5). 
 
Table 3.5: Agreement between FPG and OGTT in Diagnosing DM 
  Diabetes according to OGTT 
No Diabetes Diabetes Total 
Diabetes 
according to FPG 
No Diabetes 
Diabetes 
Total 
598 
22 
620 
20 
72 
92 
618 
94 
712 
FPG: Fasting Plasma Glucose. OGTT: Oral Glucose Tolerance Test. DM: Diabetes Mellitus. 
  
  
 The overall prevalence of IFG and isolated IFG were 5.8 and 4.2%, respectively. The 
prevalence of isolated IFG was significantly higher among females compared to males (p = 
0.042). No significant difference was observed with regard to the prevalence of IFG by 
gender (Table 3.6 and Figure 3.2). 
 
60 
 
Table 3.6: Prevalence of IFG and Isolated IFG by Age and Gender in Study Subjects 
from Northeastern Brazil 
 
 
 
 
 
Age (years) 
 
 
Prevalence of IFG 
____________________________________ 
 
   Male                 Female                 Total 
 
Prevalence of Isolated IFG  
______________________________________ 
 
      Male                    Female               Total 
 
   % (95% CI)    % (95% CI) 
    % (95% CI) % (95% CI) % (95% CI) % (95% CI) 
 
  
    
   20-35      2.7 (0.7-10.2)      8.2 (4.8-13.6)      6.4 (3.9-10.4)      1.3 (0.2-9.0)      7.0 (3.9-12.2)      5.2 (2.9-8.9) 
 
 
 
  
 
 
   36-50      3.8 (1.2-11.4)      3.7 (1.7-8.0)      3.7 (1.9-7.0)      2.6 (0.6-9.8)      3.1 (1.3-7.2)      2.9 (1.4-6.0) 
 
 
 
   
 
 
   ≥ 51      4.5 (1.7-11.6)      8.7 (5.1-14.4)      7.1 (4.5-11.2)      2.3 (0.6-8.8)      6.0 (3.1-11.2)      4.6 (2.6-8.2) 
 
 
 
  
 
 
Total      3.7 (1.9-7.1)      6.8 (4.8-9.4)      5.8 (4.3-7.7)      2.1 (0.9-4.9)      5.3 (3.6-7.7)*      4.2 (3.0-6.0) 
 
  
    
CI: Confidence Interval. IFG: Impaired Fasting Glucose.  
*p<0.05 by using Chi-square test between males and females. 
 
 
 The overall prevalence of IGT and isolated IGT were 11.8% and 8.8%, respectively. 
The total prevalence of IGT (p = 0.020) and the prevalence of IGT in males (p = 0.019) 
increased significantly with higher age. Furthermore, the total prevalence of isolated IGT 
showed a borderline non-significant increase with higher age (p = 0.058). Among males, the 
prevalence of isolated IGT increased significantly with higher age (p = 0.009). No significant 
difference was found between males and females with regard either to the prevalence of IGT 
or isolated IGT (Table 3.7 and Figure 3.2). 
 
 
Table 3.7: Prevalence of IGT and Isolated IGT by Age and Gender in Study Subjects 
from Northeastern Brazil 
 
 
 
 
 
Age (yrs) 
 
 
Prevalence of IGT 
__________________________________ 
 
Male                   Female                Total 
 
Prevalence of Isolated IGT  
________________________________________ 
 
          Male                      Female                  Total 
 
      % (95% CI)    % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) 
 
  
    
   20-35      5.3 (2.0-13.3)*      8.9 (5.3-14.4)      7.7 (4.9-11.9)*      2.7 (0.7-10.2)**      7.6 (4.3-12.9)      6.0 (3.6-9.9)† 
 
 
 
  
 
 
   36-50      6.4 (2.7-14.6)      14.1 (9.5-20.4)      11.6 (8.1-16.3)      5.1 (1.9-13.0)      9.8 (6.1-15.5)      8.3 (5.4-12.5) 
 
 
 
  
 
 
   ≥ 51      17.0 (10.5-26.5)      15.3 (10.4-22.1)      16.0 (11.8-21.2)      14.8 (8.7-23.9)      10.7 (6.6-16.7)      12.2 (8.6-17.0) 
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Total      9.9 (6.7-14.4)      12.7 (10.0-16.1)      11.8 (9.6-14.4)      7.9 (5.1-12.1)      9.3 (7.0-12.3)      8.8 (7.0-11.2) 
 
  
    
IGT: Impaired Glucose Tolerance. CI: Confidence Interval.  
*p<0.05 or **p<0.01 by using Chi-square test for variation among the age categories. 
†p=0.058 by using Chi-square test for variation among the age categories. 
 
 
Figure 3.2: Prevalence of DM, IFG, Isolated IFG, IGT and Isolated IGT by Gender in 
Study Subjects from Northeastern Brazil 
  
  
 The prevalence of DM was significantly higher among those with family history of 
DM (p<0.001) and high WHR (p<0.001) (Table 3.8 and Figure 3.3). Furthermore, the 
prevalence of DM increased significantly with higher BMI (p<0.001), lower amounts of 
physical activity (p<0.001) and lower levels of education (p<0.001), although slight 
insignificant decrease was observed for the "high school" stratum (Table 3.8). The prevalence 
of IFG (p=0.046) and IGT (p<0.001) were significantly higher among those with high WHR 
(Table 3.8 and Figure 3.3). Additionally, the prevalence of IGT increased significantly with 
lower amounts of physical activity (p=0.035) and higher BMI (p=0.016), although slight 
insignificant decrease was observed for the "normal" BMI stratum. Furthermore, the 
prevalence of IGT was significantly higher among those who were previous smokers 
compared to current smokers (p=0.009) (Table 3.8). 
 
0
5
10
15
20
Pr
e
va
le
n
ce
 
%
Males Females
Gender
DM IFG Isolated IFG
IGT Isolated IGT
62 
 
Table 3.8: Prevalence of DM, IFG and IGT by Selected Socio-Demographic / 
Behavioural and Clinical Variables in Study Subjects from Northeastern Brazil 
 n     Diabetes % 
     (95% CI) 
n      IFG %  
   (95% CI)        
n      IGT %  
   (95% CI) 
Ethnicity       
   White      120      12.5 (7.7-19.8)      120      3.3 (1.2-8.6)      120      16.7 (11.0-24.5) 
   Brown      576      17.0 (14.2-20.3)      575      6.3 (4.5-8.6)      575      10.8 (8.5-13.6) 
   Black      18      5.6 (0.7-32.0)      18      5.6 (0.7-32.0)      18      11.1 (2.7-36.3) 
 
    
  
Monthly Income       
   Low (≤ 1MW)      445      16.0 (12.8-19.7)      445      5.2 (3.5-7.7)      444      11.5 (8.8-14.8) 
   Middle (1MW - 5MW)      262      16.0 (12.1-21.0)      261      6.9 (4.4-10.7)      262      12.2 (8.8-16.8) 
   High (≥ 5MW)      5      20.0 (2.1-74.4)      5      0      5      20.0 (2.1-74.4) 
 
    
  
Education       
   University or Higher      28      10.7 (3.4-28.9)**      28      10.7 (3.4-28.9)      28      14.3 (5.4-32.9) 
   High School      178      5.6 (3.0-10.2)      177      3.4 (1.5-7.4)      178      7.3 (4.3-12.2) 
   Primary School      413      18.9 (15.4-23.0)      413      6.3 (4.3-9.1)      412      13.3 (10.4-17.0) 
   Illiterate      95      24.2 (16.6-33.9)      95      6.3 (2.8-13.4)      95      12.6 (7.3-21.0) 
 
    
  
Family History DM       
   No      429      10.0 (7.5-13.3)**      429      6.1 (4.2-8.8)      428      11.2 (8.5-14.6) 
   Yes      285      24.9 (20.2-30.3)      284      5.3 (3.2-8.6)      285      12.6 (9.2-17.0) 
 
    
  
Physical Activity       
   High      56      3.6 (0.9-13.4)**      56      1.8 (0.2-11.8)      56      5.4 (1.7-15.5)* 
   Moderate      184      6.5 (3.7-11.2)      183      3.3 (1.5-7.1)      184      8.2 (5.0-13.1) 
   Low       474      21.1 (17.6-25.0)      474      7.2 (5.2-9.9)      473      14.0 (11.1-17.4) 
 
    
  
Smoking       
   Never      428      14.5 (11.5-18.2)      428       5.4 (3.6-8.0)      428      11.9 (9.2-15.4) 
   Previous       147      19.7 (14.0-27.0)      147      7.5 (4.2-13.0)      146      16.4 (11.2-23.4)* 
   Current       139      16.5 (11.2-23.7)      138      5.1 (2.4-10.3)      139      6.5 (3.4-12.0) 
 
    
  
 BMI        
   <18.5 (Underweight)      26      7.7 (1.9-26.7)**      26      3.8 (0.5-23.6)      26      11.5 (3.7-30.8)* 
   18.5-24.99 (Normal)      246      9.8 (6.6-14.2)      245      4.1 (2.2-7.4)      246      8.1 (5.3-12.3) 
   25-29.99 (Overweight)      266      15.0 (11.2-19.9)      266      6.0 (3.7-9.6)      265      10.9 (7.7-15.3) 
   ≥30 (Obesity)      175      26.9 (20.8-33.9)      175      8.0 (4.8-13.1)      175      18.3 (13.2-24.7) 
 
    
  
WHR       
   Normal      221      2.3 (0.9-5.3)**      221      3.2 (1.5-6.5)* 221      5.4 (3.1-9.3)** 
   High      492      22.0 (18.5-25.8)      491      6.9 (5.0-9.5) 491      14.7 (11.8-18.1) 
 
    
  
DM: Diabetes Mellitus. IFG: Impaired Fasting Glucose. IGT: Impaired Glucose Tolerance. CI: Confidence Interval. MW: 
Minimum. WHR: Waist-to-Hip Ratio. 
Wage in 2012. BMI: Body Mass Index.  
*p<0.05 or **p<0.01 by Chi-square test or Fisher's Exact test. 
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Figure 3.3: Prevalence of DM, IFG, Isolated IFG, IGT and Isolated IGT by WHR in 
Study Subjects from Northeastern Brazil 
  
 
 
3.2.2   Characteristics of the Study Population with and without Diabetes 
 
 The mean age was significantly higher among those with diabetes compared to those 
without diabetes (53.3 vs. 43.6), while the mean years of education was significantly lower 
among those with diabetes (4.8 vs. 6.9). There was a significant difference between those 
with and without diabetes with regard to the amounts of physical activity (p<0.001). In 
addition, the alcohol consumption was significantly lower among those with diabetes. A 
positive family history of DM was more common among those with diabetes (p<0.001) 
(Table 3.9). 
 
Table 3.9: Socio-Demographic / Behavioural Characteristics of 714 Subjects with or 
without Diabetes from Northeastern Brazil 
 With Diabetes     Without Diabetes 
n = 714            114                600 
 
Mean or % (95% CI)       Mean or % (95% 
CI) 
 
  
Age (years)      53.3 (50.4-56.1)**      43.6 (42.3-44.8) 
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Gender   
   Male      28.1% (20.6-37.1)      35.0% (31.3-38.9) 
   Female      71.9% (62.9-79.4)      65.0% (61.1-68.7) 
 
 
 
Ethnicity   
   White      13.1% (8.1-20.7)      17.5% (14.7-20.8) 
   Brown      86.0% (78.3-91.2)      79.7% (76.2-82.7) 
   Black      0.9% (0.1-6.0)      2.8% (1.8-4.5) 
 
 
 
Monthly Income   
   Low (≤ 1MW)      62.3% (53.0-70.7)      62.5% (58.6-66.3) 
   Middle (1MW - 5MW)      36.8% (28.5-46.1)      36.8% (33.0-40.7) 
   High (≥ 5MW)      0.9% (0.1-6.0)      0.7% (0.3-1.8) 
 
 
 
Occupation   
   Student      0%      1.5% (0.8-2.9) 
   Agriculture      2.6% (0.8-7.9)      6.2% (4.5-8.4) 
   Industry and Services      23.7% (16.7-32.4)      30.5% (26.9-34.3) 
   Domestic Labour      28.1% (20.6-37.1)      28.8% (25.3-32.6) 
   Construction      1.8% (0.4-6.8)      4.2% (2.8-6.1) 
   Sick Benefit      0.9% (0.1-6.0)      0.5% (0.2-1.5) 
   Retired      37.7% (29.3-47.0)      18.8% (15.9-22.2) 
   Unemployed      2.6% (0.8-7.9)      4.3% (3.0-6.3) 
   Other      2.6% (0.8-7.9)      5.2% (3.7-7.3) 
 
 
 
Education (years)      4.8 (4.1-5.5)**      6.9 (6.5-7.3) 
 
 
 
Physical Activity   
   Low       87.7% (80.3-92.6)**      62.3% (58.4-66.1) 
   Moderate      10.5% (6.1-17.7)      28.7% (25.2-32.4) 
   High      1.8% (0.4-6.8)      9.0% (7.0-11.6) 
 
 
 
Smoking   
   Never      54.4% (45.1-63.3)      61.0% (57.0-64.8) 
   Previous      25.4% (18.3-34.3)      19.7% (16.7-23.1) 
   Current       20.2% (13.8-28.6)      19.3% (16.4-22.7) 
 
 
 
Alcohol Consumption (yes)      26.3% (19.0-35.2)*      38.2% (34.4-42.1) 
 
 
 
Family History DM (yes)      62.3% (53.0-70.7)**      35.7% (31.9-39.6) 
Family History Depression (yes)      13.2% (8.1-20.7)      12.8% (10.4-15.8) 
 
 
 
CI: Confidence Interval. MW: Minimum Wage in 2012. DM: Diabetes Mellitus. 
*p<0.05 or **p<0.01 by using Chi-square test or Independent Samples T test. 
 
 FPG, 2-hour plasma glucose, capillary HbA1c, fasting insulin, total cholesterol, 
triglycerides, LDL-C, BMI, body fat percentage, WHR, SBP, DBP, MADRS and HDRS 
scores were significantly higher among those with diabetes compared to those without 
diabetes. The mean levels of HDL-C showed lower borderline significant level among those 
with diabetes (Table 3.10). 
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Table 3.10: Clinical Characteristics of 714 Subjects with or without Diabetes from 
Northeastern Brazil 
      With Diabetes   Without Diabetes 
n = 714               114               600 
 
      Mean (95% CI)       Mean (95% CI) 
 
 
 
FPG (mmol/l)      9.37 (8.53-10.20)**      4.74 (4.69-4.79) 
2-hour Plasma Glucose (mmol/l)      15.69 (14.36-17.02)**      6.37 (6.27-6.47) 
Capillary HbA1c (%)      8.07 (7.67-8.47)**      5.99 (5.94-6.03) 
Fasting Cortisol (mcg/dl)      14.24 (13.23-15.26)      14.12 (13.72-14.53) 
Fasting Insulin (micro UI/ml)      8.23 (6.88-9.58)*      6.49 (6.14-6.85) 
Total Cholesterol (mmol/l)      5.14 (4.95-5.33)**      4.63 (4.55-4.71) 
Triglycerides (mmol/l)      2.22 (1.85-2.59)**      1.42 (1.28-1.55) 
HDL-C (mmol/l)      1.20 (1.18-1.23)†      1.23 (1.22-1.24) 
LDL-C (mmol/l)      3.02 (2.84-3.20)*      2.83 (2.75-2.90) 
BMI (Kg/m2)      29.43 (28.33-30.52)**      26.38 (25.99-26.78) 
Body Fat Percentage      36.61 (35.02-38.21)**      32.10 (31.36-32.80) 
WHR      0.98 (0.96-1.00)**      0.90 (0.89-0.91) 
SBP (mmHg)      138.81 (134.25-143.37)**      125.52 (123.71-127.32) 
DBP (mmHg)      81.10 (78.73-83.47)**      75.96 (74.53-77.39) 
MADRS score      10.41 (8.51-12.32)*      7.90 (7.25-8.56) 
HDRS score      8.85 (7.44-10.27)**      6.14 (5.67-6.60) 
 
 
 
CI: Confidence Interval. FPG: Fasting Plasma Glucose. HDL-C: High-Density Lipoprotein Cholesterol. LDL-C: 
Low-Density Lipoprotein Cholesterol. BMI: Body Mass Index. WHR: Waist-to-Hip Ratio. SBP: Systolic Blood 
Pressure. DBP: Diastolic Blood Pressure. MADRS: Montgomery-Åsberg Depression Rating Scale. HDRS: 
Hamilton Depression Rating Scale.  
*p<0.05, **p<0.01 or †p = 0.051 by using Independent Samples T test. 
 
 
3.2.3   Socio-Demographic / Behavioural and Clinical Factors Associated with Diabetes / 
Univariate and Multivariate Analyses 
 
 In order to identify the factors associated with diabetes, univariate and multivariate 
logistic regression models were used. Age, education level, amount of physical activity, 
alcohol consumption, family history of DM, BMI status, fasting insulin, total cholesterol, 
triglycerides, LDL-C, body fat percentage, WHR, SBP and DBP were found to be significant 
risk indicators for the occurrence of DM in univariate analysis. Monthly income, occupation 
and HDL-C were borderline non-significant indicators. Then, only those significant (and 
borderline non-significant) indicators were included in the multivariate regression model. 
Education level, family history of DM, triglycerides, body fat percentage, WHR, and DBP 
remained significant after controlling for potential confounding factors in the multivariate 
analysis. Of note, WHR was the prime indicator of diabetes in the study population. The risk 
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of developing diabetes was almost 6.4 times higher among those with a high WHR, compared 
to those with a normal value (Table 3.11). 
 
Table 3.11: Univariate and Multivariate Regression Models for the Relationship 
between Diabetes and Selected Socio-Demographic / Behavioural and Clinical Variables 
in 714 Subjects from Northeastern Brazil 
Variables n OR (95% CI)1 p-value 
 
OR (95% CI)2 p-value 
Socio-Demographic /  
Behavioural Variables 
     
 
     
Gender      
   Male    242      1.00 (reference)    
   Female    472      1.38 (0.89-2.15) 0.153   
 
  
  
 
Age groups (years)      
   20-35    235      1.00       1.00  
   36-50    241      2.92 (1.57-5.45) 0.001      1.27 (0.57-2.80) 0.556 
   ≥ 51    238      4.83 (2.65-8.81) < 0.001      1.14 (0.48-2.70) 0.773 
 
  
  
 
Ethnicity      
   White    120      1.00    
   Brown    576      1.44 (0.80-2.57) 0.225   
   Black    18      0.41 (0.05-3.32) 0.405   
 
  
  
 
Education      
   High School or Higher    206      1.00       1.00  
   Primary School    413      4.74 (2.28-9.86) < 0.001      4.54 (1.58-13.08) 0.005 
   Illiterate    95      3.46 (1.87-6.38) < 0.001      2.70 (1.16-6.28) 0.021 
 
  
  
 
Monthly Income      
   < 2MW    641      1.00       1.00  
   ≥ 2MW    71      1.77 (0.98-3.17) 0.057      1.64 (0.67-4.03) 0.283 
 
  
  
 
Occupation      
   Manual Labor    67      1.00       1.00  
   Not Manual Labor    647      2.51 (0.99-6.39) 0.053      0.98 (0.29-3.37) 0.973 
 
  
  
 
Physical Activity      
   High     56      1.00       1.00  
   Moderate    184      7.22 (1.73-30.12) 0.007      2.75 (0.56-13.49) 0.213 
   Low    474      1.88 (0.41-8.68) 0.417      0.83 (0.15-4.57) 0.830 
 
  
  
 
Smoking      
   Never    428      1.00    
   Previous    147      1.45 (0.89-2.36) 0.134   
   Current     139      1.17 (0.69-1.97) 0.555   
 
  
  
 
Alcohol Consumption       
   No    455      1.00       1.00  
   ≤ 4 times a month    243      0.60 (0.38-0.94) 0.027      0.78 (0.43-1.44) 0.434 
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   > 4 times a month    16      0.29 (0.04-2.26) 0.240      0.25 (0.02-2.77) 0.256 
 
  
  
 
Family History DM       
   No    429      1.00       1.00  
   Yes    285      2.98 (1.97-4.51) < 0.001      3.14 (1.86-5.28) < 0.001 
Family History Depression       
   No    622      1.00    
   Yes    92      1.03 (0.57-1.86) 0.924   
 
  
  
 
Clinical Variables      
 
  
  
 
BMI Status      
   < 25    272      1.00       1.00  
   25-29.99    266      1.68 (0.99-2.83) 0.055      0.52 (0.25-1.06) 0.073 
   ≥30    175      3.47 (2.06-5.87) < 0.001      0.69 (0.29-1.69) 0.419 
 
  
  
 
Fasting Cortisol (mcg/dl)      
   Low (<6.7)    31      1.00    
   Normal (6.7 - 22.6)    630      1.26 (0.43-3.68) 0.674   
   High (≥ 22.6)    48      1.78 (0.50-6.26) 0.372   
 
  
 
 
 
Fasting Insulin (micro UI/ml)    703      1.06 (1.02-1.10) 0.002      0.99 (0.94-1.04) 0.686 
 
  
  
 
Total Cholesterol (mmol/l)      
   Desirable (< 5.2)    506      1.00       1.00  
   Borderline High (5.2 - 6.2)    141      2.23 (1.40-3.57) 0.001      1.72 (0.72-4.13) 0.224 
   High (≥ 6.2)    61      2.29 (1.21-4.35) 0.011      1.58 (0.32-7.80) 0.575 
 
  
 
 
 
Triglycerides (mmol/l)      
   Desirable (< 1.7)    538      1.00       1.00  
   Borderline High (1.7 - 2.3)    76      2.38 (1.32-4.30) 0.004      1.80 (0.85-3.79) 0.123 
   High (≥ 2.3)    95      4.28 (2.61-7.03) < 0.001      3.47 (1.61-7.46) 0.001 
 
  
  
 
HDL-C (mmol/l)    713      0.20 (0.04-1.01) 0.051      0.17 (0.02-1.38) 0.097 
 
  
 
 
 
LDL-C (mmol/l)      
   Desirable (< 3.4)    512      1.00       1.00  
   Borderline High (3.4 - 4.1)    97      1.93 (1.14-3.28) 0.015      1.32 (0.52-3.32) 0.561 
   High (≥ 4.1)    70      1.16 (0.58-2.31) 0.677      0.37 (0.08-1.64) 0.191 
 
  
 
 
 
Body Fat Percentage    698      1.07 (1.04-1.09) < 0.001      1.06 (1.01-1.10) 0.014 
 
  
  
 
WHR      
   Normal    221      1.00       1.00  
   High    492      12.15 (4.88-30.24) < 0.001      6.38 (2.13-19.07) 0.001 
 
  
  
 
SBP (mmHg)      
   < 140    537      1.00       1.00  
   ≥ 140    175      2.35 (1.54-3.58) < 0.001      0.97 (0.47-1.98) 0.929 
 
  
  
 
DBP (mmHg)      
   < 90    631      1.00       1.00  
   ≥ 90    81      3.58 (2.15-5.96) < 0.001 2.56 (1.20-5.46) 0.015 
 
  
  
 
OR: Odds Ratio. CI: Confidence Interval. MW: Brazilian Minimum Wage in 2012. DM: Diabetes Mellitus. BMI: Body Mass Index. 
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HDL-C: High-Density Lipoprotein Cholesterol. LDL-C: Low-Density Lipoprotein Cholesterol. WHR: Waist-to-Hip Ratio. SBP: 
Systolic Blood Pressure. DBP: Diastolic Blood Pressure. 
1: Crude OR; 2: Adjusted OR for age, education, monthly income, occupation, physical activity, alcohol consumption, family 
history of diabetes, BMI status, fasting insulin, total cholesterol, triglycerides, HDL-C, LDL-C, body fat percentage, WHR, SBP 
and DBP. 
 
3.3   DEPRESSION 
3.3.1   Prevalence of Depression According to MADRS and HDRS 
 Initially, it is to be noted that those with a known diagnosis of depression were 
considered depressed, irrespective of the depressive scores obtained either with MADRS or 
HDRS.  
 When the MADRS was applied, the overall prevalence of depression (new and pre-
existing cases) was 15%. Among women, the prevalence of depression increased 
significantly with higher age (p=0.032). Moreover, the total prevalence of depression was 
significantly higher among women compared to men (p<0.001) (Table 3.12). 
 
Table 3.12: Prevalence of Depression (MADRS ≥ 20) by Age and Gender in 713 
Participants from Northeastern Brazil 
 
 
 
 
 
Age (years) 
 
 
Male 
________________________ 
 
      n                 Prevalence 
                of Depression 
 
 
Female 
_________________________ 
 
      n                 Prevalence 
                of Depression 
 
 
Total 
______________________ 
    
      n                Prevalence 
                of Depression 
 
 
  % (95% CI) 
 % (95% CI)        % (95% CI) 
 
  
  
  
   20-35      76 7.9 (3.6-16.6) 158      15.2 (10.4-21.7)* 234 12.8 (9.1-17.8) 
 
  
  
  
   36-50      78 6.4 (2.7-14.6) 163 16.6 (11.6-23.1) 241 13.3 (9.5-18.2) 
 
  
  
  
   ≥ 51      88 6.8 (3.1-14.5) 150 26.0 (19.6-33.6) 238 18.9 (14.4-24.4) 
 
  
  
  
Total      242 7.0 (4.4-11.0) 471       19.1 (15.8-22.9)** 713 15.0 (12.6-17.8) 
 
  
  
  
MADRS: Montgomery-Åsberg Depression Rating Scale. CI: Confidence Interval. 
*p<0.05 by using Chi-square test for variation among the age categories. 
**p<0.01 tested by Chi-square test between men and women. 
 
  
 When using the HDRS, the overall prevalence of depression (new and pre-existing 
cases) was 15.5%. No significant difference was observed for the prevalence of depression in 
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age specific strata. However, the total prevalence of depression was significantly higher 
among women compared to men (p<0.001) (Table 3.13). 
 
Table 3.13: Prevalence of Depression (HDRS ≥ 14) by Age and Gender in 714 
Participants from Northeastern Brazil 
 
 
 
 
 
Age (years) 
 
 
Male 
________________________ 
 
      n                 Prevalence 
                of Depression 
 
 
Female 
_________________________ 
 
      n                 Prevalence 
                of Depression 
 
 
Total 
______________________ 
    
      n                Prevalence 
                of Depression 
 
 
  % (95% CI) 
 % (95% CI)        % (95% CI) 
 
  
  
  
   20-35 76 9.2 (4.4-18.2) 159 16.4 (11.4-23.0) 235 14.0 (10.1-19.1) 
 
   
  
  
   36-50 78 7.7 (3.5-16.2) 163 18.4 (13.2-25.1) 241 14.9 (11.0-20.0) 
 
  
  
  
   ≥ 51 88 8.0 (3.8-15.9) 150 23.3 (17.2-30.8) 238 17.6 (13.3-23.0) 
 
  
  
  
Total    242 8.3 (5.4-12.5) 472       19.3 (16.0-23.1)** 714 15.5 (13.1-18.4) 
 
  
  
  
HDRS: Hamilton Depression Rating Scale. CI: Confidence Interval.  
**p<0.01 tested by Chi-square test between men and women. 
 
 
 According to MADRS and HDRS, the prevalence of depression decreased 
significantly with higher BMI, although slight insignificant increase was observed for the 
group with "obesity". Also according to both the scales, the prevalence of depression 
increased significantly with family history of depression, smoking habits and lower income. 
Only according to HDRS, those with an education level of "primary school" had a 
significantly higher prevalence of depression compared to those with a "high school" level 
(Table 3.14). 
 
Table 3.14: Prevalence of Depression According to MADRS and HDRS by Selected 
Socio-Demographic / Behavioural and Clinical Variables in Study Participants from 
Northeastern Brazil 
 
 
      n 
Depression -  
MADRS ≥ 20  
% (95% CI) 
       
      n 
Depression -  
HDRS ≥ 14  
% (95% CI) 
Ethnicity     
   White      120      11.7 (7.0-18.8)      120      11.7 (7.0-18.8) 
   Brown      575      15.7 (12.9-18.9)      576      16.5 (13.7-19.8) 
   Black      18      16.7 (5.3-41.8)      18      11.1 (2.7-36.3) 
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Monthly Income     
   High (≥ 5MW)      5      0*      5      0** 
   Middle (1MW - 5MW)      262      10.3 (7.2-14.6)      262      10.3 (7.2-14.6) 
   Low (≤ 1MW)      444      18.0 (14.7-21.9)      445      18.9 (15.5-22.8) 
 
    
Education     
   University or Higher      28      3.6 (0.5-22.1)      28      3.6 (0.5-22.1) 
   High School      178      12.4 (8.3-18.1)      178      11.8 (7.8-17.4)* 
   Primary School      412      17.2 (13.9-21.2)      413      18.6 (15.2-22.7) 
   Illiterate      95      13.7 (8.1-22.2)      95      12.6 (7.3-21.0) 
 
    
Marital Status     
   Single      159      16.4 (11.4-23.0)      159      17.0 (11.9-23.7) 
   Married / Cohabitant      476      13.4 (10.7-16.8)      477      14.0 (11.2-17.5) 
   Divorced / Separated      28      17.9 (7.5-36.8)      28      14.3 (5.4-32.9) 
   Widow(er)      49      24.5 (14.4-38.5)      49      26.5 (16.0-40.7) 
 
    
Family History Depression     
   No      621      12.9 (10.5-15.8)**      622      13.3 (10.9-16.3)** 
   Yes      92      29.3 (20.9-39.5)      92      30.4 (21.9-40.6) 
 
    
 BMI     
   <18.5 (Underweight)      26      34.6 (18.8-54.7)*      26      34.6 (18.8-54.7)* 
   18.5-24.99 (Normal)      246      13.8 (10.0-18.7)      246      14.6 (10.7-19.6) 
   25-29.99 (Overweight)      265      12.8 (9.3-17.4)      266      13.9 (10.2-18.6) 
   ≥30 (Obesity)      175      16.6 (11.7-22.9)      175      16.6 (11.7-22.9) 
 
    
Physical Activity     
   High      56      14.3 (7.3-26.2)      56      14.3 (7.3-26.2) 
   Moderate      184      12.5 (8.4-18.1)      184      13.0 (8.9-18.8) 
   Low       473      16.1 (13.0-19.7)      474      16.7 (13.6-20.3) 
 
    
Smoking     
   Never      428      11.9 (9.2-15.4)**      428      13.1 (10.2-16.6)* 
   Previous       146      15.8 (10.7-22.6)      147      15.6 (10.6-22.5) 
   Current       139      23.7 (17.4-31.6)      139      23.0 (16.7-30.8) 
 
    
MADRS: Montgomery-Åsberg Depression Rating Scale. HDRS: Hamilton Depression Rating Scale. CI: 
Confidence Interval. MW: Minimum Wage in 2012. BMI: Body Mass Index. 
*p< 0.05 or **p<0.01 by Chi-square test or Fisher's Exact test. 
 
3.3.2   Characteristics of the Study Population with and without Depression 
 
 When MADRS was used, it was found that the proportion of women was significantly 
higher among those with depression compared to those without depression (p<0.001). There 
was also a significant difference between those with and without depression with regard to 
the monthly income levels (p=0.019) and smoking habits (p=0.003). The alcohol 
consumption was significantly lower among those classified as depressed (p=0.019). 
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Furthermore, a positive family history of depression was more common among those with 
depression (p<0.001) (Table 3.15). 
 
Table 3.15: Socio-Demographic / Behavioural Characteristics of 713 Subjects with or 
without Depression According to MADRS from Northeastern Brazil 
 With Depression  
    MADRS ≥ 20 
Without Depression 
MADRS < 20 
n = 713              107                606 
 
  
 
  Mean or % (95% CI)   Mean or % (95% CI) 
 
  
Age (years)      47.3 (44.3-50.4)      44.8 (43.5-46.0) 
 
 
 
Gender   
   Male      15.9% (10.1-24.1)**      37.1% (33.4-41.1) 
   Female      84.1% (75.9-89.9)      62.9% (58.9-66.6) 
 
 
 
Ethnicity   
   White      13.1% (7.9-20.9)      17.5% (14.7-20.7) 
   Brown      84.1% (75.9-89.9)      80.0% (76.7-83.0) 
   Black      2.8% (0.9-8.4)      2.5% (1.5-4.1) 
 
 
 
Monthly Income   
   Low (≤ 1MW)      74.8% (65.6-82.1)*      60.3% (56.3-64.1) 
   Middle (1MW - 5MW)      25.2% (17.9-34.4)      38.9% (35.1-42.9) 
   High (≥ 5MW)      0%      0.8% (0.3-2.0) 
 
 
 
Occupation   
   Student      0.9% (0.1-6.4)      1.3% (0.7-2.6) 
   Agriculture      3.7% (1.4-9.6)      5.9% (4.3-8.1) 
   Industry and Services      23.4% (16.3-32.4)      30.4% (26.8-34.2) 
   Domestic Labour      35.5% (27.0-45.1)      27.6% (24.1-31.3) 
   Construction      0%      4.5% (3.1-6.4) 
   Sick Benefit      1.9% (0.5-7.2)      0.3% (0.1-1.3) 
   Retired      26.2% (18.7-35.4)      21.1% (18.0-24.6) 
   Unemployed      5.6% (2.5-12.0)      3.8% (2.5-5.7) 
   Other      2.8% (0.9-8.4)      5.1% (3.6-7.2) 
 
 
 
Education (years of study)      6.1 (5.4-6.9)      6.6 (6.3-7.0) 
 
 
 
Marital Status   
   Single      24.3% (17.1-33.4)      22.0% (18.9-25.5) 
   Married / Cohabitant      59.8% (50.2-68.7)      68.1% (64.3-71.7) 
   Divorced / Separated      4.7% (1.9-10.8)      3.8% (2.5-5.7) 
   Widow(er)      11.2% (6.5-18.8)      6.1% (4.5-8.3) 
 
 
 
Physical Activity   
   Low       71.0% (61.7-78.9)      65.5% (61.6-69.2) 
   Moderate      21.5% (14.7-30.3)      26.6% (23.2-30.2) 
   High      7.5% (3.8-14.3)      7.9% (6.0-10.4) 
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Smoking   
   Never      47.7% (38.3-57.2)**      62.2% (58.3-66.0) 
   Previous      21.5% (14.7-30.3)      20.3% (17.3-23.7) 
   Current       30.8% (22.8-40.3)      17.5% (14.7-20.7) 
 
 
 
Alcohol Consumption (yes)      26.2% (18.7-35.4)*      38.0% (34.2-41.9) 
 
 
 
Family History DM (yes)      43.9% (34.8-53.5)      39.3% (35.5-43.2) 
Family History Depression (yes)      25.2% (17.9-34.4)**      10.7% (8.5-13.5) 
 
 
 
MADRS: Montgomery-Åsberg Depression Rating Scale. CI: Confidence Interval. MW: Minimum  
Wage in 2012. DM: Diabetes Mellitus. 
*p< 0.05 or **p<0.01 by Chi-square test or Fisher's Exact test. 
  
 FPG, 2-hour Plasma Glucose, capillary HbA1c, body fat percentage, MADRS and 
HDRS scores were significantly higher among those classified as depressed (MADRS ≥ 20) 
(Table 3.16). 
 
Table 3.16: Clinical Characteristics of 713 Subjects with or without Depression 
According to MADRS from Northeastern Brazil 
 With Depression  
MADRS ≥ 20 
Without Depression 
MADRS < 20 
n = 713                 107               606 
 
 
 
 
      Mean (95% CI)       Mean (95% CI) 
 
  
FPG (mmol/l)      6.17 (5.46-6.87)*      5.36 (5.18-5.54) 
2-hour Plasma Glucose (mmol/l)      9.49 (8.21-10.77)**      7.57 (7.25-7.89) 
Capillary HbA1c (%)      6.70 (6.36-7.04)*      6.25 (6.16-6.33) 
Fasting Cortisol (mcg/dl)      13.09 (12.17-14.00)      14.32 (13.91-14.74) 
Fasting Insulin (micro UI/ml)      7.24 (6.32-8.16)      6.69 (6.29-7.10) 
Total Cholesterol (mmol/l)      4.87 (4.68-5.06)      4.69 (4.61-4.77) 
Triglycerides (mmol/l)      1.57 (1.36-1.79)      1.54 (1.40-1.69) 
HDL-C (mmol/l)      1.22 (1.20-1.25)      1.22 (1.21-1.23) 
LDL-C (mmol/l)      2.94 (2.78-3.11)      2.84 (2.77-2.92) 
BMI (Kg/m2)      27.04 (25.83-28.24)      26.83 (26.44-27.23) 
Body Fat Percentage      35.24 (33.49-36.99)**      32.36 (31.64-33.08) 
WHR      0.92 (0.90-0.94)      0.92 (0.91-0.92) 
SBP (mmHg)      125.49 (121.17-129.81)      128.03 (126.15-129.90) 
DBP (mmHg)      75.23 (73.31-77.16)      77.03 (75.58-78.48) 
MADRS score      24.27 (22.76-25.78)**      5.49 (5.11-5.86) 
HDRS score      17.58 (16.35-18.81)**      4.63 (4.34-4.92) 
 
 
 
MADRS: Montgomery-Åsberg Depression Rating Scale. CI: Confidence Interval. FPG: Fasting Plasma 
Glucose. HDL-C: High-Density Lipoprotein Cholesterol. LDL-C: Low-Density Lipoprotein Cholesterol. 
BMI: Body Mass Index. WHR: Waist-to-Hip Ratio. SBP: Systolic Blood Pressure. DBP: Diastolic Blood 
Pressure. HDRS: Hamilton Depression Rating Scale.  
*p<0.05 or **p<0.01 by using Independent Samples T test. 
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 Similarly to our previous findings, according to HDRS, the proportion of women was 
significantly higher among those classified as depressed (p<0.001). There was a significant 
difference between those with and without depression with regard to the monthly income 
levels (p=0.008) and smoking habits (p=0.019). The alcohol consumption was significantly 
lower among those with depression (p=0.047). Furthermore, a positive family history of 
depression was more common among those who were depressed (p<0.001) (Table 3.17). 
 
Table 3.17: Socio-Demographic / Behavioural Characteristics of 714 Subjects with or 
without Depression According to HDRS from Northeastern Brazil 
 With Depression 
HDRS ≥ 14 
Without Depression 
HDRS < 14 
n = 714 111 603 
 
  
 
  Mean or % (95% CI) Mean or % (95% CI) 
 
  
Age (years)      46.1 (43.1-49.1)      44.9 (43.6-46.2) 
 
 
 
Gender   
   Male      18.0% (11.9-26.3)**      36.8% (33.0-40.8) 
   Female      82.0% (73.7-88.1)      63.2% (59.2-67.0) 
 
 
 
Ethnicity   
   White      12.6% (7.6-20.2)      17.6% (14.7-20.8) 
   Brown      85.6% (77.7-91.0)      79.8% (76.4-82.8) 
   Black      1.8% (0.4-7.0)      2.6% (1.6-4.3) 
 
 
 
Monthly Income   
   Low (≤ 1MW)      75.7% (66.8-82.8)**      60.1% (56.1-63.9) 
   Middle (1MW - 5MW)      24.3% (17.2-33.2)      39.1% (35.3-43.1) 
   High (≥ 5MW)      0%      0.8% (0.3-2.0) 
 
 
 
Occupation   
   Student      0.9% (0.1-6.2)      1.3% (0.7-2.6) 
   Agriculture      3.6% (1.4-9.3)      6.0% (4.3-8.2) 
   Industry and Services      25.2% (18.0-34.2)      30.2% (26.6-34.0) 
   Domestic Labour      36.0% (27.6-45.4)      27.4% (23.9-31.1) 
   Construction      0%      4.5% (3.1-6.5) 
   Sick Benefit      0.9% (0.1-6.2)      0.5% (0.2-1.5) 
   Retired      24.4% (17.2-33.2)      21.4% (18.3-24.9) 
   Unemployed      7.2% (3.6-13.8)      3.5% (2.3-5.3) 
   Other      1.8% (0.4-7.0)      5.2% (3.8-7.4) 
 
 
 
Education (years of study)      6.2 (5.4-6.9)      6.6 (6.3-7.0) 
 
 
 
Marital Status   
   Single      24.3% (17.2-33.2)      21.9% (18.8-25.4) 
   Married / Cohabitant      60.4% (50.9-69.1)      68.1% (64.3-71.7) 
   Divorced / Separated      3.6% (1.4-9.3)      4.0% (2.7-5.9) 
   Widow(er)      11.7% (6.9-19.2)      6.0% (4.3-8.2) 
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Physical Activity   
   Low       71.2% (62.0-78.9)      65.5% (61.6-69.2) 
   Moderate      21.6% (14.9-30.3)      26.5% (23.2-30.2) 
   High      7.2% (3.6-13.8)      8.0% (6.0-10.4) 
 
 
 
Smoking   
   Never      50.5% (41.2-59.7)*      61.7% (57.7-65.5) 
   Previous      20.7% (14.1-29.3)      20.6% (17.5-24.0) 
   Current       28.8% (21.1-38.0)      17.7% (14.9-21.0) 
 
 
 
Alcohol Consumption (yes)      27.9% (20.3-37.0)*      37.8% (34.0-41.8) 
 
 
 
Family History DM (yes)      44.1% (35.2-53.5)      39.1% (35.3-43.1) 
Family History Depression (yes)      25.2% (18.0-34.2)**      10.6% (8.4-13.3) 
 
 
 
HDRS: Hamilton Depression Rating Scale. CI: Confidence Interval. MW: Minimum Wage in 
2012. DM: Diabetes Mellitus. 
*p< 0.05 or **p<0.01 by Chi-square test or Fisher's Exact test. 
 
 Furthermore, 2-hour Plasma Glucose, capillary HbA1c, body fat percentage, MADRS 
and HDRS scores were significantly higher among those classified as depressed according to 
HDRS (Table 3.18). 
 
Table 3.18: Clinical Characteristics of 714 Subjects with or without Depression 
According to HDRS from Northeastern Brazil 
 With Depression 
HDRS ≥ 14 
Without Depression 
HDRS < 14 
n = 714                111              603 
 
  
 
       Mean (95% CI)      Mean (95% CI) 
 
 
 
FPG (mmol/l)      5.99 (5.38-6.60)      5.39 (5.20-5.58) 
2-hour Plasma Glucose (mmol/l)      9.09 (7.96-10.22)*      7.63 (7.29-7.97) 
Capillary HbA1c (%)      6.61 (6.28-6.93)*      6.26 (6.17-6.35) 
Fasting Cortisol (mcg/dl)      13.30 (12.34-14.26)      14.30 (13.89-14.71) 
Fasting Insulin (micro UI/ml)      7.10 (6.20-7.99)      6.71 (6.31-7.12) 
Total Cholesterol (mmol/l)      4.86 (4.67-5.04)      4.68 (4.60-4.76) 
Triglycerides (mmol/l)      1.60 (1.37-1.84)      1.54 (1.39-1.68) 
HDL-C (mmol/l)      1.23 (1.20-1.25)      1.22 (1.21-1.23) 
LDL-C (mmol/l)      2.94 (2.78-3.09)      2.84 (2.77-2.92) 
BMI (Kg/m2)      26.71 (25.57-27.85)      26.89 (26.49-27.30) 
Body Fat Percentage      34.37 (32.66-36.08)*      32.49 (31.77-33.22) 
WHR      0.916 (0.89-0.94)      0.915 (0.91-0.92) 
SBP (mmHg)      124.08 (119.94-128.22)      128.30 (126.42-130.19) 
DBP (mmHg)      75.13 (73.13-77.12)      77.09 (75.64-78.54) 
MADRS score      23.23 (21.62-24.85)**      5.55 (5.16-5.95) 
HDRS score      17.95 (16.82-19.08)**      4.48 (4.21-4.74) 
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HDRS: Hamilton Depression Rating Scale. CI: Confidence Interval. FPG: Fasting Plasma Glucose. 
HDL-C: High-Density Lipoprotein Cholesterol. LDL-C: Low-Density Lipoprotein Cholesterol. BMI: 
Body Mass Index. WHR: Waist-to-Hip Ratio. SBP: Systolic Blood Pressure. DBP: Diastolic Blood 
Pressure. MADRS: Montgomery-Åsberg Depression Rating Scale. 
*p<0.05 or **p<0.01 by using Independent Samples T test. 
 
 
3.3.3   Socio-Demographic / Behavioural and Clinical Factors Associated with 
Depression / Univariate and Multivariate Analyses 
 
 Univariate and multivariate logistic regression analyses were used to identify the 
independent risk indicators for depression assessed by MADRS and HDRS (Tables 3.19 and 
3.20). According to MADRS, the significant risk indicators for the occurrence of depression 
in univariate analysis were gender, education level, monthly income, occupation, smoking, 
alcohol consumption, family history of depression and body fat percentage. Those significant 
variables were further used to perform a multivariate analysis. Only gender, smoking and 
family history of depression remained significant after the adjustment for the potential 
confounding factors. Being female, current smoker, and having a family history of depression 
were found to increase the risk for developing depression by 2.45, 2.53 and 2.92 times 
respectively (Table 3.19). 
 
Table 3.19: Univariate and Multivariate Regression Models for the Relationship 
between Depression (MADRS ≥ 20) and Selected Socio-Demographic / Behavioural and 
Clinical Variables in 713 subjects from Northeastern Brazil 
Variables             n OR (95% CI)1 p-value 
 
OR (95% CI)2 p-value 
Socio-Demographic /  
Behavioural Variables 
    
 
 
    
 
Gender      
   Male    242     1.00 (reference)      1.00  
   Female    471     3.13 (1.82-5.39) < 0.001     2.45 (1.17-5.11) 0.017 
 
  
  
 
Age groups (years)      
   20-35    234     1.00    
   36-50    241     1.04 (0.61-1.78) 0.882   
   ≥ 51    238     1.59 (0.96-2.62) 0.072   
 
  
  
 
Ethnicity      
   White    120     1.00    
   Brown    575     1.41 (0.77-2.56) 0.267   
   Black    18     1.51 (0.39-5.90) 0.550   
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Education      
   High School or Higher    206     1.00      1.00  
   Primary School    412     1.26 (0.61-2.61) 0.532     1.01 (0.45-2.29) 0.974 
   Illiterate     95     1.66 (1.001-2.74) 0.049     1.13 (0.64-1.98) 0.674 
 
  
  
 
Marital Status      
   Single    159     1.00    
   Married / Cohabitant    476     0.80 (0.48-1.31) 0.364   
   Divorced / Separated    28     1.11 (0.39-3.19) 0.844   
   Widow(er)    49     1.66 (0.76-3.60) 0.200   
 
  
  
 
Monthly Income      
   ≥ 2MW    71     1.00      1.00  
   < 2MW    640     3.21 (1.15-9.01) 0.026     1.92 (0.65-5.67) 0.241 
 
  
  
 
Occupation      
   Manual Labor    67     1.00      1.00  
   Not Manual Labor    646     2.99 (1.06-8.39) 0.038     1.43 (0.45-4.59) 0.546 
 
  
  
 
Physical Activity      
   High    56     1.00    
   Moderate    184     1.15 (0.52-2.53) 0.730   
   Low     473     0.86 (0.36-2.04) 0.727   
 
  
  
 
Smoking      
   Never    428     1.00      1.00  
   Previous    146     1.38 (0.81-2.36) 0.234     1.65 (0.92-2.98) 0.094 
   Current     139     2.30 (1.41-3.75) 0.001     2.53 (1.44-4.44) 0.001 
 
  
  
 
Alcohol Consumption       
   No    455     1.00      1.00  
   ≤ 4 times a month    242     0.55 (0.34-0.89) 0.014     0.76 (0.45-1.28) 0.303 
   > 4 times a month    16     1.10 (0.31-3.95) 0.886     1.16 (0.29-4.61) 0.835 
 
  
  
 
Family History DM       
   No    428     1.00    
   Yes    285     1.21 (0.80-1.83) 0.366   
Family History Depression       
   No    621     1.00      1.00  
   Yes    92     2.81 (1.69-4.66) < 0.001     2.92 (1.70-5.01) < 0.001 
 
  
  
 
Clinical Variables      
 
  
  
 
BMI (Kg/m2)      
   < 25    272     1.00    
   25-29.99    265     0.78 (0.48-1.27) 0.326   
   ≥30    175     1.06 (0.63-1.77) 0.830   
 
  
  
 
Fasting Cortisol       
   Low (<6.7)    31     1.00    
   Normal (6.7 - 22.6)    629     0.60 (0.25-1.44) 0.254   
   High (≥ 22.6)    48     0.31 (0.08-1.17) 0.085   
 
  
  
 
Fasting Insulin (micro UI/ml)    702     1.02 (0.98-1.06) 0.306   
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Total Cholesterol (mmol/l)      
   Desirable (< 5.2)    505     1.00    
   Borderline High (5.2 - 6.2)    141     1.42 (0.87-2.32) 0.155   
   High (≥ 6.2)    61     0.78 (0.34-1.78) 0.555   
 
  
 
 
 
Triglycerides (mmol/l)      
   Desirable (< 1.7)    537     1.00    
   Borderline High (1.7 - 2.3)    76     1.29 (0.68-2.46) 0.438   
   High (≥ 2.3)    95     1.56 (0.89-2.74) 0.117   
 
  
  
 
HDL-C (mmol/l)    712     0.97 (0.18-5.26) 0.972   
 
  
 
 
 
LDL-C (mmol/l)      
   Desirable (< 3.4)    511     1.00    
   Borderline High (3.4 - 4.1)    97     1.15 (0.64-2.07) 0.646   
   High (≥ 4.1)    70     0.97 (0.48-1.98) 0.931   
 
  
 
 
 
Body Fat Percentage    697     1.04 (1.01-1.07) 0.003     1.01 (0.98-1.04) 0.614 
 
  
  
 
WHR      
   Normal    221     1.00    
   High    491 1.05 (0.67-1.64) 0.837   
 
  
  
 
MADRS: Montgomery-Åsberg Depression Rating Scale. OR: Odds Ratio. CI: Confidence Interval. MW: Minimum Wage in 
2012. DM: Diabetes Mellitus. BMI: Body Mass Index. HDL-C: High-Density Lipoprotein Cholesterol. LDL-C: Low-Density 
Lipoprotein Cholesterol. WHR: Waist-to-Hip Ratio.  
1: Crude OR; 2: Adjusted OR for gender, education, monthly income, occupation, smoking, alcohol consumption, family history 
of depression and body fat percentage. 
 
  
 Similarly, according to HDRS, gender, education, monthly income, occupation, 
smoking, alcohol consumption, family history of depression, and body fat percentage were 
found to be significant indicators in univariate analysis. In multivariate analysis, only gender, 
smoking and family history of depression remained significant after adjusting for the 
potential confounding factors (Table 3.20).  
 
Table 3.20: Univariate and Multivariate Regression Models for the Relationship 
between Depression (HDRS ≥ 14) and Selected Socio-Demographic / Behavioural and 
Clinical Variables in 714 Subjects from Northeastern Brazil 
Variables             n OR (95% CI)1 p-value 
 
OR (95% CI)2 p-value 
Socio-Demographic /  
Behavioural Variables 
    
 
 
    
 
Gender      
   Male    242     1.00 (reference)      1.00  
   Female    472     2.65 (1.59-4.42) < 0.001     2.49 (1.24-5.00) 0.010 
 
  
  
 
Age groups (years)      
   20-35    235     1.00    
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   36-50    241     1.08 (0.65-1.79) 0.782   
   ≥ 51    238     1.31 (0.80-2.16) 0.284   
 
  
  
 
Ethnicity      
   White    120     1.00    
   Brown    576     1.50 (0.82-2.72) 0.188   
   Black    18     0.95 (0.20-4.56) 0.945   
 
  
  
 
Education      
   High School or Higher    206     1.00      1.00  
   Primary School    413     1.21 (0.57-2.56) 0.619     1.12 (0.49-2.55) 0.796 
   Illiterate     95        1.92 (1.16-3.18) 0.012     1.52 (0.88-2.65) 0.137 
 
  
  
 
Marital Status      
   Single    159     1.00        
   Married / Cohabitant    477     0.80 (0.49-1.30) 0.367   
   Divorced / Separated    28     0.82 (0.26-2.54) 0.724   
   Widow(er)    49     1.77 (0.83-3.77) 0.141   
 
  
  
 
Monthly Income      
   ≥ 2MW    71     1.00      1.00  
   < 2MW    641     2.62 (1.03-6.65) 0.043     1.60 (0.59-4.29) 0.355 
 
  
  
 
Occupation      
   Manual Labor    67     1.00      1.00  
   Not Manual Labor    647     3.12 (1.11-8.76) 0.031     1.99 (0.63-6.27) 0.239 
 
  
  
 
Physical Activity      
   High    56     1.00        
   Moderate    184     1.20 (0.55-2.64) 0.650   
   Low     474     0.90 (0.38-2.13) 0.811   
 
  
  
 
Smoking      
   Never    428     1.00      1.00  
   Previous    147     1.23 (0.73-2.09) 0.437     1.39 (0.79-2.48) 0.256 
   Current     139     1.99 (1.22-3.23) 0.006     1.93 (1.11-3.36) 0.020 
 
  
  
 
Alcohol Consumption       
   No    455     1.00      1.00  
   ≤ 4 times a month    243     0.61 (0.39-0.97) 0.036     0.84 (0.51-1.38) 0.485 
   > 4 times a month    16     1.08 (0.30-3.88) 0.904     1.19 (0.30-4.69) 0.808 
 
  
  
 
Family History DM       
   No    429     1.00    
   Yes    285     1.23 (0.82-1.85) 0.323   
Family History Depression       
   No    622     1.00      1.00  
   Yes    92     2.84 (1.72-4.69) < 0.001     2.84 (1.67-4.82) < 0.001 
 
  
  
 
Clinical Variables      
 
  
  
 
BMI (Kg/m2)      
   < 25    272     1.00    
   25-29.99    266     0.82 (0.51-1.31) 0.396   
   ≥30    175     1.002 (0.60-1.67) 0.994   
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Fasting Cortisol       
   Low (<6.7)    31     1.00    
   Normal (6.7 - 22.6)    630     0.62 (0.26-1.47) 0.275   
   High (≥ 22.6)    48     0.49 (0.15-1.63) 0.244   
 
  
  
 
Fasting Insulin (micro UI/ml)    703     1.01 (0.98-1.05) 0.460   
 
  
 
 
 
Total Cholesterol (mmol/l)      
   Desirable (< 5.2)    506     1.00    
   Borderline High (5.2 - 6.2)    141     1.34 (0.83-2.18) 0.237   
   High (≥ 6.2)    61     0.73 (0.32-1.67) 0.461   
 
  
 
 
 
Triglycerides (mmol/l)      
   Desirable (< 1.7)    538     1.00    
   Borderline High (1.7 - 2.3)    76     1.22 (0.64-2.32) 0.550   
   High (≥ 2.3)    95     1.47 (0.85-2.57) 0.172   
 
  
  
 
HDL-C (mmol/l)    713     1.40 (0.26-7.40) 0.696   
 
  
 
 
 
LDL-C (mmol/l)      
   Desirable (< 3.4)    512     1.00        
   Borderline High (3.4 - 4.1)    97     1.27 (0.72-2.23) 0.411   
   High (≥ 4.1)    70     0.82 (0.39-1.72) 0.601   
 
  
 
 
 
Body Fat Percentage    698     1.02 (1.00-1.05) 0.046     0.99 (0.96-1.02) 0.484 
 
  
  
 
WHR      
   Normal    221     1.00        
   High    492     0.92 (0.60-1.43) 0.722   
 
  
  
 
HDRS: Hamilton Depression Rating Scale. OR: Odds Ratio. CI: Confidence Interval. MW: Minimum Wage in 2012. DM: 
Diabetes Mellitus. BMI: Body Mass Index. HDL-C: High-Density Lipoprotein Cholesterol. LDL-C: Low-Density Lipoprotein 
Cholesterol. WHR: Waist-to-Hip Ratio. 
1: Crude OR; 2: Adjusted OR for gender, education, monthly income, occupation, smoking, alcohol consumption, family history 
of depression and body fat percentage. 
 
3.4   RELATIONSHIP BETWEEN DIABETES AND DEPRESSION (MADRS AND 
HDRS) 
3.4.1   Characteristics of the Study Sample with or without Diabetes / Depression 
 
 When MADRS was applied to assess depression, it was found that 34 (4.8%) subjects 
had both diabetes and depression, 73 (10.2%) had depression but not diabetes, 80 (11.2%) 
diabetes without depression, and 526 (73.8%) were free from both the conditions. Those 
without both the diseases (diabetes and depression) had lower age, were more likely to be 
male and white, were more educated, were less likely to be widow (er), had a moderate / high 
level of physical activity and were more likely to drink alcohol. On the other hand, subjects 
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with both diabetes and depression were more likely to be older, women, brown, less educated, 
widow (er), and have a sedentary lifestyle. Those with diabetes but not depression had a 
middle / high income, were more likely to be married, have a sedentary lifestyle, previous 
smoker, and have a positive family history of diabetes, whereas subjects with only depression 
had low income, were more likely to be single or divorced / separated, current smoker and 
have a family history of depression (Table 3.21). 
 
Table 3.21: Socio-Demographic and Behavioural Characteristics of 713 Subjects with or 
without Diabetes / Depression (MADRS ≥ 20) 
Characteristics Healthy Subjects 
(Without Diabetes 
and Depression) 
With Diabetes  / 
Without 
Depression 
With Depression / 
Without Diabetes 
With Diabetes 
and Depression 
n = 713               526               80               73               34 
 
    
 
Mean or % (95% CI) Mean or % (95% CI) Mean or % (95% CI) Mean or % (95% CI) 
 
    
Age (years)      43.5 (42.1-44.8)      53.0 (49.6-56.4)      44.3 (40.7-47.9)      53.9 (48.5-59.2) 
 
    
Gender     
   Male      37.3% (33.2-41.5)      36.3% (26.3-47.5)      19.2% (11.6-30.1)      8.8% (2.7-25.2) 
   Female      62.7% (58.5-66.8)      63.7% (52.5-73.7)      80.8% (69.9-88.4)      91.2% (74.8-97.3) 
 
  
  
Ethnicity     
   White      17.8% (14.8-21.4)      15.0% (8.6-24.8)      15.1% (8.4-25.5)      8.8% (2.7-25.2) 
   Brown      79.3% (75.6-82.5)      85.0% (75.2-91.4)      82.2% (71.4-89.5)      88.3% (71.4-95.7) 
   Black      2.9% (1.7-4.7)      0%      2.7% (0.7-10.6)      2.9% (0.4-19.8) 
 
  
  
Monthly Income     
   Low (≤ 1MW)      60.7% (56.4-64.8)      57.5% (46.2-68.0)      75.3% (63.9-84.1)      73.5% (55.5-86.1) 
   Middle (1MW - 5MW)      38.5% (34.5-42.8)      41.2% (30.8-52.5)      24.7% (15.9-36.1)      26.5% (13.9-44.5) 
   High (≥ 5MW)      0.8% (0.3-2.0)      1.3% (0.2-8.7)      0%      0% 
 
  
  
Education (years of study)      6.9 (6.5-7.3)      4.8 (3.9-5.8)      6.8 (5.8-7.8)      4.7 (3.6-5.9) 
 
  
  
Marital Status     
   Single      23.6% (20.2-27.5)      11.2% (5.9-20.5)      30.2% (20.5-41.9)      11.8% (4.3-28.6) 
   Married / Cohabitant      67.0% (62.9-70.9)      75.0% (64.1-83.4)      54.8% (43.1-66.0)      70.6% (52.5-83.9) 
   Divorced / Separated      4.2% (2.8-6.3)      1.3% (0.2-8.7)      6.8% (2.8-15.7)      0% 
   Widow(er)      5.2% (3.5-7.4)      12.5% (6.8-21.9)      8.2% (3.7-17.4)      17.6% (7.8-35.2) 
 
  
  
Physical Activity     
   Low       62.2% (57.9-66.2)      87.5% (78.1-93.2)      63.0% (51.2-73.5)      88.2% (71.4-95.7) 
   Moderate      28.7% (25.0-32.7)      12.5% (6.8-21.9)      28.8% (19.4-40.4)      5.9% (1.4-22.0) 
   High      9.1% (6.9-11.9)      0%      8.2% (3.7-17.4)      5.9% (1.4-22.0) 
 
  
  
Smoking     
   Never      63.3% (59.1-67.3)      55.0% (43.8-65.7)      45.2% (34.0-56.9)      52.9% (35.6-69.6) 
   Previous      19.2% (16.0-22.8)      27.5% (18.7-38.5)      21.9% (13.7-33.1)      20.6% (9.7-38.4) 
   Current       17.5% (14.5-21.0)      17.5% (10.5-27.7)      32.9% (22.9-44.7)      26.5% (13.9-44.5) 
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Alcohol Consumption (yes)      39.2% (35.1-43.4)      30.0% (20.8-41.1)      30.1% (20.5-41.9)      17.6% (7.8-35.2) 
 
  
  
Family History DM (yes)      35.6% (31.6-39.8)      63.7% (52.5-73.7)      37.0% (26.5-48.8)      58.8% (41.0-74.6) 
Family History Depression (yes)      11.0% (8.6-14.0)      8.8% (4.2-17.5)      26.0% (17.1-37.5)      23.5% (11.8-41.5) 
 
  
  
MADRS: Montgomery-Åsberg Depression Rating Scale. CI: Confidence Interval. MW: Minimum Wage in 2012. DM: Diabetes 
Mellitus. 
 
 Following MADRS, healthy subjects had the lowest mean values of 2-hour plasma 
glucose, capillary HbA1c, fasting insulin, total cholesterol, LDL-C, body fat percentage, 
WHR (same as in those with only depression), and HDRS scores. On the other hand, those 
with both the conditions (diabetes and depression) had the highest mean values of FPG, 2-
hour plasma glucose, capillary HbA1c, fasting insulin, total cholesterol, LDL-C, BMI and 
body fat percentage. The subjects with diabetes but not depression had the highest mean 
levels of fasting cortisol, triglycerides, WHR, SBP, and DBP, while those with only 
depression had the highest mean values of HDL-C, MADRS and HDRS scores (Table 3.22). 
Table 3.22: Clinical Characteristics of 713 Subjects with or without Diabetes / 
Depression (MADRS ≥ 20) 
Characteristics Healthy Subjects 
(Without Diabetes 
and Depression) 
With Diabetes  / 
Without 
Depression 
With Depression / 
Without Diabetes 
With Diabetes and 
Depression 
n = 713               526               80               73               34 
 
    
 
Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) 
 
  
  
FPG (mmol/l)       4.75 (4.69-4.81)       9.35 (8.40-10.30)       4.64 (4.49-4.79)       9.40 (7.62-11.18) 
2-hour Plasma Glucose (mmol/l)       6.36 (6.25-6.46)       15.56 (14.12-17.00)       6.46 (6.17-6.76)       15.98 (12.94-19.02) 
Capillary HbA1c (%)       5.98 (5.93-6.02)       8.02 (7.57-8.48)       6.02 (5.89-6.15)       8.19 (7.32-9.07) 
Fasting Cortisol (mcg/dl)       14.28 (13.84-14.71)       14.65 (13.41-15.88)       13.01 (11.94-14.08)       13.26 (11.43-15.08) 
Fasting Insulin (micro UI/ml)       6.46 (6.08-6.84)       8.19 (6.44-9.94)       6.74 (5.74-7.73)       8.32 (6.31-10.32) 
Total Cholesterol (mmol/l)       4.62 (4.54-4.71)       5.12 (4.90-5.34)       4.72 (4.51-4.92)       5.19 (4.80-5.57) 
Triglycerides (mmol/l)       1.43 (1.28-1.58)       2.28 (1.78-2.78)       1.33 (1.11-1.56)       2.08 (1.65-2.51) 
HDL-C (mmol/l)       1.23 (1.22-1.24)       1.21 (1.18-1.24)       1.24 (1.21-1.27)       1.19 (1.14-1.23) 
LDL-C (mmol/l)       2.74 (2.65-2.83)       2.87 (2.62-3.12)       2.87 (2.68-3.06)       3.04 (2.70-3.39) 
BMI (Kg/m2)       26.49 (26.08-26.91)       29.08 (27.94-30.22)       25.57 (24.38-26.76)       30.28 (27.66-32.89) 
Body Fat Percentage       31.81 (31.03-32.58)       36.07 (34.29-37.85)       34.07 (32.07-36.07)       37.95 (34.45-41.45) 
WHR       0.90 (0.89-0.91)       0.99 (0.96-1.02)       0.90 (0.87-0.92)       0.97 (0.94-1.00) 
SBP (mmHg)       126.2 (124.3-128.2)       139.9 (134.4-145.4)       120.4 (115.8-125.1)       136.3 (127.8-144.9) 
DBP (mmHg)       76.21 (74.60-77.81)       82.40 (79.45-85.36)       73.92 (71.74-76.11)       78.04 (74.18-81.91) 
MADRS score       5.57 (5.16-5.98)       4.96 (4.00-5.92)       24.75 (23.00-26.50)       23.24 (20.22-26.25) 
HDRS score       4.54 (4.23-4.84)       5.24 (4.39-6.09)       17.68 (16.32-19.05)       17.35 (14.69-20.01) 
 
  
  
MADRS: Montgomery-Åsberg Depression Rating Scale. CI: Confidence Interval. FPG: Fasting Plasma Glucose. HDL-C: High-Density 
Lipoprotein Cholesterol. LDL-C: Low-Density Lipoprotein Cholesterol. BMI: Body Mass Index. WHR: Waist-to-Hip Ratio. SBP: 
Systolic Blood Pressure. DBP: Diastolic Blood Pressure. HDRS: Hamilton Depression Rating Scale.  
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 When HDRS was the tool used to evaluate depressive symptoms, it was observed that 
35 (4.9%) subjects had both diabetes and depression, 76 (10.6%) had depression but not 
diabetes, 79 (11.1%) diabetes without depression, and 524 (73.4%) were free from both the 
conditions. Disease-free subjects were more likely to be male, white or black, had a higher 
level of education, were less likely to be widow (er), had a moderate / high level of physical 
activity and were more likely to drink alcohol. On the contrary, subjects with both diabetes 
and depression were more likely to be women, brown, widow (er), have a low level of 
physical activity, and low income. Those with diabetes but not depression were older, had a 
middle / high income, were more likely to be less educated, married, have a sedentary 
lifestyle, be previous smoker, and have a positive family history of diabetes, whereas subjects 
with only depression were younger, had a low income, were more likely to be single or 
divorced / separated, current smoker and have a family history of depression (Table 3.23). 
 
Table 3.23: Socio-Demographic and Behavioural Characteristics of 714 Subjects with or 
without Diabetes / Depression (HDRS ≥ 14) 
Characteristics Healthy Subjects 
(Without Diabetes 
and Depression) 
With Diabetes  / 
Without 
Depression 
With Depression 
/ Without 
Diabetes 
With Diabetes 
and Depression 
n = 714               524               79               76               35 
 
    
 
Mean or % (95% CI) Mean or % (95% CI) Mean or % (95% 
CI) 
Mean or % (95% 
CI) 
 
    
Age (years)       43.6 (42.3-45.0)       53.8 (50.3-57.2)       43.3 (39.8-46.8)       52.2 (46.8-57.5) 
 
    
Gender     
   Male       37.2% (33.2-41.5)       34.2% (24.4-45.5)       19.7% (12.1-30.5)       14.3% (5.8-31.1) 
   Female       62.8% (58.5-66.8)       65.8% (54.5-75.6)       80.3% (69.5-87.9)       85.7% (68.9-94.2) 
 
  
  
Ethnicity     
   White       17.9% (14.9-21.5)       15.2% (8.7-25.1)       14.5% (8.1-24.6)       8.6% (2.6-24.6) 
   Brown       79.2% (75.5-82.5)       83.5% (73.4-90.3)       82.9% (72.5-89.9)       91.4% (75.4-97.4) 
   Black       2.9% (1.7-4.7)       1.3% (0.2-8.8)       2.6% (0.6-10.2)       0% 
 
  
  
Monthly Income     
   Low (≤ 1MW)       60.5% (56.3-64.7)       57.0% (45.6-67.6)       76.3% (65.2-84.7)       74.3% (56.5-86.5) 
   Middle (1MW - 5MW)       38.7% (34.6-43.0)       41.7% (31.2-53.1)       23.7% (15.3-34.8)       25.7% (13.5-43.5) 
   High (≥ 5MW)       0.8% (0.3-2.0)       1.3% (0.2-8.8)       0%       0% 
 
  
  
Education (years of study)       6.9 (6.5-7.3)       4.8 (3.8-5.7)       6.7 (5.8-7.7)       4.9 (3.7-6.0) 
 
  
  
Marital Status     
   Single       23.5% (20.1-27.4)       11.3% (5.9-20.7)       30.3% (20.8-41.7)       11.4% (4.1-27.8) 
   Married / Cohabitant       67.1% (63.0-71.0)       74.7% (63.7-83.2)       55.2% (43.7-66.2)       71.4% (53.6-84.4) 
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   Divorced / Separated       4.4% (2.9-6.5)       1.3% (0.2-8.8)       5.3% (1.9-13.5)       0% 
   Widow(er)       5.0% (3.4-7.2)       12.7% (6.9-22.2)       9.2% (4.4-18.4)       17.2% (7.6-34.3) 
 
  
  
Physical Activity     
   Low        62.2% (58.0-66.3)       87.3% (77.8-93.1)       63.2% (51.6-73.4)       88.6% (72.2-95.9) 
   Moderate       28.6% (24.9-32.7)       12.7% (6.9-22.2)       28.9% (19.7-40.4)       5.7% (1.3-21.4) 
   High       9.2% (7.0-12.0)       0%       7.9% (3.5-16.7)       5.7% (1.3-21.4) 
 
  
  
Smoking     
   Never       62.8% (58.5-66.8)       54.4% (43.2-65.3)       48.7% (37.5-60.1)       54.3% (37.1-70.5) 
   Previous       19.5% (16.3-23.1)       27.8% (18.9-39.0)       21.1% (13.2-31.9)       20.0% (9.5-37.4) 
   Current        17.7% (14.7-21.3)       17.8% (10.7-28.0)       30.2% (20.8-41.7)       25.7% (13.5-43.5) 
 
  
  
Alcohol Consumption (yes)       39.5% (35.4-43.8)       26.6% (17.9-37.6)       28.9% (19.7-40.4)       25.7% (13.5-43.5) 
 
  
  
Family History DM (yes)       35.3% (31.3-39.5)       64.6% (53.2-74.5)       38.2% (27.8-49.8)       57.1% (39.7-72.9) 
Family History Depression (yes)       10.9% (8.5-13.9)       8.9% (4.2-17.7)       26.3% (17.5-37.6)       22.9% (11.4-40.5) 
 
  
  
HDRS: Hamilton Depression Rating Scale. CI: Confidence Interval. MW: Minimum Wage in 2012. DM: Diabetes Mellitus. 
 
 
 Regarding clinical characteristics, disease-free subjects had the lowest mean values of 
2-hour plasma glucose, fasting insulin, total cholesterol, LDL-C, body fat percentage, and 
HDRS scores. On the other hand, those with both the conditions (diabetes and depression) 
had the highest mean values of fasting insulin, total cholesterol, LDL-C, BMI and body fat 
percentage. The subjects with diabetes but not depression had the highest mean levels of FPG, 
2-hour plasma glucose, capillary HbA1c, fasting cortisol, triglycerides, WHR, SBP, and DBP, 
while those with only depression had the highest mean values of HDL-C, MADRS and 
HDRS scores (Table 3.24). 
 
Table 3.24: Clinical Characteristics of 714 Subjects with or without Diabetes / 
Depression (HDRS ≥ 14) 
Characteristics Healthy Subjects 
(Without Diabetes 
and Depression) 
With Diabetes  / 
Without 
Depression 
With Depression / 
Without Diabetes 
With Diabetes and 
Depression 
n = 714               524               79               76               35 
 
  
  
 
Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) 
 
  
  
FPG (mmol/l)       4.76 (4.70-4.81)       9.58 (8.55-10.60)       4.63 (4.49-4.78)       8.89 (7.38-10.41) 
2-hour Plasma Glucose (mmol/l)       6.36 (6.25-6.46)       16.06 (14.54-17.58)       6.44 (6.16-6.73)       14.84 (12.10-17.59) 
Capillary HbA1c (%)       5.99 (5.94-6.03)       8.10 (7.64-8.56)       5.98 (5.85-6.12)       8.01 (7.15-8.87) 
Fasting Cortisol (mcg/dl)       14.26 (13.83-14.70)       14.53 (13.30-15.76)       13.18 (12.05-14.31)       13.58 (11.71-15.45) 
Fasting Insulin (micro UI/ml)       6.49 (6.10-6.87)       8.20 (6.43-9.96)       6.55 (5.60-7.50)       8.31 (6.32-10.29) 
Total Cholesterol (mmol/l)       4.62 (4.54-4.71)       5.10 (4.88-5.31)       4.68 (4.49-4.88)       5.23 (4.85-5.62) 
Triglycerides (mmol/l)       1.43 (1.28-1.58)       2.23 (1.74-2.72)       1.33 (1.11-1.55)       2.20 (1.66-2.73) 
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HDL-C (mmol/l)       1.23 (1.22-1.24)       1.21 (1.18-1.23)       1.24 (1.21-1.27)       1.20 (1.15-1.24) 
LDL-C (mmol/l)       2.74 (2.65-2.84)       2.87 (2.63-3.11)       2.84 (2.65-3.02)       3.03 (2.65-3.41) 
BMI (Kg/m2)       26.52 (26.10-26.94)       29.38 (28.23-30.53)       25.41 (24.30-26.52)       29.53 (27.00-32.06) 
Body Fat Percentage       31.90 (31.12-32-67)       36.59 (34.79-38.39)       33.36 (31.41-35.32)       36.66 (33.25-40.07) 
WHR       0.90 (0.89-0.91)       0.99 (0.96-1.02)       0.89 (0.87-0.92)       0.96 (0.94-0.99) 
SBP (mmHg)       126.5 (124.6-128.5)       140.1 (134.6-145.7)       118.7 (114.4-122.9)       135.8 (127.4-144.3) 
DBP (mmHg)       76.33 (74.72-77.94)       82.13 (79.22-85.03)       73.44 (71.30-75.60)       78.79 (74.60-82.98) 
MADRS score       5.55 (5.14-5.97)       5.54 (4.27-6.82)       24.08 (22.27-25.88)       21.40 (18.03-24.77) 
HDRS score       4.41 (4.13-4.70)       4.89 (4.18-5.60)       18.01 (16.77-19.26)       17.80 (15.35-20.25) 
 
  
  
HDRS: Hamilton Depression Rating Scale. CI: Confidence Interval. FPG: Fasting Plasma Glucose. HDL-C: High-Density 
Lipoprotein Cholesterol. LDL-C: Low-Density Lipoprotein Cholesterol. BMI: Body Mass Index. WHR: Waist-to-Hip Ratio. SBP: 
Systolic Blood Pressure. DBP: Diastolic Blood Pressure. MADRS: Montgomery-Åsberg Depression Rating Scale. 
 
3.4.2   Prevalence of DM among Depressed Subjects and Prevalence of Depression 
among Diabetics Compared to Disease-Free Individuals  
 
 When MADRS was used to assess depression, the prevalence of DM among those 
with depression (MADRS ≥ 20) was significantly higher compared to those without 
depression only among women (22.0% vs. 7.6%, p=0.001) (Figure 3.4). However, when 
HDRS was the tool used, the prevalence of DM among the subjects with depression (HDRS ≥ 
14) was significantly higher compared to those without depression in both genders (Female: 
22.6% vs. 7.4%, p<0.001 / Male: 25.0% vs. 6.9%, p=0.032) (Figure 3.5). 
 
Figure 3.4: Prevalence of DM among Those with and without Depression (MADRS ≥ 
20), by Gender 
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Figure 3.5: Prevalence of DM among Those with and without Depression (HDRS ≥ 14), 
by Gender 
  
  
  
 
 Similarly, when using MADRS, the prevalence of depression (MADRS ≥ 20) was 
significantly higher among diabetics compared to those without diabetes only among women 
(32.5% vs. 12.3%, p=0.001) (Figure 3.6). However, when HDRS was employed as a tool for 
assessing depression, the prevalence of depression (HDRS ≥ 14) was significantly higher 
among those with diabetes compared to those without diabetes for both genders (Female: 
35.0% vs. 12.8%, p<0.001 / Male: 22.2% vs. 6.0%, p=0.032) (Figure 3.7). 
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Figure 3.6: Prevalence of Depression (MADRS ≥ 20) among Those with and without 
DM, by Gender 
 
 
 
Figure 3.7: Prevalence of Depression (HDRS ≥ 14) among Those with and without DM, 
by Gender 
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3.4.3   Univariate and Multivariate Regression Models 
 
 When MADRS was applied to assess depression, the significant risk indicators for the 
occurrence of diabetes in univariate analysis were age, education, physical activity, family 
history of diabetes, depression (MADRS ≥ 20), BMI status, fasting insulin, total cholesterol, 
triglycerides, LDL-C, body fat percentage, WHR, SBP and DBP. Then, only these significant 
indicators in univariate analysis were further included in the multivariate regression model. 
Family history of DM, depression, triglycerides, body fat percentage, and WHR remained 
significant in multivariate analysis. The risk for developing diabetes was about 8 times higher 
among those with a high WHR and almost 4 times higher among depressed subjects (Table 
3.25). 
 
Table 3.25: Univariate and Multivariate Regression Models for the Relationship 
between Diabetes and Selected Socio-Demographic / Behavioural and Clinical Variables 
(Including Depression - MADRS ≥ 20) in 632 Subjects from Northeastern Brazil 
Variables n OR (95% CI)1 p-value 
 
OR (95% CI)2 p-value 
Socio-Demographic /  
Behavioural Variables 
     
 
     
Gender      
   Male    218      1.00 (reference)    
   Female    414      1.19 (0.66-2.13) 0.561   
 
  
  
 
Age groups (years)      
   20-35    229      1.00       1.00  
   36-50    214      2.07 (0.99-4.30) 0.050      0.79 (0.32-1.99) 0.623 
   ≥ 51    189      2.63 (1.28-5.41) 0.009      0.45 (0.16-1.27) 0.132 
 
  
  
 
Ethnicity      
   White    108      1.00    
   Brown    507      1.34 (0.61-2.91) 0.464   
   Black    17      0.78 (0.09-6.67) 0.822   
 
  
  
 
Education      
   High School or Higher    199      1.00       1.00  
   Primary School    353      3.02 (1.18-7.73) 0.022      3.22 (0.84-12.25) 0.087 
   Illiterate    80      2.62 (1.24-5.53) 0.011      2.02 (0.77-5.33) 0.156 
 
  
  
 
Monthly Income      
   < 2MW    569      1.00    
   ≥ 2MW    61      1.84 (0.86-3.95) 0.120   
 
  
  
 
Occupation      
   Manual Labor    65      1.00    
   Not Manual Labor    567      2.22 (0.67-7.32) 0.190   
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Physical Activity      
   High     53      1.00       1.00  
   Moderate    167      7.51 (1.02-55.50) 0.048      2.71 (0.30-24.59) 0.375 
   Low    412      1.61 (0.18-14.05) 0.669      0.78 (0.08-8.22) 0.839 
 
  
  
 
Smoking      
   Never    387      1.00    
   Previous    126      1.49 (0.78-2.87) 0.222   
   Current     119      1.13 (0.55-2.32) 0.739   
 
  
  
 
Alcohol Consumption       
   No    388      1.00    
   ≤ 4 times a month    229      1.07 (0.61-1.88) 0.808   
   > 4 times a month    15      0.72 (0.09-5.64) 0.755   
 
  
  
 
Family History DM       
   No    394      1.00       1.00  
   Yes    238      2.57 (1.48-4.45) 0.001      3.08 (1.56-6.06) 0.001 
Family History Depression       
   No    553      1.00    
   Yes    79      0.96 (0.42-2.19) 0.917   
 
  
  
 
Clinical Variables      
 
  
  
 
Depression (MADRS ≥ 20)      
   No    558      1.00       1.00  
   Yes    73      3.10 (1.62-5.92) 0.001      3.90 (1.69-8.99) 0.001 
 
  
  
 
BMI Status      
   < 25    243      1.00       1.00  
   25-29.99    237      2.66 (1.20-5.91) 0.016      0.75 (0.27-2.07) 0.580 
   ≥30    152      5.62 (2.56-12.31) < 0.001      1.18 (0.35-3.98) 0.785 
 
  
  
 
Fasting Cortisol (mcg/dl)      
   Low (<6.7)    27      1.00    
   Normal (6.7 - 22.6)    556      1.21 (0.28-5.25) 0.801   
   High (≥ 22.6)    45      2.30 (0.44-12.00) 0.322   
 
  
 
 
 
Fasting Insulin (micro UI/ml)    622      1.08 (1.03-1.14) 0.001      0.99 (0.91-1.06) 0.686 
 
  
  
 
Total Cholesterol (mmol/l)      
   Desirable (< 5.2)    452      1.00       1.00  
   Borderline High (5.2 - 6.2)    123      2.57 (1.39-4.75) 0.003      1.79 (0.61-5.22) 0.287 
   High (≥ 6.2)    52      2.56 (1.11-5.92) 0.028      3.03 (0.38-24.37) 0.298 
 
  
 
 
 
Triglycerides (mmol/l)      
   Desirable (< 1.7)    483      1.00       1.00  
   Borderline High (1.7 - 2.3)    68      3.36 (1.62-6.95) 0.001      2.44 (1.03-5.80) 0.044 
   High (≥ 2.3)    77      4.44 (2.30-8.55) < 0.001      2.95 (1.11-7.84) 0.030 
 
  
  
 
HDL-C (mmol/l)    631      1.10 (0.12-10.24) 0.936   
 
  
 
 
 
LDL-C (mmol/l)      
   Desirable (< 3.4)    456      1.00       1.00  
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   Borderline High (3.4 - 4.1)    86      2.54 (1.32-4.89) 0.005      1.61 (0.53-4.90) 0.399 
   High (≥ 4.1)    62      1.06 (0.40-2.80) 0.914      0.24 (0.03-1.84) 0.167 
 
  
 
 
 
Body Fat Percentage    622      1.08 (1.04-1.12) < 0.001      1.06 (1.004-1.11) 0.034 
 
  
  
 
WHR      
   Normal    211      1.00       1.00  
   High    421      16.03 (3.87-66.37) < 0.001      8.11 (1.73-38.00) 0.008 
 
  
  
 
SBP (mmHg)      
   < 140    483      1.00       1.00  
   ≥ 140    147      2.79 (1.60-4.88) < 0.001      1.91 (0.75-4.89) 0.175 
 
  
  
 
DBP (mmHg)      
   < 90    563      1.00       1.00  
   ≥ 90    67      4.33 (2.29-8.17) < 0.001      1.98 (0.77-5.10) 0.159 
 
  
  
 
MADRS: Montgomery-Åsberg Depression Rating Scale. OR: Odds Ratio. CI: Confidence Interval. MW: Brazilian Minimum 
Wage in 2012. DM: Diabetes Mellitus. BMI: Body Mass Index. HDL-C: High-Density Lipoprotein Cholesterol. LDL-C: Low-
Density Lipoprotein Cholesterol. WHR: Waist-to-Hip Ratio. SBP: Systolic Blood Pressure. DBP: Diastolic Blood Pressure. 
1: Crude OR; 2: Adjusted OR for age, education, physical activity, family history of diabetes, depression (MADRS ≥ 20), BMI 
status, fasting insulin, total cholesterol, triglycerides, LDL-C, body fat percentage, WHR, SBP and DBP. 
MADRS and HDL-C have 1 missing value; monthly income, SBP and DBP have 2 missing values; fasting cortisol and 
triglycerides have 4; total cholesterol has 5; fasting insulin and body fat percentage have 10; and LDL-C has 28.  
 
 
  
 In the same way, when HDRS was used, age, education, physical activity, family 
history of diabetes, depression (HDRS ≥ 14), BMI status, fasting insulin, total cholesterol, 
triglycerides, LDL-C, body fat percentage, WHR, SBP and DBP were found to be significant 
indicators of diabetes in univariate analysis. Again, family history of DM, depression, 
triglycerides, body fat percentage, and WHR remained significant in multivariate analysis, 
controlling for age, education, physical activity, family history of diabetes, depression 
(HDRS ≥ 14), BMI status, fasting insulin, total cholesterol, triglycerides, LDL-C, body fat 
percentage, WHR, SBP and DBP. The risk for developing diabetes was more than 8 times 
higher among those with a high WHR and more than 4 times higher among those classified as 
depressed (Table 3.26). 
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Table 3.26: Univariate and Multivariate Regression Models for the Relationship 
between Diabetes and Selected Socio-Demographic / Behavioural and Clinical Variables 
(Including Depression - HDRS ≥ 14) in 632 Subjects from Northeastern Brazil 
Variables n OR (95% CI)1 p-value 
 
OR (95% CI)2 p-value 
Socio-Demographic /  
Behavioural Variables 
     
 
     
Gender      
   Male    218      1.00 (reference)    
   Female    414      1.19 (0.66-2.13) 0.561   
 
  
  
 
Age groups (years)      
   20-35    229      1.00       1.00  
   36-50    214      2.07 (0.99-4.30) 0.050      0.83 (0.33-2.10) 0.692 
   ≥ 51    189      2.63 (1.28-5.41) 0.009      0.45 (0.16-1.28) 0.134 
 
  
  
 
Ethnicity      
   White    108      1.00    
   Brown    507      1.34 (0.61-2.91) 0.464   
   Black    17      0.78 (0.09-6.67) 0.822   
 
  
  
 
Education      
   High School or Higher    199      1.00       1.00  
   Primary School    353      3.02 (1.18-7.73) 0.022      3.09 (0.81-11.76) 0.099 
   Illiterate    80      2.62 (1.24-5.53) 0.011      1.89 (0.71-5.03) 0.205 
 
  
  
 
Monthly Income      
   < 2MW    569      1.00    
   ≥ 2MW    61      1.84 (0.86-3.95) 0.120   
 
  
  
 
Occupation      
   Manual Labor    65      1.00    
   Not Manual Labor    567      2.22 (0.67-7.32) 0.190   
 
  
  
 
Physical Activity      
   High     53      1.00       1.00  
   Moderate    167      7.51 (1.02-55.50) 0.048      2.53 (0.28-23.15) 0.412 
   Low    412      1.61 (0.18-14.05) 0.669      0.75 (0.07-7.91) 0.808 
 
  
  
 
Smoking      
   Never    387      1.00    
   Previous    126      1.49 (0.78-2.87) 0.222   
   Current     119      1.13 (0.55-2.32) 0.739   
 
  
  
 
Alcohol Consumption       
   No    388      1.00    
   ≤ 4 times a month    229      1.07 (0.61-1.88) 0.808   
   > 4 times a month    15      0.72 (0.09-5.64) 0.755   
 
  
  
 
Family History DM       
   No    394      1.00       1.00  
   Yes    238      2.57 (1.48-4.45) 0.001      3.03 (1.54-5.98) 0.001 
Family History Depression       
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   No    553      1.00    
   Yes    79      0.96 (0.42-2.19) 0.917   
 
  
  
 
Clinical Variables      
 
  
  
 
Depression (HDRS ≥ 14)      
   No    554      1.00       1.00  
   Yes    78      3.86 (2.08-7.15) < 0.001      4.55 (2.02-10.29) < 0.001 
 
  
 
 
 
BMI Status      
   < 25    243      1.00       1.00  
   25-29.99    237      2.66 (1.20-5.91) 0.016      0.78 (0.28-2.16) 0.632 
   ≥30    152      5.62 (2.56-12.31) < 0.001      1.14 (0.34-3.86) 0.832 
 
  
  
 
Fasting Cortisol (mcg/dl)      
   Low (<6.7)    27      1.00    
   Normal (6.7 - 22.6)    556      1.21 (0.28-5.25) 0.801   
   High (≥ 22.6)    45      2.30 (0.44-12.00) 0.322   
 
  
 
 
 
Fasting Insulin (micro UI/ml)    622      1.08 (1.03-1.14) 0.001      0.98 (0.91-1.06) 0.678 
 
  
  
 
Total Cholesterol (mmol/l)      
   Desirable (< 5.2)    452      1.00       1.00  
   Borderline High (5.2 - 6.2)    123      2.57 (1.39-4.75) 0.003      1.76 (0.61-5.08) 0.297 
   High (≥ 6.2)    52      2.56 (1.11-5.92) 0.028      2.68 (0.33-21.78) 0.355 
 
  
 
 
 
Triglycerides (mmol/l)      
   Desirable (< 1.7)    483      1.00       1.00  
   Borderline High (1.7 - 2.3)    68      3.36 (1.62-6.95) 0.001      2.52 (1.06-6.01) 0.037 
   High (≥ 2.3)    77      4.44 (2.30-8.55) < 0.001      3.04 (1.15-8.05) 0.025 
 
  
  
 
HDL-C (mmol/l)    631      1.10 (0.12-10.24) 0.936   
 
  
 
 
 
LDL-C (mmol/l)      
   Desirable (< 3.4)    456      1.00       1.00  
   Borderline High (3.4 - 4.1)    86      2.54 (1.32-4.89) 0.005      1.68 (0.55-5.07) 0.362 
   High (≥ 4.1)    62      1.06 (0.40-2.80) 0.914      0.26 (0.03-1.98) 0.193 
 
  
 
 
 
Body Fat Percentage    622      1.08 (1.04-1.12) < 0.001      1.06 (1.01-1.12) 0.016 
 
  
  
 
WHR      
   Normal    211      1.00       1.00  
   High    421      16.03 (3.87-66.37) < 0.001      8.40 (1.78-39.55) 0.007 
 
  
  
 
SBP (mmHg)      
   < 140    483      1.00       1.00  
   ≥ 140    147      2.79 (1.60-4.88) < 0.001      2.15 (0.84-5.51) 0.110 
 
  
  
 
DBP (mmHg)      
   < 90    563      1.00       1.00  
   ≥ 90    67      4.33 (2.29-8.17) < 0.001      1.88 (0.73-4.84) 0.190 
 
  
  
 
HDRS: Hamilton Depression Rating Scale. OR: Odds Ratio. CI: Confidence Interval. MW: Brazilian Minimum Wage in 2012. 
DM: Diabetes Mellitus. BMI: Body Mass Index. HDL-C: High-Density Lipoprotein Cholesterol. LDL-C: Low-Density 
Lipoprotein Cholesterol. WHR: Waist-to-Hip Ratio. SBP: Systolic Blood Pressure. DBP: Diastolic Blood Pressure. 
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1: Crude OR; 2: Adjusted OR for age, education, physical activity, family history of diabetes, depression (HDRS ≥ 14), BMI 
status, fasting insulin, total cholesterol, triglycerides, LDL-C, body fat percentage, WHR, SBP and DBP. 
 
 
 In univariate analysis, the significant risk indicators for the occurrence of depression 
(MADRS ≥ 20) were gender, smoking, family history of depression, diabetes, triglycerides 
and body fat percentage. However, in multivariate analysis, only gender, smoking, diabetes 
and family history of depression remained significant after adjusting for gender, smoking, 
family history of depression, diabetes, triglycerides and body fat percentage. The risk for 
developing depression was approximately 3 times higher among women and individuals with 
diabetes (Table 3.27). 
 
Table 3.27: Univariate and Multivariate Regression Models for the Relationship 
between Depression (MADRS ≥ 20) and Selected Socio-Demographic / Behavioural and 
Clinical Variables (Including Diabetes) in 631 Subjects from Northeastern Brazil 
Variables             n OR (95% CI)1 p-value 
 
OR (95% CI)2 p-value 
Socio-Demographic /  
Behavioural Variables 
    
 
 
    
 
Gender      
   Male    218     1.00 (reference)      1.00  
   Female    413     2.43 (1.32-4.46) 0.004     3.20 (1.46-7.00) 0.004 
 
  
  
 
Age groups (years)      
   20-35    228     1.00    
   36-50    214     0.89 (0.49-1.62) 0.705   
   ≥ 51    189     1.18 (0.66-2.13) 0.572   
 
  
  
 
Ethnicity      
   White    108     1.00    
   Brown    506     1.34 (0.67-2.72) 0.411   
   Black    17     1.31 (0.26-6.55) 0.745   
 
  
  
 
Education      
   High School or Higher    199     1.00    
   Primary School    352     1.20 (0.52-2.78) 0.669   
   Illiterate     80     1.39 (0.79-2.45) 0.256   
 
  
  
 
Marital Status      
   Single    151     1.00    
   Married / Cohabitant    418     0.67 (0.38-1.18) 0.168   
   Divorced / Separated    25     0.84 (0.23-3.07) 0.797   
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   Widow(er)    36     1.77 (0.71-4.40) 0.220   
 
  
  
 
Monthly Income      
   ≥ 2MW    61     1.00    
   < 2MW    568     2.72 (0.83-8.91) 0.099   
 
  
  
 
Occupation      
   Manual Labor    65     1.00    
   Not Manual Labor    566     2.92 (0.89-9.54) 0.077   
 
  
  
 
Physical Activity      
   High    53     1.00    
   Moderate    167     0.89 (0.38-2.10) 0.787   
   Low     411     0.75 (0.29-1.91) 0.539   
 
  
  
 
Smoking      
   Never    387     1.00      1.00  
   Previous    125     1.52 (0.81-2.87) 0.191     1.77 (0.90-3.47) 0.097 
   Current     119     2.49 (1.40-4.42) 0.002     2.67 (1.45-4.93) 0.002 
 
  
  
 
Alcohol Consumption       
   No    388     1.00    
   ≤ 4 times a month    228     0.69 (0.40-1.18) 0.170   
   > 4 times a month    15     1.04 (0.23-4.75) 0.960   
 
  
  
 
Family History DM       
   No    393     1.00    
   Yes    238     1.10 (0.67-1.81) 0.707   
Family History Depression       
   No    552     1.00      1.00  
   Yes    79     2.67 (1.47-4.83) 0.001     2.51 (1.32-4.76) 0.005 
 
  
  
 
Clinical Variables      
 
  
  
 
Diabetes      
   No    573     1.00      1.00  
   Yes    58     3.10 (1.62-5.92) 0.001     3.00 (1.45-6.21) 0.003 
 
  
  
 
BMI (Kg/m2)      
   < 25    243     1.00    
   25-29.99    236     0.70 (0.39-1.25) 0.233   
   ≥30    152     1.04 (0.57-1.89) 0.908   
 
  
  
 
Fasting Cortisol       
   Low (<6.7)    27     1.00    
   Normal (6.7 - 22.6)    555     0.57 (0.21-1.57) 0.278   
   High (≥ 22.6)    45     0.31 (0.07-1.44) 0.136   
 
  
  
 
Fasting Insulin (micro UI/ml)    621     1.04 (0.99-1.09) 0.114   
 
  
 
 
 
Total Cholesterol (mmol/l)      
   Desirable (< 5.2)    451     1.00    
   Borderline High (5.2 - 6.2)    123     1.38 (0.77-2.46) 0.282   
   High (≥ 6.2)    52     0.67 (0.23-1.93) 0.457   
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Triglycerides (mmol/l)      
   Desirable (< 1.7)    482     1.00      1.00  
   Borderline High (1.7 - 2.3)    68     1.56 (0.75-3.25) 0.236     1.23 (0.57-2.68) 0.598 
   High (≥ 2.3)    77     2.01 (1.05-3.85) 0.036     1.57 (0.77-3.23) 0.219 
 
  
  
 
HDL-C (mmol/l)    630     1.98 (0.26-15.05) 0.510   
 
  
 
 
 
LDL-C (mmol/l)      
   Desirable (< 3.4)    455     1.00    
   Borderline High (3.4 - 4.1)    86     1.02 (0.50-2.10) 0.958   
   High (≥ 4.1)    62     0.99 (0.43-2.28) 0.974   
 
  
 
 
 
Body Fat Percentage    621     1.03 (1.001-1.06) 0.039     0.99 (0.96-1.03) 0.633 
 
  
  
 
WHR      
   Normal    211     1.00    
   High    420     1.03 (0.61-1.73) 0.914   
 
  
  
 
MADRS: Montgomery-Åsberg Depression Rating Scale. OR: Odds Ratio. CI: Confidence Interval. MW: Minimum Wage in 2012. 
DM: Diabetes Mellitus. BMI: Body Mass Index. HDL-C: High-Density Lipoprotein Cholesterol. LDL-C: Low-Density Lipoprotein 
Cholesterol. WHR: Waist-to-Hip Ratio.  
1: Crude OR; 2: Adjusted OR for gender, smoking habits, family history of depression, diabetes, triglycerides and body fat 
percentage. 
Marital status and HDL-C have 1 missing value; monthly income has 2 missing values; triglycerides and fasting cortisol have 4; 
total cholesterol has 5; fasting insulin and body fat percentage have 10; and LDL-C has 28. 
 
 
 Following HDRS, the significant risk indicators for the occurrence of depression in 
univariate analysis were gender, education level, occupation, smoking, family history of 
depression, diabetes and triglycerides. In multivariate analysis, gender, smoking, diabetes and 
family history of depression remained significant after adjustment for the potential 
confounding factors (Table 3.28). 
 
Table 3.28: Univariate and Multivariate Regression Models for the Relationship 
between Depression (HDRS ≥ 14) and Selected Socio-Demographic / Behavioural and 
Clinical Variables (including Diabetes) in 632 Subjects from Northeastern Brazil 
Variables             n OR (95% CI)1 p-value 
 
OR (95% CI)2 p-value 
Socio-Demographic /  
Behavioural Variables 
    
 
 
    
 
Gender      
   Male    218     1.00 (reference)      1.00  
   Female    414     2.22 (1.25-3.96) 0.007     2.17 (1.12-4.23) 0.023 
 
  
  
 
Age groups (years)      
   20-35    229     1.00    
95 
 
   36-50    214     0.99 (0.56-1.76) 0.980   
   ≥ 51    189     1.04 (0.58-1.87) 0.884   
 
  
  
 
Ethnicity      
   White    108     1.00    
   Brown    507     1.49 (0.74-3.00) 0.262   
   Black    17     0.61 (0.07-5.12) 0.651   
 
  
  
 
Education      
   High School or Higher    199     1.00      1.00  
   Primary School    353     1.12 (0.47-2.68) 0.804     0.94 (0.36-2.48) 0.905 
   Illiterate     80     1.74 (0.99-3.06) 0.056     1.34 (0.73-2.48) 0.345 
 
  
  
 
Marital Status      
   Single    151     1.00    
   Married / Cohabitant    419     0.71 (0.41-1.22) 0.212   
   Divorced / Separated    25     0.51 (0.11-2.32) 0.383   
   Widow(er)    36     1.96 (0.81-4.71) 0.135   
 
  
  
 
Monthly Income      
   ≥ 2MW    61     1.00    
   < 2MW    569     2.13 (0.75-6.04) 0.155   
 
  
  
 
Occupation      
   Manual Labor    65     1.00      1.00  
   Not Manual Labor    567     3.15 (0.96-10.29) 0.057     1.88 (0.51-6.99) 0.344 
 
  
  
 
Physical Activity      
   High    53     1.00    
   Moderate    167     0.99 (0.43-2.31) 0.984   
   Low     412     0.75 (0.29-1.91) 0.539   
 
  
  
 
Smoking      
   Never    387     1.00      1.00  
   Previous    126     1.39 (0.76-2.56) 0.287     1.50 (0.77-2.93) 0.240 
   Current     119     2.02 (1.15-3.58) 0.015     2.03 (1.09-3.81) 0.027 
 
  
  
 
Alcohol Consumption       
   No    388     1.00    
   ≤ 4 times a month    229     0.71 (0.42-1.19) 0.188   
   > 4 times a month    15     0.97 (0.21-4.43) 0.971   
 
  
  
 
Family History DM       
   No    394     1.00    
   Yes    238     1.25 (0.77-2.02) 0.366   
Family History Depression       
   No    553     1.00      1.00  
   Yes    79     2.65 (1.48-4.75) 0.001     2.49 (1.33-4.66) 0.004 
 
  
  
 
Clinical Variables      
 
  
  
 
Diabetes      
   No    574     1.00      1.00  
   Yes    58     3.86 (2.08-7.15)    < 0.001     3.51 (1.78-6.90) < 0.001 
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BMI (Kg/m2)      
   < 25    243     1.00    
   25-29.99    237     0.72 (0.41-1.25) 0.244   
   ≥30    152     1.02 (0.57-1.84) 0.947   
 
  
  
 
Fasting Cortisol       
   Low (<6.7)    27     1.00    
   Normal (6.7 - 22.6)    556     0.60 (0.22-1.65) 0.323   
   High (≥ 22.6)    45     0.55 (0.14-2.11) 0.383   
 
  
  
 
Fasting Insulin (micro UI/ml)    622     1.04 (0.99-1.09) 0.127   
 
  
 
 
 
Total Cholesterol (mmol/l)      
   Desirable (< 5.2)    452     1.00    
   Borderline High (5.2 - 6.2)    123     1.35 (0.77-2.37) 0.303   
   High (≥ 6.2)    52     0.61 (0.21-1.77) 0.367   
 
  
 
 
 
Triglycerides (mmol/l)      
   Desirable (< 1.7)    483     1.00      1.00  
   Borderline High (1.7 - 2.3)    68     1.43 (0.69-2.97) 0.338     1.08 (0.50-2.36) 0.838 
   High (≥ 2.3)    77     2.01 (1.07-3.78) 0.031     1.42 (0.70-2.85) 0.330 
 
  
  
 
HDL-C (mmol/l)    631     2.71 (0.37-19.64) 0.323   
 
  
 
 
 
LDL-C (mmol/l)      
   Desirable (< 3.4)    456     1.00    
   Borderline High (3.4 - 4.1)    86     1.18 (0.60-2.32) 0.625   
   High (≥ 4.1)    62     0.78 (0.32-1.90) 0.586   
 
  
 
 
 
Body Fat Percentage    622     1.02 (0.99-1.05) 0.190   
 
  
  
 
WHR      
   Normal    211     1.00    
   High    421     0.94 (0.57-1.55) 0.806   
 
  
  
 
HDRS: Hamilton Depression Rating Scale. OR: Odds Ratio. CI: Confidence Interval. MW: Minimum Wage in 2012. DM: 
Diabetes Mellitus. BMI: Body Mass Index. HDL-C: High-Density Lipoprotein Cholesterol. LDL-C: Low-Density Lipoprotein 
Cholesterol. WHR: Waist-to-Hip Ratio.  
1: Crude OR; 2: Adjusted OR for gender, education level, occupation, smoking, family history of depression, diabetes and 
triglycerides. 
 
 
3.5   CORRELATION BETWEEN MADRS AND HDRS 
 The correlation between MADRS and HDRS scores was obtained with the Pearson's 
correlation coefficient. It was positive and significant (r=0.91, p < 0.001), as shown in Figure 
3.8. 
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Figure 3.8: Correlation (r=0.91, p < 0.001) between the Total Scores of 714 Subjects 
Assessed by HDRS, and 713 by MADRS 
   
  
  
 Furthermore, when measuring the level of agreement between MADRS and HDRS, a 
Kappa of 0.913 was found (p < 0.001) (Table 3.29). 
 
Table 3.29: Agreement between MADRS and HDRS 
  Depression according to MADRS 
No Depression Depression Total 
Depression  
according to HDRS 
No Depression 
Depression 
Total 
596 
10 
606 
6 
101 
107 
602 
111 
713 
MADRS: Montgomery-Åsberg Depression Rating Scale. HDRS: Hamilton Depression Rating Scale. 
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4.1   METHODOLOGICAL DISCUSSION 
4.1.1   Study Design 
 This research study was an observational inquiry and was based on a cross-sectional 
design. It was observational since no intervention (active attempt to make changes regarding 
the determinants or the progress of diseases) took place. It included a descriptive aspect, since 
the occurrence of diabetes and depression were investigated, as well as an analytical aspect, 
since it was investigated whether and to what extent both the conditions were associated (97). 
 Often called prevalence studies, cross-sectional studies allow the investigation of a 
disease prevalence and its risk indicators in relation to the socio-economic, demographic and 
health-related characteristics of the population under study. The major aim of cross-sectional 
studies is to describe individuals in the population and their simultaneous exposure at a 
particular point in time. Furthermore, they are relatively easy to carry out, can be completed 
rapidly (data are collected only at one point in time), usually are not very resource-intensive, 
and numerous variables can be analyzed at once (97). Another advantage of using such a 
design is the uncommon existence of major ethical difficulties, since the study participants 
are not deliberately exposed, treated, or not treated (98).  
Considering the fact that in cross-sectional studies the measurements of the exposures 
and effects are carried out simultaneously, it is not easy to assess the causes for the 
associations found. Moreover, a cause-effect relationship or the sequence of the events cannot 
be determined. On the other hand, follow-up studies, also called cohort or incidence studies, 
can provide the best information about the potential causes to certain disease (the sequence of 
the events can be observed), and the most direct measurement of the risk of getting the 
disease (97). Therefore, such a design would be the most appropriate methodology to provide 
a better understanding of the directionality of the relationship between diabetes and 
depression, i.e. a cohort study would provide a clearer answer to this “chicken-or-the-egg 
dilemma” – which one comes first: diabetes or depression? (76). However, prospective 
cohort studies usually require the involvement of a large study population, are resource-
intensive, and take a long time to be completed (97). Despite its limitations, a cross-sectional 
design was chosen due to the limited time frame and budget available, as well as because of 
the valuable and useful data that could be generated. Even though it limits the conclusions 
regarding the causal nature and the direction of the relationship, questions about the very 
existence of the association in northeastern Brazil could be assessed. As described previously, 
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data about the magnitude of depression in subjects with type 2 diabetes in Brazil are scarce. 
Thus in order to generate some epidemiological evidence regarding such an association in 
Brazilians, this cross-sectional study was conducted. Moreover, through the study, it was 
possible to find out the prevalence of the diseases, and establish some risk indicators. When 
investigating chronic diseases like diabetes, in which the cause of the disease has been 
somewhat established, data from cross-sectional surveys may also serve as a foundation for 
developing or strengthening hypotheses about related risk factors, as well as promoting the 
development of new management and preventive guidelines. It is also noteworthy to mention 
that although the study design applied here was similar to previous classical cross-sectional 
epidemiological studies, the participants were mostly newly diagnosed with diabetes and 
usually not aware of their blood glucose status.   
 
4.1.2   Population and Sample Size 
 In this study, eight hundred and six subjects were randomly selected and invited to 
participate. Out of these, seven hundred and fourteen agreed to join the study (participation 
rate: 88.6%). Among 92 individuals who refused, 63% were males. The estimated sample 
size (approximately 530 subjects) required to have a statistical power of 90%, at a 
significance level of 0.05 was reached. 
 In the process of hypothesis testing, two types of error can occur. Type I error (α), 
also called an error of the first kind, involves the rejection of the null hypothesis when the 
null hypothesis is true, that is, when the data lead us to believe that there is a difference when 
in reality there is not. Type II error (β), also known as an error of the second kind, occurs 
when the null hypothesis is not rejected when in reality it is false, that is, when we conclude 
that there is not a difference but in reality there is (99). In this study, a proper sample size 
calculation was difficult to be made due to missing data on depression and diabetes in the 
population under investigation. Thus the possibility that type II errors occurred in the 
inferences made cannot be entirely ruled out. However, the sample size was reasonably large 
which could increase the precision. 
4.1.3   Assessment of Depression 
 Although there is a large number of scales available for evaluating depressive 
conditions, the MADRS (91) and HDRS (92) are the two most common rating scales in use. 
They are not diagnostic instruments, but rather methods of comprehensively surveying the 
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type and magnitude of depressive symptoms. Moreover, they are usually applied to establish 
clinical criteria for distinguishing levels of illness severity and for measuring evolution of and 
recovery from a depressive episode (100).  
 Considered the “gold standard” of depression measures, the HDRS has served as a 
reference point for more recently developed scales. Since it was first introduced by Hamilton, 
many studies about the HDRS have been performed (101). A review of studies published 
between 1979 and 2003 has shown good internal, interrater, and retest reliability estimates for 
the overall scale, but weak interrater and retest coefficients at the item level (102). On the 
other hand, the MADRS items have been conceptualized to solve some of the psychometric 
limitations of the HDRS and to measure change during treatment. Of note, the MADRS does 
not focus on somatic symptoms as much as the HDRS does, therefore the interference of 
organic dysfunctions or treatment side effects can be minimized (101).  
 Although there is ample evidence indicating that both scales are valid measures of 
symptom outcome in major depression, reliability and validity studies in Brazil are rare (101). 
In a study from 1987 conducted in São Paulo, the MADRS was applied to a Brazilian 
depressed population, and its performance compared with those of the HDRS, the Visual 
Analogue Mood Scale (VAMS), and the global clinical assessment of independent Brazilian 
psychiatrists. A significant correlation was observed between MADRS and the three other 
assessments, indicating that the MADRS is a useful and operational instrument to evaluate 
depressed patients in Brazil. However, the results indicated that the HDRS had a lower 
sensitivity and specificity compared to MADRS (103). According to another study conducted 
in Brazil, it was observed that both MADRS and HDRS had good levels of reliability and 
validity, suggesting that they were able to measure the gravity of depressive symptoms (101).  
4.1.4   Errors 
 Epidemiological studies aim to produce accurate measures of disease occurrence (or 
other outcomes). Although there are many possibilities for errors in measurements, 
researchers should attempt to minimize errors as much as possible and assess the impact of 
errors that cannot be eliminated. Sources of error can be systematic or random. A systematic 
error, also called bias, takes place when the results differ from the true values in a systematic 
way, towards one direction. On the other hand, random errors will not influence the results 
only in one direction (the effects of random errors can go either of the two ways). Random 
errors occur when a value of the sample measurement diverges from that of the true 
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population value due to chance alone. If the sample size is large enough, the effects of 
random errors will be balanced (97). Since the sample in this study was reasonably large, it is 
unlikely that random errors had a significant effect on the results. 
4.1.4.1   Selection Bias 
  The systematic introduction of error may occur during the selection of the study 
participants and is known as selection bias. Selection bias takes place when there is a 
systematic difference between the characteristics of the people selected for a study and the 
characteristics of those who were not (97).   
 In this study, by using a probability sampling method, the selection bias / sampling 
errors could be minimized since all citizens in the health registry list of the city had equal 
chance to be selected. However, the list used to select the subjects had been updated for the 
last time only three years ago. Given the possible changes in the population that might have 
happened in this period (e.g., migration), as well as the potential mistakes that might have 
occurred when making the list (some individuals might have been left out); the possibility of 
some degree of selection bias cannot be excluded.  
 4.1.4.2   Measurement Bias   
 Measurement bias occurs when the individual measurements or classifications of 
disease or exposure are inaccurate. There are several sources of measurement bias and their 
effects have varying importance (97). 
 Information bias refers to bias that arises from measurement errors and can be defined 
as a systematic error in collecting information from study subjects (97). In this study, 
interviewer-administered questionnaires were used. Compared to self-reported questionnaires, 
interviewer-guided questionnaires usually provide higher response rates and more complete 
answers. However, the subjects' answers may have been influenced by the interviewers. 
Asking questions in different ways or interpreting or coding information differently may 
result in information bias (104). In this study, in order to minimize this type of bias, all 
members of the research team and field workers were trained before the start of the data 
collection with regard to filling in the questionnaires. In addition, it was checked twice during 
the study period whether the data entries were been done according to protocol. Since the 
field workers and research assistants were from the local community, they knew the local 
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language and had a good understanding of the cultural norms. If a question was not answered, 
a variable would present missing values in the final analysis. 
 Although recall bias (differential recall of information by subjects with or without a 
disease of interest) is more important in retrospective case control studies, it may also have 
happened in this cross-sectional study (97). For instance, information about family history of 
disease, dietary habits, use of medications, etc, may have presented some deviations. 
Furthermore, the possibility of reporting bias cannot be excluded. Reporting bias, defined as 
selective revealing or suppression of information (97), may have occurred for example when 
questions about past medical history, alcohol consumption, smoking habits and monthly 
income were made. It is also noteworthy to consider the possibility of recall and reporting 
bias in the assessment of depression by the MADRS and HDRS. When assessing depression, 
some items of the scales may be subject to differential recall by the participants. Moreover, 
several sensitive questions need to be asked (e.g., questions about suicidal thoughts or 
attempts, genital disturbances, hypochondriacal delusions, etc), and some people may have 
concealed the truth due to religious or cultural reasons. 
 Concerning the anthropometric, blood pressure and body fat percentage measurements, 
only one team member performed the assessments after proper training. Everyday the 
weighing machine was calibrated against a standard (15Kg). The automatic electronic 
sphygmomanometer used was properly validated, checked and calibrated before the start of 
the data collection. However, it is acknowledged that electronic sphygmomanometers may 
produce systematic errors in some patients (105). Thus, the blood pressure measurements 
were taken twice in order to minimize any potential errors. All blood analyses were 
performed in a certified laboratory. Additionally, since misclassification errors can occur 
when estimating LDL-C levels by the Friedewald formula (95), those with triglyceride 
concentration exceeding 400mg/dl were not taken into account. They were considered as 
missing values. 
4.1.5   Confounding   
 The term "confounding" comes from the Latin confundere, and means "to mix 
together". In a study of the association between exposure to a cause (or risk factor) and the 
occurrence of a disease, confounding can arise when another exposure exists in the study 
population and is associated both with the disease and the exposure being investigated. Thus 
confounding may take place when the effects of two exposures (risk factors) have not been 
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separated and the analysis concludes that the effect is due to one variable rather than the other. 
The influence of confounding factors can be quite substantial, and may even change the 
apparent direction of an association. For instance, a variable that seems to be protective may, 
after control of confounding, be actually harmful (97).  
 Since the problem may occur if this extraneous factor is unequally distributed between 
the exposure subgroups, the subjects were randomly selected to participate in this study. 
Additionally, the effect of age and gender was minimized by stratifying some of the analyses. 
Moreover, the most common confounding variables, which have been identified in the 
literature to influence the occurrence and association of diabetes and depression, were 
assessed and analyzed simultaneously by using multivariate statistical modeling. However, it 
must be acknowledged that some confounders might have not been controlled for. 
4.1.6   Internal Validity 
 Internal validity can be described as the degree to which the results of an observation 
are correct for the particular population under study. Internal validity can be threatened by all 
sources of systematic error but can be increased by appropriate design and attention to detail 
(97). In order to secure internal validity, important strategies were applied to reduce the 
confounding effects and measurement bias as described above.   
4.1.7   External Validity 
 External validity or generalizability is the extent to which the results of a study can be 
applied to other situations and other people (97). As mentioned previously, Brazil is a 
continental country with huge socioeconomic, ethnic and regional disparities. Therefore the 
findings in the present study may not be representative for the whole country. Caution should 
be taken when making generalizations of the results. Besides the city chosen to be the study 
site is located in a semi-urban area. Thus the prevalence of diabetes and depression might 
have been overestimated compared to rural areas and underestimated in relation to urban 
areas. However, it is relevant to state that the sample studied is still valid to compare gender 
differences and identify risk indicators for diabetes and depression in northeastern Brazil. 
Furthermore, this research can be used for national references and provide the basis for 
further studies to investigate whether the present findings are replicable in other regions of 
Brazil. 
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4.1.8   Strengths of the Study 
 This is the first population-based study about the relationship between diabetes and 
depression conducted in Brazil that included adults of all ages, both genders, and did not use 
self-reported data on diabetes. As described above, a reasonably large sample from the 
general population was randomly selected to participate in this study (an effort was made to 
keep the selection procedures of the subjects as random as possible). Thus the final sample 
was large enough to meet the required sample size for analysis. Additionally, since the 
participation rate in the study was high, it is less likely that non-respondent biases have taken 
place in the analysis. 
 As mentioned before, anthropometric parameters and body fat percentage were 
measured by one well-trained investigator. A validated automatic electronic 
sphygmomanometer was used to take blood pressure measurements, and the mean value of 
two measurements was used for analysis. Socio-demographic, economic and physical activity 
data were collected by one research assistant that was adequately trained before the start of 
the study. Pretesting of the questionnaires was also undertaken. 
 Depression was assessed by two rating scales and the agreement between them could 
be evaluated. The MADRS was conducted by a nurse with a long experience in the 
management of mental health patients, while the HDRS was performed by a general 
physician also skilled in the area (principal investigator). Both of them assessed depressive 
symptoms after proper training under the supervision of an experienced psychiatrist 
(Professor Fábio Gomes de Matos e Souza, local supervisor). All measures of depression 
were undertaken between the first (fasting sample) and second (2-hour post glucose load) 
blood drawings. The measurement of capillary HbA1c was only performed after the 
depression assessments. Since the results for the test of diabetes were not ready by the time 
the assessments of depression were complete, it is unlikely that those results influenced the 
depression scores. 
 Additionally, most potential confounding factors described in the literature about the 
topic of interest (age, gender, BMI, WHR, physical activity, smoking, etc) were carefully 
controlled in the multivariate regression models. 
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4.1.9   Limitations of the Study 
 The study was based on a cross-sectional design which cannot proove causal 
relationship between exposure and outcome as discussed previously. Despite random 
selection procedures, the samples were collected from one semi-urban area in the Northeast 
region of Brazil. Therefore the results ought to be interpreted with caution with respect to 
generalization to the whole country. However, since similar results have been found in 
studies in other populations (strong association between diabetes and depression), the 
external validity of this study is supported.  
 It is also noteworthy to state that this study has assessed symptoms of depression, 
rather than depression itself. Therefore the data cannot provide a true prevalence of 
depression per se. Additionally, the MADRS and HDRS do not differentiate between types of 
depression, or between unipolar and bipolar depression. Moreover, no interrater reliability 
tests were performed for the study population. However, previous studies have shown high 
levels of reliability for both the MADRS and HDRS in Brazil and other parts of the world 
(101). Moreover, we have examined the agreement between both scales (MADRS and HDRS) 
which was found to be excellent (Kappa = 0.913). 
 
4.2   DISCUSSION OF THE MAIN RESULTS 
4.2.1   Diabetes 
 In the present study, the overall prevalence rates of DM, IFG and IGT were 16.0%, 
5.8% and 11.8% respectively. The prevalence of IGT and DM were higher than in any 
previous large studies in Brazil, while the prevalence of IFG showed more similar results (22, 
23, 106). Additionally, in comparison with surveys in other countries in the Americas that 
used the WHO criteria, the prevalence of DM in this study showed similar results to those 
found in the United States, Jamaica, Mexico, Bolivia and Trinidad and Tobago (107). In the 
United States, the National Health and Nutrition Examination Survey (NHANES III, 1988-
1994) observed a prevalence of DM of 14.3% in subjects aged 40-74 years (108). As 
mentioned previously, the Brazilian Multicenter Study (the first population-based survey in 
Brazil that used the WHO criteria for the diagnosis of diabetes, and the only one using a 
representative sample of the urban Brazilian population until now), conducted among 21,847 
individuals aged 30-69 years from 1986 to 1988, found that the overall rates were 7.6 and 7.8% 
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for diabetes and IGT, respectively (22). Another population-based, cross-sectional study 
conducted in Minas Gerais, Brazil in 1997 (simple probabilistic sample of 816 adults aged 
18-59 years) showed that the prevalence of DM and IFG were 2.33% and 5.64% respectively 
(106). On the other hand, a survey conducted in Ribeirão Preto, Brazil between 1996 and 
1997 (random sample of 1,473 individuals aged 30-69 years) showed that the prevalence of 
DM and IGT (according to the WHO criteria) were 12.1% and 7.7% respectively  (23).  
 As described previously, the prevalence of DM has been increasing throughout the 
world, especially in developing countries that have been undergoing a rapid industrialization 
and urbanization like Brazil. This increase has been related to lifestyle changes that have 
resulted in overweight, obesity, and decreased physical activity levels (107). This 
phenomenon may explain the elevated prevalence of DM found in Pindoretama, since this 
city has experienced growing urbanization and modernization over the past years. 
Corroborating such a relationship, among the previous studies conducted in Brazil, the 
prevalence of DM found in Ribeirão Preto (city that has also experienced environmental and 
lifestyle changes) was the closest to our results (23). It has been shown that post-prandial 
glucose concentrations are more determined by glucose uptake in insulin-sensitive tissues and 
are therefore more likely to be influenced by insulin resistance (109). On the other hand, it 
has been observed that β-cell dysfunction is significantly higher in IFG than IGT (110). Thus, 
the higher prevalence of IGT and similar rates of IFG in our study in relation to other surveys 
conducted many years back in Brazil support the hypothesis that lifestyle changes have led to 
higher levels of obesity, insulin resistance and occurrence of IGT and DM.    
 As observed in many other studies in Brazil and throughout the world, in our study, 
the prevalence of diabetes increased significantly with higher age and BMI, lower levels of 
physical activity and education, as well as among those with a family history of diabetes and 
higher WHR (22-24).  
 In the Brazilian Multicenter Study, age was an important indicator for the occurrence 
of DM, with a prevalence of 17.4% in the 60-69 year-old group (22). Another study from Rio 
de Janeiro, Brazil, age was also a relevant factor and the prevalence of DM was 22.4% 
among the women of this same age group (111). In our study, although the occurrence of 
diabetes increased significantly among older subjects (among those aged ≥ 51 years, the 
diabetes prevalence was 24.8%), age did not remain a significant indicator of diabetes in 
multivariate analysis. Similarly to age, lower level of physical activity was not independently 
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associated with diabetes. This can possibly be explained because almost 70% of the study 
population had sedentary lifestyles. In contrast, family history of DM, BF% and WHR, level 
of education, triglycerides and DBP were found to be strong risk indicators of DM, since they 
were independently associated with diabetes in multivariate analysis.   
 In our study, no significant difference was found between the different ethnic groups 
with regard to the prevalence rates of DM, IFG and IGT. Our results are in agreement with 
what was observed in the study from Ribeirão Preto, as well as in the Brazilian Multicenter 
Study (22, 23). In contrast, in the United States, the prevalence of DM among non-Hispanic 
blacks and Mexican-Americans was 1.6 to 1.9 times higher than among non-Hispanic whites 
(112). However, as described previously, it is likely that the extensive miscegenation of the 
overall Brazilian population may have reduced the differences among the ethnic groups. 
 As stated above, level of education was also found to be an important indicator of 
diabetes. Again, our findings are similar to those from the study conducted in Ribeirão Preto, 
since they observed that the prevalence of DM was 2.0 times higher among subjects with 
only basic education. One possible explanation may be the increased occurrence of other risk 
indicators in the population of lower education level. For instance, in Ribeirão Preto, the 
prevalence of obesity evaluated in the same population was higher among people of lower 
educational level (23). In this study, those who were illiterate had a significantly greater 
proportion of high WHR compared to those who had an education level of high school or 
higher (78.9% vs. 51.9%). 
 Although BMI was an important indicator in univariate analysis, it did not remain 
significantly associated with diabetes in multivariate analysis. For epidemiological studies, 
the body mass index has been regarded as a suitable indicator for overweight and obesity. 
Although it has been shown in many studies that high levels of BMI are related to increased 
morbidity and mortality, from the physiological point of view, it is not the degree of excess 
weight (as measured by the BMI) but the degree of body fatness that is important as a risk 
indicator. Additionally, accumulating evidence has suggested that the relationship between 
BMI and BF% may be different between ethnic groups (113, 114). Possibly because of 
differences in body build, energy intake or physical activity, the BMI cut-off values for 
overweight and obesity recommended by the WHO may not correspond to the same degree of 
fatness across different populations (115). Furthermore, in addition to the degree of obesity, 
some studies have shown that diabetic subjects present the android (upper body, male) 
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adipose tissue distribution more often than the gynoid (lower body, female) type of fat 
distribution (116). Kissebah et al. have observed that obese women without overt clinical 
symptoms of DM are more likely to have IGT and hyperinsulinemia, if their excessive fat 
mass is predominantly distributed above the waist (upper body obesity) than if the fat mass is 
mostly over the hips, thighs, and buttocks (lower body obesity) (117). In our study, BF% and 
WHR were independently associated with DM, indicating that, in this population, the degree 
of body fatness (BF%) and the abdominal adipose tissue distribution (WHR) were probably 
stronger indicators of diabetes than the total body fat mass (BMI) (115). Moreover, in line 
with the literature, in addition to central obesity and hyperglycemia, our study has also found 
that hypertension and dyslipidemia (all components of the metabolic syndrome) are 
independent risk indicators for T2DM (24). 
  
4.2.2   Depression 
 In this study, we found that depressive symptoms were highly prevalent. Following 
MADRS, the prevalence of depression was 15.0%, while according to HDRS, the prevalence 
was 15.5%. In comparison with other community surveys that have used clinically defined 
case finding methods, our results are in line with what has been observed in countries like the 
United States and England (59). 
 As stated previously, population-based studies of psychiatric morbidity in Latin 
America and Brazil are rare. Many studies have been conducted in primary health care 
settings, or for specific populations, not allowing estimations of population rates. One of the 
reasons for this paucity of community-based surveys in Brazil is that the country is very large, 
with a diversity of cultural and socioeconomic aspects. Thus, it is difficult to make 
comparisons and deeper analyses about the burden of depression in the Brazilian population. 
One of the very few community surveys carried out in Brazil was a two-stage cross-sectional 
study conducted in 1997 in three metropolitan areas (Brasília, São Paulo and Porto Alegre). A 
44-item screening instrument designed to assess psychiatric morbidity in adults in Brazilian 
urban areas was initially applied. Then, sub-samples of probable cases and non-cases (n=836) 
were interviewed by psychiatrists using the DSM-III Symptom Checklist. In that study, 
depression showed great variation between areas: from less than 3% (São Paulo and Brasilia) 
to 10% (Porto Alegre). As described by the authors, the great difference in the prevalence of 
depression in these three research sites might have occurred due to methodological problems, 
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such as low stability of the screening instrument and the distinct sampling designs, which 
might have biased the comparability of the data (53). Another community survey conducted 
in São Paulo, Brazil (including 1,464 residents aged 18 years or older) in 2002 reported that 
16.8% of the subjects had at least one lifetime diagnosis of depressive episode, 7.1% in the 
year, and 4.5% in the month prior to interview. The instrument used was the Brazilian version 
of the Composite International Diagnostic Interview (CIDI), version 1.1, which provides 
lifetime, 12-month, and 1-month prevalence estimates for ICD-10 diagnoses (54). In our 
study, the prevalence rates found were higher than most of the figures observed in those 
previous studies conducted in Brazil. In both studies mentioned, the instruments used to 
assess depression were different from the scales applied here. Additionally, compared to 
those cities in which the other studies were conducted, the northeastern region of Brazil and 
more specifically our study site present lower socio-economic status, higher unemployment 
rates, lower level of education and worse health indicators. The above mentioned factors may 
explain the higher prevalence of depression in our study. Furthermore, longitudinal studies 
conducted elsewhere have shown that there is an increase in the prevalence of depression 
over time (51). Since the previous studies from Brazil have been conducted many years ago, 
it is also possible that an increase in the risk of depression has taken place over the recent 
years. 
 Following both the MADRS and HDRS, the prevalence of depression decreased 
significantly with higher BMI, although slight insignificant increase was observed for the 
group with obesity. Studies about the association between obesity and depression have shown 
conflicting results. Some have found a positive association, some a negative association and 
some no association at all (118). In a study conducted in Bangladesh among 1,271 subjects, 
also using the MADRS to assess depression, overweight individuals had fewer depressive 
symptoms than normal weight subjects (119). On the other hand, a study from the 
Netherlands among a sample of 43,534 individuals has found a very significant U-shaped 
association between BMI categories (underweight, normal, overweight and obesity) and 
depression (118). In our study, it is more likely that BMI and depression present a u-shaped 
association, even though our findings are far from conclusive. It is possible that if we had a 
larger sample size, we could have found a clearer picture regarding this issue. In addition, 
interestingly, in univariate analysis, depression following both scales was associated with 
higher BF%. However, in multivariate analysis, this association did not remain significant. 
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 In multivariate analysis, the significant risk indicators of depression following both 
scales were gender, smoking habits and family history of depression. The prevalence of 
depressive symptoms was higher among females compared to males, as reported in many 
other studies from Brazil and other parts of the world (52, 55, 59). In our study, following the 
MADRS and HDRS, those who were current smokers were around 2.5 and 2.0 times more 
likely to have depressive symptoms, respectively. These results are in agreement with many 
other studies, since a strong association between smoking and depression has been found 
consistently (59, 120). Furthermore, numerous studies have shown that a positive family 
history of depression is associated with an increased risk of depression, which is also in line 
with our findings (61). 
 As described before, major depressive disorder has been associated with altered 
activity of the HPA axis. This abnormality has been demonstrated by an increase in plasma, 
urine, or cerebrospinal fluid levels of cortisol or by nonsuppression of cortisol in response to 
dexamethasone (the dexamethasone suppression test) (121-123). However, in our study, we 
did not observe a significant difference with regard to fasting plasma cortisol between 
depressed and non-depressed individuals. In a study conducted in the United States, a group 
of endogenously depressed patients evaluated over 24 hours was reported to hypersecrete 
cortisol primarily in the afternoon and evening hours. These findings suggested that the mean 
cortisol levels between 1 and 4 pm were a reliable and convenient indication of cortisol 
secretion, powerfully discriminating between cortisol hypersecretors and normosecretors 
(121). In a recent meta-analysis, clinically depressed and non-depressed individuals exhibited 
similar baseline and stress cortisol levels, but depressed patients had much higher cortisol 
levels during the recovery period. There was also a significant time of day effect in which 
afternoon studies were more likely to reveal higher baseline cortisol levels, blunted stress 
reactivity, and impaired recovery in depressed patients (124). Since in our study we evaluated 
only morning cortisol levels, it is possible that we could not find any significant difference 
between depressed and non-depressed subjects due to the time of the day in which the 
analysis was performed. Additionally, it has been found that melancholic depressed patients 
present increased HPA axis activity, whereas non-melancholic depressed patients show 
normal HPA axis activity (125). Thus, we cannot rule out the possibility that, in our study 
population, the depressed group might have been primarily composed by non-melancholic 
depressed patients, without significantly increased levels of cortisol. It is also noteworthy to 
mention that, given the scarce number of population-based studies on depression in Brazil, 
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the cut-off point that most correlates with depression in the Brazilian population is unknown. 
Thus it is also likely that the cut-off points applied in our study might have not been adequate, 
masking our ability to find an association between cortisol categories and depression. 
Moreover, the analysis of plasma cortisol levels provides a measure of the total cortisol, 
unbound and bound. Thus such an assessment may be affected by factors that influence 
corticosteroid-binding globulin (CBG) levels. Other measures of cortisol levels have been 
found to present a higher sensitivity and specificity such as twenty-four-hour urinary free 
cortisol (using high-performance liquid chromatography) (126). However, since this test is 
more expensive and troublesome, we could not apply it in our study. 
 
 
4.2.3   Relationship between Diabetes and Depression 
 
 In this study, we found that depression (measured by MADRS and HDRS) was the 
second strongest indicator for the occurrence of diabetes after controlling for potential 
confounding fators. The risk for developing diabetes was about 4 times higher among 
depressed subjects. On the other hand, diabetes was the strongest independent risk indicator 
for the occurrence of depression in multivariate analysis following HDRS and the second 
strongest indicator according to MADRS. The risk for developing depression was 
approximately 3 and 3.5 times higher among individuals with diabetes following MADRS 
and HDRS, respectively. These findings are in line with other several studies conducted in 
different countries around the world (80, 83, 127, 128). 
 A recent study conducted in the United States among 1,665 elderly diabetic patients 
did not find a significant relationship between depression and hyperglycemia (129). This may 
have occurred because this study included only subjects older than 55 years of age, with pre-
existing diabetes, and used a self-report measure of depression. Furthermore, since there was 
a high drop-out rate, we cannot rule out the possibility that a greater percentage of subjects 
lost to follow-up were depressed, which might have biased the results. Besides, older age is 
known to be associated with all chronic conditions. Therefore, the apparent lack of 
association between diabetes and depression may have been diluted in this older population 
with uncertain estimates of depression. 
 As described previously, studies about the relationship between diabetes and 
depression in Brazil are scarce, and most of them have been conducted in specialized diabetic 
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centers and included a small sample size. To the best of our knowledge, only one 
representative community survey conducted in Brazil on the comorbidity of diabetes and 
depression has been published so far. This cross-sectional study, carried out in the South 
region of Brazil among individuals aged 60 years and over (n=6,963), has observed that the 
burden of comorbid depression/diabetes appears to be comparable to that found in higher 
income countries. The comorbidity was present in 3.62% (52.5% beyond expectation). 
Depression without diabetes was reported by 17.3%, while diabetes without depression by 
7.7%. Additionally, comorbid depression/diabetes was more likely in women and young 
elderly (aged 60-69 years) (87). In our study, following MADRS and HDRS, approximately 
5.0% of the subjects had both diabetes and depression, around 10.0% had depression but not 
diabetes and 11.0% diabetes without depression. Furthermore, following MADRS, the 
subjects with both diabetes and depression were also more likely to be older and women. 
Thus, our results are in accordance with the findings from the South, since we have also 
observed a significant association between diabetes and depression. However, we have found 
a higher prevalence of those with both diabetes and depression, as well as a higher rate of 
diabetes without depression. In that survey, they used self-report data to identify the subjects 
with diabetes, which might have underestimated the true prevalence of DM. Additionally, the 
important socio-economic and cultural disparities between the South and Northeast regions 
may also explain part of the differences. Moreover, in our study, we included adults above 20 
years of age, while the other survey included only individuals above 60 years. Thus, their 
higher rate of depression without diabetes (17.3% vs. 10.0%) might be in part due to the 
different age of the participants included.  
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CHAPTER 5 
 
CONCLUSIONS AND IMPLICATIONS 
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5.1   IMPLICATIONS OF THE RESULTS 
 Research has established a link between depression and diabetes, even though the 
underlying mechanisms in this relationship are still debated. This thesis explored the 
relationship between depression and diabetes and implications for future studies related to the 
practice in the areas of screening, diagnosis, and management of depression in diabetic 
patients. 
 The association between diabetes and depression is not undisputed and warrants 
cross-cultural validity of the findings. Therefore the relationship between diabetes and 
depression should be studied in different cultures and set-ups. Information on this issue is 
scarce in Brazil and therefore the data presented in the thesis may serve as a reference for 
future studies. 
 Interventions for depression may be necessary in addition to lifestyle changes in order 
to prevent the expected substantial increase in the occurrence of type 2 diabetes. Our data 
may suggest exploring the effectivity of a simultaneous approach including psychiatric 
treatment in diabetes care for improved glycemic control in this population. 
 New public health policies of more effective depression screening programs and 
optimal management of depression and diabetes may be developed, and our data may serve 
as an important reference. However before undertaking such measures, a randomized clinical 
trial will be necessary to see the effect of simultaneous treatment of diabetes and depression 
for glycaemic control compared to those treated with only diabetes.  Focused health 
promotion strategies for people with the double burden of diabetes and depression may 
reduce suffering and result in better quality of life. 
 
5.2   CONCLUSIONS AND RECOMMENDATIONS 
 We found a high prevalence of both diabetes and depression in Northeastern Brazil. 
Diabetes was a strong independent risk indicator for the occurrence of depressive symptoms. 
An inverse significant association between symptoms of depression and the risk for 
developing diabetes was also observed. Given the socio-economic and cultural disparities in 
Brazil, these results should be further tested in other regions of the country in order to be 
confirmed. The directional nature and underlying pathophysiological mechanisms of this 
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relationship are still unclear and also warrant further research. Randomized controlled trials 
are needed to determine the effects of depression treatment on glycemic control and the long 
term course of diabetes. 
 Since comorbid depression in diabetes has been associated with poorer health 
outcomes and higher health care costs, clinical awareness and treatment options targeted 
toward these comorbid conditions should be emphasized. Health professionals who treat 
people with depression and/or diabetes should pay more attention to the recognition of this 
comorbidity. 
 Our data suggest that mental health should be included in diabetes prevention 
programs. Primary care providers are often responsible for managing these conditions and are 
well positioned to provide integrated care improving patients' physical and mental health 
outcomes. All diabetic patients should be routinely screened for depression. Management of 
these concomitant conditions should use a comprehensive approach that may include 
medication or referral for psychotherapy. 
 
5.3   FULTURE RESEARCH 
- We need large scale prospective studies to identify the direction of the relationship 
between diabetes and depression. 
- Studies should be applied in different cultures and set-ups. 
- Brazil is a multicultural and multiethnic country and therefore we need to conduct 
studies in different parts of the country with identical approach. 
- Further studies are needed to confirm with a randomized clinical trial the effect of 
simultaneous treatment of diabetes and depression for glycaemic control compared to 
those treated with only diabetes. 
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Questionnaire - General Information, Socio-Demographic, Economic and Medical Data 
ID Number:        Date: 
Interviewer: 
1. Gender: ………….     
(Male = 1, Female = 2) 
2. Age: ……………….. 
3. Place of birth: …………………….. 
4. Race: …………………… 
(White = 1, Pardo (Brown) = 2, Black = 3, Yellow (i.e. East Asian) = 4, Indigenous = 
5, Other = 6) 
5. Religion: …………….                    
(Catholicism = 1, Protestantism = 2, Kardecist Spiritism = 3, Afro-Brazilian Religions 
= 4, Other Religion = 5, No Religion = 6) 
6. Marital Status: …………………….   
(Married = 1, Single = 2, Divorced / Separated = 3, Cohabitant = 4, Widow / er = 5, 
Other = 6) 
7. Level of Education: ........................... 
(Illiterate = 1, Primary School = 2, High School = 3, University or Higher = 4) 
8. Years of Education completed: ...................... 
9. Occupation:  
a. Current Status: ………………….. 
(Unemployed = 1, Part Time = 2, Full Time = 3, Retired = 4, Sick Benefit = 5) 
b. In case of being currently at work → Type of Occupation: …………….. 
(Student =1, Agriculture = 2, Industry and Services = 3, Domestic Labour = 4, 
Construction = 5, Other = 6) 
10. What is your monthly income? …………………. 
11. How many members are there in your family?  
A) > 18 years: ………….    B) <18years: ……………. 
12. Health  
a. What is your present state of health? ………….. 
(Poor = 1, Not so Good =2, Good = 3, Very Good = 4) 
b. Do you have any of these illnesses or have you suffered from them in the past? 
Are you on treatment? How long? What type of treatment? Regularly? 
 
 Has the 
Disease 
Had 
the 
Disease 
Age 
of  
Onset 
On 
Treatment 
How 
Long 
Type of 
Treatment 
Regular 
Treatment 
Diabetes Type 
1 
       
Diabetes Type 
2 
       
Heart Disease        
Hypertension        
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Stroke / TIA        
Depression        
Kidney 
Disorders 
       
Hepatic 
illnesses 
       
 
c. Are you in use of any medication for conditions not mentioned 
previously? …………… 
(Yes = 1, No = 2) 
- If Yes, which types? ………….. 
d. For females → Are you pregnant? …………….  / Have you ever received a 
diagnosis of Gestational Diabetes Mellitus? …………….. 
(Yes =1, No = 2) 
13. Family History 
a. Have your parents or any of your siblings suffered from the following illnesses? 
 Mother Age of 
Onset 
Father Age of 
Onset 
Siblings Age of  
Onset 
Yes No   Yes No   Yes No  
Type 2 Diabetes          
Heart Disease          
Hypertension          
Stroke / TIA          
Depression          
14. Smoking 
a. Smoking History: ………….. 
(Never = 0, Previous Mild = 1, Previous Heavy = 2, Current Mild = 3, Current 
Heavy = 4) 
b.  If you smoke daily at the moment, what do you smoke? 
 Yes No 
Cigarettes   
Cigars   
Other   
c. If you have smoked before, how long is it since you stopped 
smoking? ………..  
d. If you smoke now, or have smoked before: 
- How many cigarettes do you or did you usually smoke 
daily? ………… 
- How old were you when you started smoking? ………….. 
- How many years altogether have you smoked? ………….. 
15. Food and Drink 
a. How often do you usually eat the following kinds of foods? 
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 Seldom / 
Never 
1-3 
times 
pr. 
month 
 
1-3 
times 
pr. 
week 
 
4-6 
times 
pr. 
week 
 
Daily 
Fruits      
Cooked Vegetables      
Raw Vegetables / Salad      
Meat (beef, pork, chicken, etc)      
Fish       
Eggs      
Cereals (bread, noodles, biscuits, 
cookies or any food made from rice, 
maize, wheat, etc) 
     
White Tubers and Roots (white 
potatoes, cassava, or foods made 
from roots) 
     
Legumes, Nuts and Seeds (beans, 
peas, lentils, nuts, seeds, etc) 
     
Chocolates / Sweets      
b. What kind of fat do you use usually? 
 Dairy-
Butter 
Hard 
Margarine 
Soft / Light 
Margarine 
Oil Do Not 
Use 
On Bread      
For 
Cooking 
     
16. How Often? 
 Seldom / Never 1-3 times 
pr. month 
 
1-3 times 
pr. week 
 
4-6 times 
pr. week 
 
Daily 
On Bread      
For Cooking      
 
a. How much do you usually drink of the following? 
 Seldom / 
Never 
1-6 glasses 
pr. wk 
1 glass 
pr. day 
2-3 glasses 
pr. day 
4 glasses or 
more pr. day 
Full Cream Milk, 
Yoghurt 
     
Semi-Skimmed Milk, 
Light Yoghurt 
     
Skimmed Milk (sour / 
sweet) 
     
Fruit Juice      
Water      
Coca-Cola, Pepsi 
Cola or suchlike 
     
Other “fizzy” drinks / 
Thirst Quenchers 
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b. How many cups of tea or coffee do you drink daily? 
Number Cups Tea: ……….. 
Number Cups Coffee: ……….. 
-     Do you take sugar with tea or coffee? ……… 
(Yes = 1, No = 2) 
c. How often have you consumed alcohol in the course of the past year? (Low 
alcohol beer and non alcoholic beer are not included) 
 
 
 
 
 
To be filled by the Investigators 
17. Fasting Blood Sample →Date and Time………………………… 
Time of Last Meal…………….. 
18. Glucose Drink →Time: ………………………. 
19. Anthropometrics 
Height (cm): …….. Weight (Kg): ……… Hip circumference (cm): …….Waist 
circumference (cm): ……… 
20. Body Fat Percentage: ............ 
21. Blood pressure (SBP/DBP) → First measure: …………………. Second 
Measure: ……………….. 
22. Second Blood Sample →Time: ……………. 
23. HbA1c: ................... 
 
 
 
 
 
 
 
 
 
 
Never  About once 
pr. mth  
2-4 times pr. 
mth  
 
ca. 2-3 times 
 pr. wk 
ca. 4 or more 
times 
 pr. wk 
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International Physical Activity Questionnaire (IPAQ) 
 
 I am going to ask you about the time you spent being physically active in the last 7 
days. Please answer each question even if you do not consider yourself to be an active person. 
Think about the activities you do at work, as part of your house and yard work, to get from 
place to place, and in your spare time for recreation, exercise or sport. 
 Now, think about all the vigorous activities which take hard physical effort that you 
did in the last 7 days. Vigorous activities make you breathe much harder than normal and 
may include heavy lifting, digging, aerobics, or fast bicycling. Think only about those 
physical activities that you did for at least 10 minutes at a time. 
 
1. During the last 7 days, on how many days did you do vigorous physical activities? 
 _____  Days per week       
 (   ) Don't Know/Not Sure   
 (   ) Refused 
 [Interviewer clarification: Think only about those physical activities that you do for 
at least 10 minutes at a time.] 
[Interviewer note: If respondent answers zero, refuses or does not know, skip to 
Question 3] 
2. How much time did you usually spend doing vigorous physical activities on one of 
those days?  
 __ __  Hours per day  
 __ __ __ Minutes per day     
   
 (   ) Don't Know/Not Sure   
 (   ) Refused  
[Interviewer clarification: Think only about those physical activities you do for at 
least 10 minutes at a time.] 
[Interviewer probe: An average time for one of the days on which you do vigorous 
activity is being sought. If the respondent can't answer because the pattern of time 
spent varies widely from day to day, ask: "How much time in total would you spend 
over the last 7 days doing vigorous physical activities?”  
__ __  Hours per week      
 __ __ __ __Minutes per week   
 (   ) Don't Know/Not Sure   
 (   ) Refused  
    
          Now think about activities which take moderate physical effort that you did in the last 
7 days. Moderate physical activities make you breathe somewhat harder than normal and may 
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include carrying light loads, bicycling at a regular pace, or doubles tennis. Do not include 
walking. Again, think about only those physical activities that you did for at least 10 minutes 
at a time. 
 
3. During the last 7 days, on how many days did you do moderate physical activities? 
 ____ Days per week            
 (   ) Don't Know/Not Sure   
 (   ) Refused  
[Interviewer clarification: Think only about those physical activities that you do for 
at least 10 minutes at a time] 
 
[Interviewer Note: If respondent answers zero, refuses or does not know, skip to 
Question 5] 
4. How much time did you usually spend doing moderate physical activities on one of 
those days? 
 __ __ Hours per day        
 __ __ __ Minutes per day        
 (   ) Don't Know/Not Sure   
 (   ) Refused  
[Interviewer clarification: Think only about those physical activities that you do for 
at least 10 minutes at a time.] 
[Interviewer probe: An average time for one of the days on which you do moderate 
activity is being sought. If the respondent can't answer because the pattern of time 
spent varies widely from day to day, or includes time spent in multiple jobs, ask: 
“What is the total amount of time you spent over the last 7 days doing moderate 
physical activities?” 
__ __ __  Hours per week      
__ __ __ __Minutes per week    
 (   ) Don't Know/Not Sure   
 (   ) Refused  
 Now think about the time you spent walking in the last 7 days. This includes at work 
and at home, walking to travel from place to place, and any other walking that you have done 
solely for recreation, sport, exercise, or leisure. 
5. During the last 7 days, on how many days did you walk for at least 10 minutes at a 
time? 
____ Days per week       
 (   ) Don't Know/Not Sure   
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 (   ) Refused  
[Interviewer clarification: Think only about the walking that you do for at least 10 
minutes at a time.] 
[Interviewer Note: If respondent answers zero, refuses or does not know, skip to 
Question 7] 
 
 6. How much time did you usually spend walking on one of those days? 
 __ __  Hours per day         
 __ __ __  Minutes per day      
 (   ) Don't Know/Not Sure   
 (   ) Refused  
[Interviewer probe: An average time for one of the days on which you walk is being 
sought.  If the respondent can't answer because the pattern of time spent varies widely 
from day to day, ask: “What is the total amount of time you spent walking over the 
last 7 days?” 
__ __ __   Hours per week      
__ __ __ __Minutes per week    
 (   ) Don't Know/Not Sure   
 (   ) Refused  
 
           Now think about the time you spent sitting on week days during the last 7 days. 
Include time spent at work, at home, while doing course work, and during leisure time. This 
may include time spent sitting at a desk, visiting friends, reading or sitting or lying down to 
watch television. 
7. During the last 7 days, how much time did you usually spend sitting on a week day?
  
   __ __  Hours per weekday      
    __ __ __ Minutes per weekday      
 (   ) Don't Know/Not Sure   
 (   ) Refused  
                                                                                           
[Interviewer clarification: Include time spent lying down (awake) as well as 
sitting] 
[Interviewer probe: An average time per day spent sitting is being sought.  If the 
respondent can't answer because the pattern of time spent varies widely from day to 
day, ask: “What is the total amount of time you spent sitting last Wednesday?” 
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__ __  Hours on Wednesday      
__ __ __   Minutes on Wednesday   
 (   ) Don't Know/Not Sure   
 (   ) Refused  
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Montgomery-Åsberg Depression Rating Scale (MADRS) 
 
1. APPARENT SADNESS - Representing despondency, gloom and despair (more than just 
ordinary transient low spirits), reflected in speech, facial expression, and posture. Rate by 
depth and inability to brighten up. 
0 = No sadness. 
1 
2 = Looks dispirited but does brighten up without difficulty. 
3 
4 = Appears sad and unhappy most of the time. 
5 
6 = Looks miserable all the time. Extremely despondent. 
 
2. REPORTED SADNESS - Representing reports of depressed mood, regardless of whether 
it is reflected in appearance or not. Includes low spirits, despondency or the feeling of being 
beyond help and without hope. Rate according to intensity, duration and the extent to which 
the mood is reported to be influenced by events. 
0 = Occasional sadness in keeping with the circumstances. 
1 
2 = Sad or low but brightens up without difficulty. 
3 
4 = Pervasive feelings of sadness or gloominess. The mood is still influenced by external 
circumstances. 
5 
6 = Continuous or unvarying sadness, misery or despondency. 
 
3. INNER TENSION - Representing feelings of ill-defined discomfort, edginess, inner 
turmoil, mental tension mounting to either panic, dread or anguish. Rate according to 
intensity, frequency, duration and the extent of reassurance called for. 
0 = Placid. Only fleeting inner tension. 
1 
2 = Occasional feelings of edginess and ill-defined discomfort. 
3 
4 = Continuous feelings of inner tension or intermittent panic which the patient can only 
master with some difficulty. 
5 
6 = Unrelenting dread or anguish. Overwhelming panic. 
 
4. REDUCED SLEEP - Representing the experience of reduced duration or depth of sleep 
compared to the subject's own normal pattern when well. 
0 = Sleeps as usual.  
1 
2 = Slight difficulty dropping off to sleep or slightly reduced, light or fitful sleep. 
3 
4 = Sleep reduced or broken by at least two hours. 
5 
6 = Less than two or three hours sleep. 
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5. REDUCED APPETITE - Representing the feeling of a loss of appetite compared with 
when well. Rate by loss of desire for food or the need to force oneself to eat. 
0 = Normal or increased appetite. 
1 
2 = Slightly reduced appetite. 
3 
4 = No appetite. Food is tasteless. 
5 
6 = Needs persuasion to eat at all. 
 
6. CONCENTRATION DIFFICULTIES - Representing difficulties in collecting one's 
thoughts mounting to incapacitating lack of concentration. Rate according to intensity, 
frequency, and degree of incapacity produced. 
0 = No difficulties in concentrating. 
1 
2 = Occasional difficulties in collecting one's thoughts. 
3 
4 = Difficulties in concentrating and sustaining thought which reduces ability to read or hold 
a conversation. 
5 
6 = Unable to read or converse without great difficulty. 
 
7. LASSITUDE - Representing difficulty in getting started or slowness in initiating and 
performing everyday activities. 
0 = Hardly any difficulties in getting started. No sluggishness. 
1 
2 = Difficulties in starting activities. 
3 
4 = Difficulties in starting simple routine activities, which are carried out with effort. 
5 
6 = Complete lassitude. Unable to do anything without help. 
8. INABILITY TO FEEL - Representing the subjective experience of reduced interest in the 
surroundings, or activities that normally give pleasure. The ability to react with adequate 
emotion to circumstances or people is reduced. 
0 = Normal interest in the surroundings and in other people. 
1 
2 = Reduced ability to enjoy usual interests. 
3 
4 = Loss of interest in the surroundings. Loss of feelings for friends and acquaintances. 
5 
6 = The experience of being emotionally paralyzed, inability to feel anger, grief or pleasure 
and a complete or even painful failure to feel for close relatives and friends. 
 
9. PESSIMISTIC THOUGHTS - Representing thoughts of guilt, inferiority, self-reproach, 
sinfulness, remorse and ruin. 
0 = No pessimistic thoughts. 
1 
2 = Fluctuating ideas of failure, self-reproach or self- depreciation. 
3 
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4 = Persistent self-accusations, or definite but still rational ideas of guilt or sin. Increasingly 
pessimistic about the future. 
5 
6 = Delusions of ruin, remorse and unredeemable sin. Self- accusations which are absurd and 
unshakable. 
 
10. SUICIDAL THOUGHTS - Representing the feeling that life is not worth living, that a 
natural death would be welcome, suicidal thoughts, and preparations for suicide. Suicidal 
attempts should not in themselves influence the rating. 
0 = Enjoys life or takes it as it comes. 
1 
2 = Weary of life. Only fleeting suicidal thoughts. 
3 
4 = Probably better off dead. Suicidal thoughts are common, and suicide is considered as a 
possible solution, but without specific plans or intention. 
5 
6 = Explicit plans for suicide when there is an opportunity. Active preparations for suicide. 
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Hamilton Depression Rating Scale (HDRS) 
 
1. DEPRESSED MOOD (sadness, hopeless, helpless, worthless) 
0 = Absent. 
1 = These feeling states indicated only on questioning. 
2 = These feeling states spontaneously reported verbally. 
3 = Communicates feeling states non-verbally, i.e. through facial expression, posture, voice 
and tendency to weep. 
4 = Patient reports virtually only these feeling states in his/her spontaneous verbal and non-
verbal communication. 
 
2. FEELINGS OF GUILT 
0 = Absent. 
1 = Self reproach, feels he/she has let people down. 
2 = Ideas of guilt or rumination over past errors or sinful deeds. 
3 = Present illness is a punishment. Delusions of guilt. 
4 = Hears accusatory or denunciatory voices and/or experiences threatening visual 
hallucinations. 
3. SUICIDE 
0 = Absent. 
1 = Feels life is not worth living. 
2 = Wishes he/she were dead or any thoughts of possible death to self. 
3 = Ideas or gestures of suicide. 
4 = Attempts at suicide (any serious attempt rates 4). 
 
4. INSOMNIA: EARLY IN THE NIGHT 
0 = No difficulty falling asleep. 
1 = Complains of occasional difficulty falling asleep, i.e. more than 1⁄2 hour. 
2 = Complains of nightly difficulty falling asleep. 
 
5. INSOMNIA: MIDDLE OF THE NIGHT 
0 = No difficulty. 
1 = Patient complains of being restless and disturbed during the night. 
2 = Waking during the night – any getting out of bed rates 2 (except for purposes of voiding). 
 
6. INSOMNIA: EARLY HOURS OF THE MORNING 
0 = No difficulty. 
1 = Waking in early hours of the morning but goes back to sleep. 
2 = Unable to fall asleep again if he/she gets out of bed. 
 
7. WORK AND ACTIVITIES 
0 = No difficulty. 
1 = Thoughts and feelings of incapacity, fatigue or weakness related to activities, work or 
hobbies. 
2 = Loss of interest in activity, hobbies or work – either directly reported by the patient or 
indirect in listlessness, indecision and vacillation (feels he/she has to push self to work or 
activities). 
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3 = Decrease in actual time spent in activities or decrease in productivity. Rate 3 if the patient 
does not spend at least three hours a day in activities (job or hobbies) excluding routine 
chores. 
4 = Stopped working because of present illness. Rate 4 if patient engages in no activities 
except routine chores, or if patient fails to perform routine chores unassisted. 
 
8. RETARDATION (slowness of thought and speech; impaired ability to concentrate; 
decreased motor activity) 
0 = Normal speech and thought. 
1 = Slight retardation during the interview. 
2 = Obvious retardation during the interview. 
3 = Interview difficult. 
4 = Complete stupor. 
 
9. AGITATION 
0 = None. 
1 = Fidgetiness. 
2 = Playing with hands, hair, etc. 
3 = Moving about, can’t sit still. 
4 = Hand wringing, nail biting, hair-pulling, biting of lips. 
 
10. ANXIETY PSYCHIC 
0 = No difficulty. 
1 = Subjective tension and irritability. 
2 = Worrying about minor matters. 
3 = Apprehensive attitude apparent in face or speech. 
4 = Fears expressed without questioning. 
11. ANXIETY SOMATIC (physiological concomitants of anxiety, such as: - Gastro-
intestinal: dry mouth, wind, indigestion, diarrhea, cramps, belching. - Cardio-vascular: 
palpitations, headaches. – Respiratory: hyperventilation, sighing. - Urinary Frequency – 
Sweating) 
0 = Absent. 
1 = Mild. 
2 = Moderate. 
3 = Severe. 
4 = Incapacitating. 
 
12. SOMATIC SYMPTOMS GASTRO-INTESTINAL 
0 = None. 
1 = Loss of appetite but eating without staff encouragement. Heavy feelings in abdomen. 
2 = Difficulty eating without staff urging. Requests or requires laxatives or medication for 
bowels or medication for gastro-intestinal symptoms. 
 
13. GENERAL SOMATIC SYMPTOMS 
0 = None. 
1 = Heaviness in limbs, back or head. Backaches, headaches, muscle aches. Loss of energy 
and fatigability. 
2 = Any clear-cut symptom rates 2. 
14. GENITAL SYMPTOMS (symptoms such as: loss of libido, menstrual disturbances) 
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0 = Absent. 
1 = Mild. 
2 = Severe. 
 
15. HYPOCHONDRIASIS 
0 = Not present. 
1 = Self-absorption (bodily). 
2 = Preoccupation with health. 
3 = Frequent complaints, requests for help, etc. 
4 = Hypochondriacal delusions. 
 
16. LOSS OF WEIGHT (Rate either A or B) 
A) According to the patient: 
0 = No weight loss.  
1 = Probable weight loss associated with present illness. 
2 = Definite (according to patient) weight loss. 
 
OR  
 
B) According to weekly measurements: 
0 = Less than 1 lb (500 g), weight loss in week. 
1 = Greater than 1lb (500 g), weight loss in week. 
2 = Greater than 2 lb (1000 g), weight loss in week. 
 
17. INSIGHT 
0 = Acknowledges being depressed and ill. 
1 = Acknowledges illness but attributes cause to bad food, climate, overwork, virus, need for 
rest, etc. 
2 = Denies being ill at all. 
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